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ABSTRACT 
A Systems Biology approach for the characterization of metabolic bottlenecks in 
recombinant protein production processes 
 
The main purpose of this thesis is to investigate the influence of recombinant protein production 
in the reorganization of the metabolic activities and the resulting stress-induced responses in the 
bacterium Escherichia coli. More specifically, the focus is on the RelA-mediated stringent 
response, a stress response that is triggered by the sudden lack of intracellular amino acids and 
that has been associated with the metabolic burden imposed by recombinant processes. 
To identify the main metabolic bottlenecks in recombinant biosynthetic processes, which include 
maintenance of recombinant DNA and expression of heterologous genes, a systematic modelling 
approach is proposed, capable of predicting the amino acid shortages caused by recombinant 
processes and the consequent activation of the RelA-dependent guanosine pentaphosphate 
(ppGpp) synthesis.  
The view of ppGpp as a primarily regulator of gene transcription has been expanded and it is now 
clear that the response controlled by ppGpp is crucial for cell survival during the adaptation to 
stressful conditions. Major advances have been achieved to understand this regulatory system 
governing gene expression in response to environmental growth perturbations, but so far mainly 
transcriptome and proteome analyses that have been applied to elucidate the stringent control 
mediated by ppGpp. Metabolomics analysis can provide substantial information on the impact of 
this stress response at the biochemical level, in particular during recombinant bioprocesses. 
Therefore, two metabolomics-based approaches were applied: metabolic profiling to evaluate the 
intracellular metabolic profiles and metabolic footprinting to estimate the profiles of extracellular 
metabolites.  
In these metabolomics studies two E. coli strains (E. coli W3110 and the isogenic ∆relA mutant) 
were used to investigate the influence of recombinant processes on the host cells’ metabolism, 
as well as the main metabolic activities affected by the RelA activity under different growth 
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conditions. The mutant strain presented a “relaxed” phenotype that characterized this bacterial 
system by an acute delay in most metabolic adaptations to transient growth conditions. Most 
importantly, it was shown that these mutant cells lack metabolic adjustments that are often 
observed after metabolic burden phenomena. Nevertheless, this cellular system presented major 
advantages in terms of biomass yield and productivity, which imply a remarkable improvement in 
recombinant bioprocesses. Thus, alleviating stress responses can be beneficial if they impair the 
desired quality and quantity of the recombinant product. However, it must be pointed out that 
this may be an alternative as long as recombinant bioprocesses are designed to achieve a finer 
balance between strain improvement strategies and culturing conditions. 
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RESUMO 
Caracterização das limitações metabólicas durante a produção de proteína 
recombinante usando abordagens da Biologia de Sistemas  
 
O trabalho realizado no âmbito desta tese teve como principal finalidade a avaliação das 
alterações metabólicas relacionadas com a produção de proteínas recombinantes em células 
bacterianas de Escherichia coli e a consequente activação de respostas de stress. Foi 
evidenciada a resposta restringente promovida pela actividade da enzima RelA, dado ser uma 
das principais respostas de stress induzidas pelo decréscimo da quantidade de aminoácidos 
disponíveis no meio intracelular como consequência da expressão de proteínas recombinantes. 
As diferenças na composição em aminoácidos entre as proteínas da biomassa e recombinantes, 
têm sido apontadas como principais causas para o desequilíbrio metabólico que conduz à 
exaustão de alguns metabolitos, nomeadamente de aminoácidos. 
De modo a explorar estes fenómenos e avaliar o impacto dos processos recombinantes no 
metabolismo das células hospedeiras, foi proposto um modelo matemático capaz de identificar 
pontos de estrangulamento na rede metabólica. Estes locais correspondem a vias metabólicas 
que apresentam limitações na capacidade catalítica e que serão essenciais para compensar o 
consumo desproporcionado de aminoácidos levado a cabo pela síntese de proteínas 
recombinantes. Associado a este fenómeno foi considerada a descrição da síntese de 
nucleótidos guanosina pentafosfato (ppGpp) induzida pela escassez de aminoácidos no meio 
intracelular.  
O reconhecimento deste nucleótido como um regulador fundamental na transcrição da 
informação genética tem sido amplamente descrito e tornou-se evidente que as respostas 
celulares controladas pelo ppGpp são determinantes para a sobrevivência e adaptação dos 
organismos a condições adversas. Neste sentido, vários estudos foram elaborados para elucidar 
o papel do ppGpp no controlo destas respostas de stress e nas alterações fisiológicas que advêm 
destes processos, nomeadamente ao nível do metabolismo. A análise do metaboloma, em 
comparação com o transcriptoma ou o proteoma, é capaz de capturar de forma mais directa a 
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relação entre as actividades metabólicas e a fisiologia dos organismos, designadamente em 
sistema recombinantes.  
Neste trabalho foram elaborados alguns estudos em que se aplicaram duas abordagens de 
análise metabolómica distintas: profiling metabólico, que se refere à análise do perfil de 
metabolitos intracelulares; e footprinting metabólico, que se refere à análise do perfil de 
metabolitos extracelulares. Nestes estudos foram usadas duas estirpes de E. coli (W3110 e a 
estirpe isogénica com mutação no gene relA) clonadas com um vector de expressão pTRC-His-
AcGP1 que codifica a proteína verde fluorescente AcGFP1, derivada da proteína AcGFP da 
Aequorea coerulescens. Foram avaliadas as principais alterações metabólicas provocadas pela 
indução da produção de proteína recombinante e pela actividade catalítica da enzima RelA em 
diversas condições de crescimento. Comparando os perfis metabólicos das duas estirpes, foram 
estimadas várias diferenças significativas que se podem revelar críticas durante processos 
recombinantes. A estirpe mutante revelou um comportamento típico de um fenótipo “relaxado”, 
que é caracterizado por um retardamento significativo na adaptação do metabolismo a 
alterações nas condições de crescimento. Não obstante, a estirpe mutante exibiu melhores 
resultados em termos de rendimento em biomassa e produtividade, o que representa uma 
vantagem notável para a aplicação destes sistemas bacterianos recombinantes ao nível 
industrial. Em resumo, a restrição de respostas de stress pode trazer benefícios se a qualidade e 
quantidade do produto estiverem em causa, mas deve salientar-se que não é uma solução 
absoluta, sendo que as condições de processamento devem ser também levadas em 
consideração na implementação destes bioprocessos. 
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OUTLINE OF THE THESIS 
The key contributions of this thesis are to the elucidation of the impact of the stringent response 
in the E. coli metabolism during recombinant bioprocesses and, in broader terms, to the 
importance of metabolomics-driven approaches to understand the metabolic behaviour of these 
recombinant cells.  
To assist the study of the stringent response phenomenon in E. coli cells, a literature mining 
exercise was first developed to compile, process, and analyse information that has been reported 
in the last four decades. Fundamental details on the mechanisms underlying the activation of this 
stress response and the pleiotropic effects of the ppGpp on cellular processes are given in 
Chapter 2. 
In Chapter 3, a modelling approach is proposed to describe the effects of recombinant protein 
production in the host cells’ metabolism and the consequent induction of the activity of RelA, a 
ribosome-bounded enzyme that synthesizes the key regulator of the stringent response, ppGpp. 
This approach combines a genome-scale model for the E. coli metabolism and kinetic 
descriptions for biomass, recombinant protein and ppGpp formation, as well as plasmid 
maintenance. 
To investigate how the inactivation of the relA gene is associated with changes in E. coli 
metabolism, metabolomics techniques were used In Chapter 4, E. coli W3110 and the isogenic 
mutant ∆relA strains were grown under steady-state conditions at different dilution rates. The 
intracellular metabolite levels of amino and non-amino organic acids were measured by GC/MS 
and metabolite profiles were evaluated to discriminate between metabolic states of E. coli cells. 
In Chapter 5, the ∆relA mutant strain, cloned with the vector pTRC-His-AcGFP1, was used to 
assess the impact of recombinant processes on the E. coli metabolism, which includes plasmid 
maintenance and protein formation. Because the stringent factor RelA is expected to impair the 
production of recombinant proteins, this work aimed at understanding if the deletion of the relA 
gene might be a potential strategy to enhance the performance of recombinant cells. 
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An alternative metabolomics approach was applied to inspect the metabolic behaviour of E. coli 
cells during the production of recombinant proteins. Chapter 6 presents the implementation of a 
metabolic footprinting approach to measure the extracellular metabolite levels during 
recombinant E. coli fed-batch cultures, the common industrial mode of operation of these 
processes. The physiological and metabolic changes associated to the induction of protein 
expression and nutritional shifts during the fed-batch process were inspected. 
In Chapter 7, conclusions and final remarks are devised.  
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OBJECTIVES OF THE THESIS 
Systems engineering strategies to enhance the productivity of recombinant proteins are still 
reliant on the E. coli cellular capabilities to cope with stressful conditions elicited by recombinant 
processes. To gain fundamental insight into the molecular mechanisms governing these events, 
particularly the stringent response, and to use this information to identify strategies for 
minimizing the impact of this phenomenon, the following objectives were considered in this 
thesis: 
• To present a comprehensive analysis of the literature on the E. coli stringent response, 
where key players and molecular mechanisms involved in this response are detailed; 
• To uncover new molecular players, which functional roles have not been directly 
associated with the E. coli stringent response in previous studies, but are relevant entities 
or participate in cellular processes closely related with this stress response; 
• To systematically analyse and characterize the stimulus of the stringent response during 
recombinant processes, as a consequence of the amino acids deprivation caused by the 
additional drainage of biosynthetic precursors for the production of recombinant proteins; 
• To identify key metabolic bottlenecks in the E. coli metabolism during recombinant 
processes, which indicate network points at which metabolic fluxes are to a certain extent 
restricted due to the unbalanced withdrawn of biosynthetic precursors; 
• To assess the ability of metabolomics approaches, in particular metabolic profiling and 
metabolic footprinting, to discriminate between cells in different metabolic states, as well 
as with different genetic backgrounds (e.g. E. coli W3110 and the isogenic mutant 
∆relA).  
• To characterize the RelA-mediated stringent response by comparing the metabolic 
behaviour of an E. coli W3110 strain with its isogenic mutant (∆relA); 
• To evaluate the impact of recombinant processes, including plasmid maintenance and 
expression of a recombinant protein (AcGFP1, a green fluorescent protein derived from 
xx Objectives of the thesis 
 
A Systems Biology approach for the characterization of metabolic bottlenecks in recombinant protein production processes 
Universidade do Minho, 2010 
Aequorea coerulescens), in the metabolism of E. coli cells, and evaluate the effect of the 
relA mutation in this response; 
• To verify if E. coli ∆relA mutant strains can enhance the productivity of recombinant 
proteins, since the relA gene mutation would limit the ppGpp-induced stringent response 
during recombinant processes;  
• To determine the metabolic differences when recombinant bioprocesses are performed 
at different growth rates. 
 
CHAPTER 1 
GENERAL INTRODUCTION 
 
“...a new understanding of life emerged at the forefront of science.”  
Fritjof Capra in Complexity and Life,  
Theory Culture Society 2005; 22; 33 
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2 General Introduction 
 
1.1 ABSTRACT 
This chapter aims to introduce the main aspects involving the application 
of system-level approaches in the understanding of cellular processes 
during recombinant bioprocesses. The successful use of genetically 
engineered bacteria, like Escherichia coli, to overexpress recombinant 
proteins and the main problems associated with these bioprocesses, in 
particular the metabolic burden and physiological stress responses, with 
major focus on the stringent response, are reviewed. To fully characterize 
the impact of recombinant processes in the metabolism of E. coli and the 
consequent induction of the stringent response, modelling approaches are 
suggested. Finally, metabolomics approaches are introduced as relevant 
tools for studying recombinant E. coli bioprocesses. The main procedures 
to perform metabolome analysis are viewed in detail, as well as the last 
developments in bioinformatics tools for storing, analysing and 
interpreting metabolome data. Several examples are provided to illustrate 
the strengths and still existing limitations of this analytical approach. 
Topics on the main questions studied throughout this thesis are referred 
in the end of this chapter. 
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1.2 E. COLI: A MICROBIAL SYSTEM FOR RECOMBINANT 
PROTEIN EXPRESSION 
In the last decades, microbial cells have been exploited for the production of a variety of 
products. Recombinant DNA technologies, developed in the late 70's, offered a very powerful tool 
for the economical and large-scale production of recombinant proteins. These products are 
diverse and find their main applications in industries such as pharmaceutical, food, health care 
and environment. For instance, the human insulin was the first recombinant protein approved by 
the Food and Drug Administration (FDA) to enter in the market and is produced in the bacterium 
E. coli. Since then, many other recombinant proteins with industrial interest have been produced 
in several microbial systems such as bacteria, being E. coli the most common system, or yeasts, 
such as Saccharomyces cerevisiae and Pichia pastoris. In Figure 1.1 some of the therapeutic 
products that have been produced in recombinant E. coli systems within the last years are 
summarized.  
 
Figure 1.1. Biopharmaceutical products approved by the European Union that are 
synthesised via recombinant E. coli systems (Ferrer-Miralles N et al., 2009). 
4 General Introduction 
 
E. coli is by far the first choice for the production of recombinant proteins, and has been quite 
important in the development of certain molecular procedures, such as cloning, genetic 
modification and also for the small-scale production for research purposes. Besides its ability to 
grow rapidly and achieve high cellular densities on inexpensive substrates, it is one of the best 
characterized biological systems. However, several obstacles to the production of high quality 
proteins limit its application as a microbial factory. Post-translational modifications are often 
limited in E. coli systems and only recombinant proteins that are naturally non-glycosylated or are 
also active without glycosylation can be expressed with this microbial system (Demain AL and 
Vaishnav P, 2009; Ferrer-Miralles N et al., 2009; Schmidt FR, 2004). Moreover, the frequency of 
codons occurring in eukaryotic genes is different from that appearing in E. coli genes, which 
basically determines the low abundance of specific tRNAs, often leading to the premature 
termination of protein synthesis or to amino acid mis-incorporation, reducing the efficiency of 
protein expression (Gustafsson C et al., 2004; Kane JF, 1995).  
Yet, recent progress in the fundamental understanding of cellular processes in E. coli, together 
with the availability of improved expression vector systems, is making this bacterium more 
adequate for the expression of complex eukaryotic proteins. Several strategies to enhance 
recombinant protein production have become available: (i) reduction of plasmid copy number 
(Jones KL et al., 2000); (ii) use of different promoters to regulate expression (Peti W and Page R, 
2007); (iii) secretion of proteins into the periplasmic space or into the medium (Mergulhao FJ et 
al., 2005); (iv) changing the growth medium (Sahdev S et al., 2008); (v) lowering of temperature 
(Sahdev S et al., 2008); (vi) chromosomal insertion of the foreign genes (Srinivasan S et al., 
2003); and (vii) coexpression/knockout of certain key genes (Kim SY et al., 2009; Wong MS et 
al., 2008). This last approach is probably one of the most effective ones and is related with the 
metabolic engineering field. Stephanopoulos and co-authors (Stephanopoulos G et al., 1998) 
defined it as “the directed improvement of product formation or cellular properties through the 
modification of specific biochemical reactions or introduction of new ones with the use of 
recombinant DNA technology”. The metabolic engineering field proposes the directed 
modification of the genetic background of organisms to implement desirable metabolic 
capabilities in living cells. For example, Flores and co-workers (Flores S et al., 2004) developed a 
strategy to overcome the reduction of growth rate due to foreign protein expression, by modifying 
the pentose phosphate (PP) pathway. By increasing the carbon flux through the oxidative branch 
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of the PP pathway, it was possible to partially recover growth capacities of the recombinant E. 
coli cells. 
These approaches have resulted in some high-quality results by identifying some metabolic 
activities that could be manipulated to improve cell physiology during recombinant protein 
production, though other cellular phenomena capable to hinder recombinant bioprocesses are 
still unresolved. For example, the metabolic burden is associated with cellular processes related 
to plasmid DNA replication, plasmid-encoded mRNA transcription and the corresponding 
recombinant protein synthesis. These processes require the additional drain of biosynthetic 
precursors, energy and other cellular resources that are shared with the analogous host 
metabolic processes. The competition for a limited pool of cellular resources, like 
deoxyribonucleotides (dATP, dGTP, TTP, dCTP), ribonucleotides (ATP, GTP, UTP, CTP), amino 
acids and high-energy molecules, like NADH and NADPH, provokes serious perturbations in the 
cellular metabolism (Glick BR, 1995). Typically, in recombinant cultures this promotes the 
reduction of the cellular growth rate and final biomass yields. As metabolic precursors and high-
energy molecules are being consumed in the recombinant process, the host metabolic processes 
engaged in the cellular growth are severely burdened, unbalancing the host metabolism.  
Moreover, as many amino acid precursors are drained from the TCA cycle, the fluxes over this 
pathway are lowered and the carbon flux through glycolysis exceeds the capacity of the TCA cycle 
to assimilate the surplus of acetyl-CoA, which is directed to the production of acetate (Majewski 
RA and Domach MM, 1990). The accumulation of toxic levels of acetate is undesirable, mostly 
because it represents a diversion of carbon that might otherwise have generated biomass or the 
recombinant product and it ends by retarding cellular growth (Luli GW and Strohl WR, 1990; 
Ponce E, 1999; Suarez DC and Kilikian BV, 2000; Turner C et al., 1994) and inhibiting protein 
formation (Shiloach J et al., 1996; Suarez DC and Kilikian BV, 2000; Turner C et al., 1994). Also, 
since most cellular processes are closely regulated by growth rate conditions, a decrease in the 
biomass formation indicates reduced amounts of components for the protein producing system, 
including ribosomal proteins or translation elongation factors, and of most catabolic enzyme 
levels. Thereby, the translational activity and the supply for most anabolic precursors become 
limiting factors as the recombinant protein synthesis rate increases.  
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Additionally, it has been shown that during the expression of recombinant proteins in E. coli, a 
variety of cellular responses can be elicited (Duerrschmid K et al., 2008; Seo JH et al., 2003): 
heat-shock-like responses, due to the accumulation of misfolded proteins (Allen SP et al., 1992; 
Thomas JG and Baneyx F, 1996); SOS responses if cells are exposed to agents that cause 
damage to DNA or interfere with DNA replication (Gill RT et al., 2000); and starvation responses 
caused by the excessive drainage of metabolic precursors and energy (Bonomo J and Gill RT, 
2005; Sanden AM et al., 2003). It has been reported (Dedhia N et al., 1997; Sanden AM et al., 
2003) that the expression of recombinant proteins may lead to an increase in intracellular 
concentration of guanosine tetraphosphate or ppGpp, which was first identified as a key regulator 
involved in the cellular response to amino acid starvation, the so-called stringent response 
(Cochran JW and Byrne RW, 1974; Haseltin WA and Block R, 1973; Magnusson LU et al., 2005; 
Stephens JC et al., 1975) (detailed in the next subsection and Chapter 2). Lately, this molecule 
was also associated with other nutrient starvation responses (Lin HY et al., 2004; Traxler MF et 
al., 2006). For example, the E. coli response to glucose starvation was linked to the induction of 
both the stringent and the general stress responses (Schweder T et al., 2002). The concentration 
of the corresponding regulators, i.e. ppGpp and the alternative RpoS sigma factor (also called σS) 
were shown to be tightly regulated by the cell in situations when a nutrient shift occurs. Indeed, 
many stress responsive genes that are regulated by the σS have been observed to be expressed 
during recombinant protein production (Duerrschmid K et al., 2008), namely dnaK and ibpA that 
encode proteins involved in the heat shock like response (Han MJ et al., 2004; Jurgen B et al., 
2000). Such typical stress response is commonly elicited to prevent the aggregation of unfolded 
proteins into inclusion bodies and has been explored to improve the productivity of specific 
recombinant systems (Endo S et al., 2006; Kohda J et al., 2002; Kwon MJ et al., 2002; 
Yokoyama K et al., 1998).  
In general, different stresses might be elicited simultaneously, working together as a complex 
regulatory system with a multitude of molecular components to ensure a coordinated and an 
effective answer. For example, it has been shown (Gill RT et al., 2000), by monitoring 
transcriptome and proteome profiles, that the production of recombinant proteins induces the 
expression of genes belonging to the heat-shock (e.g. dnaK and ibpA), SOS (e.g. recA), and 
starvation response regulons (e.g. rpoS), albeit to different levels and with different time profiles. 
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Thus, the interplay of several stress proteins may be critical to protect bacterial cells when 
exposed to environmental insults. As suggested in Chapter 2, some of the biological entities 
involved in the stringent response may as well participate in other stress responses. Proteins that 
are involved in responses to starvation, DNA damage, osmotic, oxidative or SOS stresses were 
highlighted in the bibliome analysis of the E. coli stringent response, which suggests that ppGpp 
might be involved in many cellular responses, other than the stringent response. Indeed, some 
links between the stringent response and others stress responses were evidenced. For example, 
the response to DNA damage stimulus was assigned by the RecA, RecG and Mfd proteins that 
intervene in the early dissociation of the elongation complex stalled by ppGpp (Trautinger BW et 
al., 2005) and the RecA regulator and the UvrABC nucleotide excision repair complex have been 
implicated in the DNA repair process and SOS response (Bichara M et al., 2007). 
 
1.2.1 STRINGENT RESPONSE 
From such a variety of stress responses, stringent response has been perhaps the less studied in 
recombinant systems. Currently, the regulatory mechanisms of the ppGpp activity during 
recombinant processes and the impact of this stress response in the metabolism are not entirely 
clear. It is acknowledged that under conditions of stress, cells accumulate high levels of ppGpp 
initiating a global change in the cellular physiology. However, most studies (Durfee T et al., 2008; 
Haddadin FT et al., 2009; Haddadin FT and Harcum SW, 2005) have just uncovered the main 
changes observed at the proteome or transcriptome levels. To investigate this cellular response 
at the metabolic level (i.e. the closest indicator of the physiological state of cells), the basis of the 
ppGpp mechanisms are first reviewed. 
The discovery that this unusual guanosine nucleotide is accumulated in response to starvation 
was followed by extensive studies on the downstream regulatory circuits of the stringent 
response, which suggested that the accumulation of ppGpp is an important link between 
nutritional stress and bacterial adaptation. It was first proposed by (Haseltin WA and Block R, 
1973) that the ratio of aminoacylated tRNA to free tRNA is one of the critical parameters that 
regulate the synthesis of ppGpp. When free tRNA is encountered at the A-site of the 50S 
ribosome, protein synthesis is delayed, resulting in an idling reaction in which ribosome-bound 
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RelA is activated to synthesize ppGpp (initially pppGpp is produced and is then converted to 
ppGpp). Thus, an increase in the population of free tRNA during starvation leads to an 
accumulation of ppGpp (Chatterji D and Ojha AK, 2001) (Figure 1.2). Since the induction of 
recombinant proteins can cause the exhaustion of the intracellular amino acid pools resulting in a 
change in the aminoacylated-tRNA to uncharged tRNA ratio, the accumulation of ppGpp is 
presumably associated with the induction of the classical stringent response. 
Less is known about the mechanism behind SpoT-dependent production of ppGpp and how SpoT 
senses starvation conditions. Nevertheless, it appears that SpoT is primarily responsible for the 
accumulation of ppGpp in response to most stresses and nutrient limitations apart from amino 
acid starvation (Murray KD and Bremer H, 1996; Vinella D et al., 2005). In addition, SpoT 
exhibits dual functions and is also responsible for hydrolyzing ppGpp. A strain lacking both RelA 
and SpoT is completely unable to produce ppGpp and the response to starvation of such a strain 
is called the relaxed response (Xiao H et al., 1991).  
One of the first effects of high-level intracellular ppGpp to be discovered was a sudden decrease 
in the transcriptional rate of ribosomal RNA (Baracchini E and Bremer H, 1988). Direct negative 
effects of ppGpp on promoters have been detected in vitro (Barker MM et al., 2001b; Jores L and 
Wagner R, 2003; Kajitani M and Ishihama A, 1984; Raghavan A and Chatterji D, 1998) and 
several mechanisms for direct negative regulation by ppGpp have been suggested (Barker MM et 
al., 2001b; Barker MM et al., 2001a; Gralla JD, 2005; Jores L and Wagner R, 2003; Roberts JW, 
2009; Srivatsan A and Wang JD, 2008). One of the effects of ppGpp appears to be a 
destabilization of the RNAP–promoter open complex. The rRNA promoters form intrinsically 
unstable open complexes with RNAP and are therefore thought to be specifically sensitive to 
further destabilization (Magnusson LU et al., 2005; Oshima T et al., 2002; Paul BJ et al., 
2004b). It has recently been shown that the negative effects of ppGpp on transcription in vitro 
are amplified by the presence of the protein DksA. DksA binds to RNAP by protruding into the 
secondary channel of RNAP (Perederina A et al., 2004) and decreases open complex stability, 
which accentuates the negative effects of ppGpp on rRNA promoters. DksA has also been 
suggested to contribute to the positive effects of ppGpp (Paul BJ et al., 2004a). 
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Figure 1.2. The (p)ppGpp-mediated stringent response (Figure 2.1 in Chapter 2).  
(A) Low amino-acid concentrations lead to decreased charging of the corresponding tRNAs. (B) The translational 
machinery depends on the translocation along the mRNA whereby a new acetylated-tRNA is positioned in the 
ribosome. Whenever an uncharged tRNA binds to the ribosome, the elongation of the polypeptide chain is stalled. (C) 
The stringent factor RelA is then activated in the presence of the ribosomal protein L11, catalyzing the synthesis of 
(p)ppGpp nucleotides. (D) These nucleotides bind directly to the RNA polymerase and affect the binding abilities of 
sigma factors to the core RNA polymerase. (E) The co-factor DksA also binds to the RNA polymerase and augments 
the (p)ppGpp regulation of the transcription initiation at certain σ70-dependent promoters, functioning both as 
negative and positive regulators. (F) These regulators change the gene expression: (i) decreasing the transcription 
activity of genes involved in the translational activity; (ii) and increasing the transcription of stress-related operons 
and genes encoding for enzymes needed for the synthesis and the transport of amino acids.   
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Among the positively regulated promoters are many that are dependent on alternative sigma 
factors (e.g. σS and σ54) (Brown L et al., 2002) and also those that are dependent on the 
housekeeping sigma factor, σ70 (e.g. promoters controlling genes encoding the universal stress 
proteins (Kvint K et al., 2003) and proteins involved in amino acid biosynthesis and uptake). In 
general, σ70-dependent genes involved in cell proliferation and growth are negatively regulated by 
ppGpp, whereas the σ70-dependent genes implicated in maintenance and stress defence are 
positively regulated by the alarmone (Nystrom T, 2004). Other models suggest that ppGpp acts 
through changes in the availability of RNAP, rather than decreasing the open complex stability. 
An increased availability of free RNAP during growth arrest has been suggested to be a 
consequence of RNAP falling off stable RNA promoters as a result of decreased open complex 
stability (Barker MM et al., 2001a; Zhou YN and Jin DJ, 1998). The positively regulated 
promoters are then induced because they are argued to be relatively poor at recruiting RNAP and 
are sub-saturated during normal growth. Jensen and Pedersen (Jensen KF and Pedersen S, 
1990) have argued that ‘stringent’ promoters, for example stable RNA promoters, require high 
concentrations of RNAP to be transcribed at their maximal rate and are therefore especially 
sensitive to a diminished availability of RNAP. 
Despite the many existing hypothesis, there is a general consensus that stringent response 
influences a cascade of events, starting with the over-accumulation of ppGpp molecules that later 
mediate the regulation of basic cellular processes, like the metabolism, translational activities or 
stress responses. The discovery of ppGpp accumulation during bacterial recombinant processes 
promoted even more the interest of the industry and researchers on this stress response. 
Limitations imposed by this response during recombinant bioprocesses represent significant 
losses in the quality and quantity of recombinant products. Moreover, the discovery of ppGpp as 
a key regulator of various cellular processes is another significant achievement that suggests that 
adaption to starvation is more complex than it was initially understood. And so, four decades after 
its discovery, stringent response still has an enormous scope for study. 
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1.3 MODELLING THE STRINGENT RESPONSE IN 
RECOMBINANT SYSTEMS   
All biological systems are characterized by a multitude of functional units that support cellular 
growth, reproduction and survival. The description of these systems is often complex, not only 
because it increases with the amount of functional units enclosed in the system, but also with the 
intricacy of their relationships. With the recent developments in omics technologies, combined 
with computational analysis, the identification of most biological molecules and the multi-level 
interactions among them needed to carry out cellular functions, was made possible (Figure 1.3). 
Most of these research studies address the system-level understanding of the organization and 
dynamics of cellular processes (e.g. transcriptional regulation, signal transduction pathways, etc). 
With the increasing interest on the development of new strategies to improve the efficiency of 
recombinant bioprocesses, several modelling approaches considering this systems-level 
perspective have been implemented (Chou CP, 2007; Gnoth S et al., 2008). Process 
optimization for recombinant protein production has been traditionally focused on genetic-based 
solutions for high-level gene expression (Baneyx F, 1999; Hannig G and Makrides S, 1998; 
Sorensen HP and Mortensen KK, 2005). However, with the application of these novel 
approaches, aspects like the host metabolism or its genetic background can now be engineered, 
improving considerably the performance of recombinant bioprocesses. A successful example was 
demonstrated by Wong and co-workers (Wong MS et al., 2008) that reduced ten-fold acetate 
accumulation in recombinant E. coli culture by disabling the phosphoenolpyruvate:sugar 
phosphotransferase system (PEP-PTS) through the deletion of the ptsHI operon. It is 
acknowledged that the production of acetate retards cell growth and inhibits protein formation, 
and these were significantly attenuated when using this mutated host strain and the final 
biomass concentration and volumetric productivity of recombinant proteins were increased.  
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Similar strategies to overcome the consequences of metabolic burden or physiological stresses, 
triggered during the overproduction of recombinant proteins, have been reported (Chou CP, 
2007; Gnoth S et al., 2008). For instance, the manipulation of stress-responsive genes (e.g. 
ibpAB, relA) or metabolic factors, can improve cell physiology during recombinant bioprocesses. 
As an example, the co-expression of the small heat-shock proteins (IbpA and IbpB) has proven to 
reduce the physiological stress associated with protein misfolding (Lethanh H et al., 2005). 
Moreover, it has been reported that by increasing the availability of NADH, a common energy 
carrier and cofactor involved in various biosynthesis pathways, cell physiology and recombinant 
protein production can be improved, which was achieved through the overexpression of the pncB 
gene in E. coli (San KY et al., 2002). The impact of the stringent response in recombinant protein 
production was also verified and it was found that ppGpp-less strains were able to produce 
recombinant protein 20-fold higher than the wild-type cells (Dedhia N et al., 1997). Although 
significant improvements in the production of recombinant proteins were obtained with these 
strategies, rational selection of the proper gene(s) to be coexpressed, overexpressed or deleted is 
still challenging. Systematic approaches for identifying potential targets and develop fine-tuned 
strategies to overexpress the recombinant product and suppress the natural responses to 
physiological stresses, becomes critical to improve recombinant bioprocesses.  
Mathematical modelling emerged as an important tool to examine central problems in the 
biological sciences, ranging from the organizational principles of individual cells to the dynamics 
of particular cellular processes. Although the mathematical representation of biological systems is 
perhaps one of the most complicated problems in systems biology, it is also one of the most 
practical ways to describe the properties of a system. Thus, to understand the whole scenario 
that leads to most of the limitations in recombinant bioprocesses, it would be important to 
explore the dynamics of the main cellular activities involved in the synthesis of recombinant 
protein, and in particular cellular responses to the metabolic burden and the ppGpp-induced 
response. 
To achieve a systems-level understanding of the impact of recombinant protein production in the 
host metabolism, it is crucial to mathematically represent the entire metabolic network of the 
organism. There are several modelling methodologies capable of describing the cellular 
metabolism, but there is, however, one modelling and simulation approach that has shown a 
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surprising ability to simulate and predict the metabolic behaviour of living cells - Flux Balance 
Analysis (FBA) (Edwards JS et al., 2001; Edwards JS et al., 2002; Pramanik J and Keasling JD, 
1997; Price ND et al., 2003; Reed JL and Palsson BO, 2003; Saner U et al., 1992; Schilling CH 
et al., 1999; Urbanczik R and Wagner C, 2005; Varma A and Palsson BO, 1993; Varner JD, 
2000) that assumes a steady-state condition for the internal fluxes of the system and optimal flux 
distribution. Many organisms have been studied by using these so-called stoichiometric models 
(Borodina I et al., 2005; Chung BK et al., 2010; Duarte NC et al., 2004; Feist AM et al., 2006; 
Feist AM et al., 2007; Navid A and Almaas E, 2009; Nogales J et al., 2008; Oliveira AP et al., 
2005; Reed JL et al., 2003; Schilling CH et al., 2002; Sheikh K et al., 2005; Varma A and 
Palsson BO, 1994), and E. coli metabolism was one of the first to be modelled using this 
approach (Varma A and Palsson BO, 1994), where the stoichiometry of metabolic pathways and 
maximal growth principles were used to predict cellular growth and the flux distribution through 
the metabolic network. 
More generally, metabolic models usually based on the fundamental law of mass conservation, 
where the metabolic state of a cell is described by mass balance equations written for all the 
metabolite concentrations (c) that are mathematically expressed as follows in the matrix form: 
vS
dt
dC .=  (1) 
Here, the dilution effect caused by biomass growth is considered negligible. Metabolic 
interactions are expressed in the stoichiometric matrix S, where each element Sij represents the 
stoichiometric coefficient that indicates the participation of the ith metabolite in the jth reaction. 
Vector v corresponds to the reaction rates or fluxes through the metabolic reactions. Figure 1.4 
shows an example. 
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Figure 1.4. Representation of the stoichiometry and mass balance equations in a metabolic 
network.  
(a) Small reaction network consisting of three metabolites (A, B, and C) and six biochemical reactions (v). Material 
balances for each metabolite. (c) Metabolic model or material balance equations according to Eq. 1. 
 
Under steady-state conditions, metabolite concentrations are constant and mass balances can be 
simplified to: 
0. =vS  (2) 
When the number of fluxes is greater than the number of metabolites, then the system is 
mathematically considered underdetermined and the solution space is defined as the null space 
of S, where an infinite number of feasible flux distributions satisfy the mass balance equations 
(Edwards JS and Palsson BO, 1998). For that reason, constraints imposed by the 
thermodynamics (e.g. reaction reversibility/irreversibility) and enzyme kinetic properties (e.g. 
maximum reaction rates) can be included in the model to reduce the solution space (Covert MW 
et al., 2003; Edwards JS et al., 2002). These constraints can be introduced as linear inequalities: 
Njv jjj ,...1, =≤≤ βα  (3) 
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Although constraints reduce the solution space of the system, they do not allow to define a single 
solution. FBA uses linear-optimization techniques to calculate an optimal flux distribution (a 
unique optimal solution) based on a pre-defined objective function (Edwards JS et al., 2001; 
Edwards JS et al., 2002; Pramanik J and Keasling JD, 1997; Price ND et al., 2003; Reed JL and 
Palsson BO, 2003; Schilling CH et al., 1999; Varma A and Palsson BO, 1993; Varner JD, 2000). 
The linear objective function (Z) can be maximized or minimized, according to the cellular 
function to be optimized (e.g., production of toxic by-products or cellular growth). The 
optimization problem can be formulated as: 
ZMaximize  
0. =vStosubject  
Njv jjj ,...1, =≤≤ βα  
(4) 
In nature and in specific circumstances, microbial cells have evolved towards maximization of 
biomass formation and, thus, this has been successfully used as an objective function in FBA 
simulations, to explore the capabilities and limitations of the metabolic network and predict 
cellular behaviour (Burgard AP and Maranas CD, 2003; Edwards JS et al., 2001; Edwards JS 
and Palsson BO, 2000; Ibarra RU et al., 2002; Schilling CH et al., 2002).  
The metabolic behaviour of recombinant systems has been investigated using flux balance 
approaches (Ow DS et al., 2009; Weber J et al., 2002). A genome-scale metabolic model for E. 
coli (Reed JL et al., 2003) was complemented with mass balance equations for the expression of 
recombinant proteins and plasmid maintenance (Ozkan P et al., 2005) and flux distributions 
provided access to information on metabolic pathway utilization and potential limitations. Flux 
distributions were quantitatively evaluated and revealed that metabolic perturbations imposed by 
the synthesis of recombinant proteins reduce cell growth rates and change the activity of 
catabolic pathways like the Embden-Meyerhof-Parnas (EMP) pathway and the tricarboxylic acid 
(TCA) cycle. Moreover, it was found that the maximizing growth rate as the cellular objective 
function does not provide the best description for the underlying cellular behaviour. Instead, 
maximization of maintenance energy (ATPm) expenditure generates a metabolic flux distribution 
that explains better the physiological state of recombinant E. coli (Ow DS et al., 2009).  
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Yet, predicted flux distributions by FBA simulations have shown certain inconsistencies between 
the model and experimental data. Some reasons have been pointed out, such as the lack of 
descriptions on regulatory phenomena or gaps in metabolic information (Breitling R et al., 2008; 
Feist AM and Palsson BO, 2008; Orth JD and Palsson BO, 2010; Raman K and Chandra N, 
2009). In most cases, the cell metabolism operates in a quasi- or pseudo-steady state, where 
metabolite concentrations do not change significantly over time, but some metabolic reactions 
can be heavily dependent on regulation. FBA models are therefore insufficient to predict 
metabolic activities; instead, they provide a snapshot of the metabolism at defined physiological 
states. The integration of transcriptional regulatory information into metabolic models using 
Boolean logic formulations has been already proposed (Covert MW et al., 2001). Still, the 
dynamics of some metabolic processes cannot be neglected and therefore kinetic models may 
need to be used, despite the complexity of this modelling approach. Dynamic flux balance 
analysis (DFBA) was alternatively proposed (Mahadevan R et al., 2002); however, the kinetic 
parameters of some important reactions are required, which is not always easy to get.  
Clearly, there is no single modelling approach capable of representing all cellular phenomena, 
mainly because the level of detail of mathematical model descriptions depends largely on the 
information available about the system. Sometimes, the best modelling approach relies on the 
combination of different types of mathematical representations, according to the major purposes 
of the study. As an example, a three-level integrated approach, where the integration of a 
stoichiometric metabolic network with a Boolean transcriptional regulatory network (rFBA) and a 
set of ordinary differential equations (ODEs) to describe the dynamic variation of certain 
metabolite variables, was reported (Covert MW et al., 2008). This modelling approach was able 
to model the E. coli central metabolism generating a metabolic flux distribution that was globally 
more accurate and informative.  
As follows, in this thesis a two-step modelling approach is presented, combining a stoichiometric 
and a kinetic model to represent the metabolic perturbations imposed by recombinant protein 
synthesis and the ppGpp-induced response, respectively (see Chapter 3). Since a more detailed 
understanding on the ppGpp-induced response is expected with such approach, a kinetic model 
was implemented to represent the induction of the RelA activity upon depletion of the amino 
acids pool. Indeed, kinetic models are more suited to detail the dynamics of cellular processes 
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that are highly dependent on regulation, such as protein translation processes (Zouridis H and 
Hatzimanikatis V, 2007) or folding and inclusion body formation in E. coli (Hoffmann F et al., 
2001). The combination of a flux balance model based on the stoichiometry of E. coli metabolic 
pathways (Reed JL et al., 2003) and kinetic reactions for biomass formation, recombinant protein 
production, plasmid maintenance and ppGpp synthesis, are here proposed to get a first 
systematic representation of the effect of the accumulation of ppGpp in the cell physiology during 
recombinant protein production. It was aimed to develop a large scale modelling approach 
integrating different model representations that, ultimately, simplifies the computational efforts by 
restraining the number of variables that need to be evaluated by dynamic modelling. As 
exemplified in Figure 1.5, this approach reduces the need for kinetic parameters, while the 
dynamics of certain metabolite concentrations can be inferred using metabolic fluxes predicted 
by the flux balance model (e.g. metabolite D).  
 
Figure 1.5. Example of an integrated modelling approach.  
The flux balance model describes the steady-state flux distributions (v1, v2, v3, v4, v5 and v6) through the metabolic 
network composed by metabolites A, B and C. Reaction rates v1 and v6 can be obtained from experimental 
measurements (e.g. substrate uptake rates). In the kinetic model, the expression for the reaction v7, is based on a 
Michaelis-Menten equation that describes the dynamic conversion of metabolites D and E into F and G.   
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1.4 METABOLOMICS APPROACHES FOR INVESTIGATING THE 
BEHAVIOUR OF RECOMBINANT E. COLI  CELLS  
The design of novel strategies to elucidate recombinant systems has been the primary goal of 
systems biotechnology (Bulter T et al., 2003; Glick BR, 1995). The optimal design and 
development of upstream to downstream recombinant bioprocesses have recently been 
expanded mainly due to the advent of diverse omics technologies. The increasing availability of 
omics data has provided scientists with an unforeseen level of information on many different 
recombinant systems. For example, DNA microarrays have been used to investigate 
transcriptome profiles of recombinant E. coli, where thousands of genes were identified to 
change their expression levels along the fermentation process. Among these genes, those 
associated with the stress responses, like heat shock and stringent responses, were found to be 
up-regulated and genes related to translation processes and energy synthesis were down-
regulated (Bonomo J and Gill RT, 2005; Haddadin FT and Harcum SW, 2005; Oh MK and Liao 
JC, 2000). Transcriptome analyses demonstrated that recombinant cultures are exposed to 
stressful conditions, which is denoted by the global changes in gene expression. To adapt to such 
conditions, cells engender a multitude of responses that often lead to important productivity 
losses, as well as cellular growth arrest.  
The impact of recombinant protein production in E. coli cells has also been investigated by 
proteomic studies (Aldor IS et al., 2005; Duerrschmid K et al., 2008; Kabir MM and Shimizu K, 
2001; Lee DH et al., 2007; Wang YH et al., 2005). Proteome changes reflected the physiological 
responses to heterologous protein production in recombinant E. coli, in particular the down-
regulation of glycolytic enzymes, TCA cycle associated enzymes and ATP synthase, and up-
regulation of cell protection proteins and some sugar transport proteins (Lee DH et al., 2007). 
Apparently, the production of recombinant proteins can interfere with the performance of many 
metabolic pathways in the host metabolism, entailing a series of metabolic changes (Bentley WE 
et al., 1990; Gill RT et al., 2000; Harcum SW and Bentley WE, 1999). The association of these 
metabolic adjustments with stress-related processes, like the stringent response, has also been 
reported (Andersson L et al., 1996; Chao YP et al., 2002; Haddadin FT et al., 2009; Hoffmann F 
and Rinas U, 2004; Schweder T et al., 1995). The stringent response has been characterized by 
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the down-regulation of nucleic acid and protein synthesis, and the simultaneous up-regulation of 
protein degradation (Ferullo DJ and Lovett ST, 2008; Jain V et al., 2006; Magnusson LU et al., 
2005), which in turn would result in considerable losses during recombinant bioprocesses. The 
view of ppGpp as a global regulator of gene transcription has been expanded and it is now clear 
that cellular processes controlled by ppGpp are widespread and involve many cellular 
mechanisms important during cellular growth (Magnusson LU et al., 2005). It has been reported 
(Schweder T et al., 1995) that the accumulation of intracellular ppGpp, especially in slow-growing 
fed-batch conditions, seems to have a great impact in the recombinant protein synthesis, mainly 
due to the uncoupling between cell growth and protein production. Although important aspects 
regarding the physiology of recombinant systems have been found with transcriptome and 
proteome analysis, the metabolic alterations mediated by recombinant bioprocesses are still 
poorly uncovered. Moreover, it has been argued that the generation of hypotheses through these 
omics data alone, is incomplete and may lead to incorrect interpretations (Zhang W et al., 2010).  
As the metabolome level is the closest indicator of the cells’ phenotype, metabolomics is now 
becoming the most relevant omics technology for understanding biological systems. 
Metabolomics aims at analysing and quantifying the complete set of metabolites (small organic 
molecules), providing substantial information on the organization of metabolism (see Table 1.1 
for definitions used in the metabolomics field). In fact, metabolites play significant roles in the 
cell, as they are key participants in catabolic and anabolic pathways, regulate metabolic activities 
at the genetic (e.g. transcriptional effectors) or at the enzymatic (e.g. inhibitors/activators or 
cofactors) level and can be external (or internal) indicators of the environmental conditions. It is 
now widely recognized that metabolites are key biomolecules that govern the whole cell 
functioning, as elucidated by the complexity of interactions with many other functional units (see 
Figure 1.3). Metabolomics is a systematic analysis focused on this holistic view and encloses 
major advantages compared to other omics technologies, such as:  
• Tractability: cells contain, in general, less metabolites than genes, transcripts, or 
proteins; 
• Good discriminatory skills: changes in concentrations of metabolites are faster compared 
with the concentrations of proteins or transcripts and sometimes changes in the 
metabolite levels are not always detected in transcriptome or proteome profiles; 
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• Cost-effectiveness: costs per analyses are lower compared to proteomics and 
transcriptomics.  
 
Table 1.1. Summary of some definitions used in the metabolomics field based on (Dunn WB 
and Ellis DI, 2005; Goodacre R et al., 2004). 
Term Definition 
Metabolome The complete set of small metabolites present in a biological sample. 
Endometabolome Small metabolites found in the intracellular medium 
Exometabolome Small metabolites that are secreted by cells 
Metabolomics 
Non-biased identification and quantification of the whole metabolome in a sample under a 
given set of conditions. 
Metabonomics 
Analysis of the dynamic metabolic responses to biochemical perturbations caused by 
diseases, drugs and toxins, often employed to evaluate tissues and biological fluids. 
Metabolic 
profiling 
Identification and quantification focused on a group of metabolites, for example, a class of 
compounds such as carbohydrates, amino acids or those associated with a specific 
pathway. 
Metabolic 
footprinting 
Analysis of the set of metabolites that are secreted (or consumed) by cells into (or from) the 
extracellular medium. 
Metabolic 
fingerprinting 
High-throughput, rapid, global analysis providing sample classification based on the 
qualitative metabolic profiles exhibited by a biological sample. 
Metabolite target 
analysis 
Qualitative and quantitative analysis of a specific set of metabolites, for example, that are 
involved in a particular enzyme system that would be affected by genetic/environmental 
perturbations. 
 
In the past few years, several studies have employed metabolomics approaches to evaluate the 
metabolic profiles of diverse microbial systems (Catchpole G et al., 2009; Dobson G et al., 2010; 
Dunn WB, 2008; Dunn WB and Ellis DI, 2005; Kell DB, 2004; Kol S et al., 2010; Mashego MR et 
al., 2007; Oldiges M et al., 2007; Pasikanti KK et al., 2008; van der Werf MJ, 2003; Yuliana ND 
et al., 2010). Although the measurement of metabolites per se exists since the early days of 
biochemistry and techniques are basically the same used for years in analytical chemistry, the 
analysis of several metabolites in parallel in a unique sample is the novelty of this approach. 
Metabolite analysis is challenging due to the number of analytes present in biological samples, 
their concentration ranges and, most significantly, their chemical diversity. Progresses have been 
accomplished by the development of new experimental procedures and technological advances.  
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In a basic workflow procedure, there are three essential steps that define the capacity and 
success of the designed metabolome analysis (Figure 1.6). From the sample preparation that 
should take into consideration the chemical diversity and dynamic concentrations range of the 
metabolites under analysis, to the selection of the proper analytical platform, which can be 
comprised by a single analytical technique or the combination of various techniques, and the 
definition of data analysis methods, all these steps are crucial to obtain a more comprehensive 
analysis of the metabolome. These major steps will be further detailed below. 
 
 
Figure 1.6. General workflow procedure of the metabolome analysis. 
(1) The range of biological samples to be analysed is vast, which influences largely the applied methodologies to 
prepare theses sample. (2) With the latest technological advances, several analytical platforms became available 
increasing the sensitivity, quantitativeness and robustness of metabolomic analyses. (3) However, the growing 
application of these approaches in the identification and quantification of metabolites with a large chemical diversity, 
analytical software tools are facing some challenges. The need for specialized mathematical, statistical and 
bioinformatic tools is increasing.  
 
1.4.1 SAMPLE PREPARATION 
During this step, metabolites contained inside the cell (i.e. endometabolome) or the extracellular 
metabolite pool secreted into the culture broth (i.e. exometabolome) are collected. The 
endometabolome is more technically demanding than the exometabolome. Besides the difficulty 
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in designing protocols capable of extracting metabolites from the intracellular milieu, a previous 
quenching step has to be devised to assure a rapid metabolic activity arrest. The quenching step 
is essential to assure that all metabolic activities inside the cell are arrested, and thus no further 
enzymatic conversions of metabolites are taking place. Usually, quenching protocols employ a 
rapid increase or decrease in temperature to prevent enzyme activity (Dunn WB, 2008), which is 
followed by the release of metabolites from the interior of the cell using heat or cold and 
occasionally acid or base solutions to assist cell lysis.  
The first procedure combining fast quenching and subsequent separation of cells and 
supernatants, was developed by de Koning and van Dam (de Koning W and van Dam K, 1992). 
The quenching solution (60% methanol at -40ºC) was used to halt yeast metabolism and cells 
were collected after centrifugation at -20ºC. However, this method and others using cold 
methanol as a quenching agent have been contested due to cellular leakage (Taymaz-Nikerel H 
et al., 2009; Villas-Boas SG and Bruheim P, 2007; Wittmann C et al., 2004). During quenching 
procedures it is crucial that metabolites remain inside the cells, otherwise the levels of 
metabolites after cellular extraction would be underestimated. Therefore, several quenching 
protocols have been proposed, and successfully applied, to different microbial cells (see Table 
1.2).  
 
Table 1.2. List of some quenching solutions that have been applied in microbial metabolome 
analysis.  
Quenching agent Details References 
Cold methanol/water 60% (v/v) methanol at -40ºC (de Koning W and van 
Dam K, 1992) 
Cold perchloric acid 35% (w/w) in water  at -40ºC (Weuster-Botz D, 1997) 
Liquid nitrogen liquid N2 at -150ºC (Chassagnole C et al., 
2002) 
Cold methanol/water with 
ammonium carbonate or HEPES 
60% (v/v) methanol buffered with 0.85% (w/v) 
ammonium carbonate or with 70 mM HEPES at -
40ºC 
(Faijes M et al., 2007) 
Cold glycerol/saline 3:2 (v/v) glycerol:saline solution (13.5%NaCl) at -
20ºC 
(Villas-Boas SG and 
Bruheim P, 2007) 
Cold methanol/glycerol 3:2 (v/v) methanol:glycerol at -50ºC (Link H et al., 2008) 
Cold ethanol/sodium chloride 40% ethanol and 0.8% (w/v) sodium chloride at -
20ºC 
(Spura J et al., 2009) 
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Following the quenching procedure, cells are separated from the quenching solution by 
centrifugation or filtration, and subsequently subjected to extraction procedures through 
permeabilization of cell walls, usually with chemical or physical agents. These agents should 
allow for maximum extraction (i.e. as many metabolites as possible) with minimal alteration of 
the extracted metabolites. Logically, the choice for the most appropriate extraction method 
depends on the used microbial system, since cell wall and membrane structures, as well as 
composition, differ from organism to organism. Currently, the range of available chemical agents 
(Table 1.3) offers the possibility to optimize the extent and diversity of extracted metabolites in 
order to obtain meaningful metabolome data. 
 
Table 1.3. List of chemical extraction methodologies applied to microbial cells to remove 
intracellular metabolites.  
Extraction 
agent 
Details 
Microbial 
cells 
References 
Perchloric 
acid 
Cold perchloric acid 50% (v/v) is added to samples and 
after rapid vortexing, the mixture is kept on ice for 10 min. 
Then, it is centrifuged for 10 min and extracts are 
neutralized with 15N KOH. 
Bacteria (Maharjan RP and 
Ferenci T, 2003) 
Potassium 
hydroxide 
Hot solution of 0.2N KOH at 80ºC is added to samples 
and incubated for 10 min. After cooling on ice for 5 min, 
cell debris is removed by centrifugation and the extracts 
are neutralized with 0.1 mL perchloric acid (0.5 N). 
Bacteria 
Filamentous 
fungus 
(Hajjaj H et al., 1998; 
Maharjan RP and 
Ferenci T, 2003) 
Hot ethanol Samples are boiled in 75% (v/v) ethanol at 80ºC. After 
evaporation of the ethanol/water mixture, the pellet is 
resuspended in water. 
Yeast  (Gonzalez B et al., 
1997) 
Methanol/ 
chloroform 
1:2 (v/v) methanol/ chloroform at -20ºC is added to the 
samples and the mixture is vortexed for 30 s. Then 
samples are transfered to dry ice, where they are kept for 
45 min and vortexed for 30 s every 15 min. The 
suspensions are then centrifuged for 10 min at 0ºC. 
Yeast (de Koning W and van 
Dam K, 1992) 
Hot 
methanol 
2:1(v/v) methanol/water is added to the sample and 
incubated for 30 min at 70ºC. The suspensions are then 
centrifuged for 10 min. 
Bacteria (Maharjan RP and 
Ferenci T, 2003) 
Tris-
H2SO4/EDTA 
Samples are added to half the volume of Tris-H2SO4/EDTA 
(20 mM/2 mM), pH 7.75, at −25°C. After 1 min, samples 
are thawed and pipetted into another one-half volume of 
Tris-H2SO4/EDTA, pH 7.75, at 90°C. The mixture is then 
vortexed and after 10 min centrifuged. 
Bacteria 
Yeast 
(Buziol S et al., 2002) 
Cold 
methanol 
Freeze-thawing cycles at low temperatures (-20ºC). To 
enhance recovery, cells are washed with cold methanol 
once or twice. 
Bacteria 
Yeast 
Filamentous 
fungus 
(Maharjan RP and 
Ferenci T, 2003; Smart 
KF et al., 2010; Villas-
Boas SG et al., 2005) 
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1.4.2 ANALYTICAL PLATFORMS 
Once the biological samples are prepared there are several analytical platforms available that can 
be applied in metabolomics: gas chromatography (GC), capillary electrophoresis (CE), or liquid 
chromatography (LC) coupled with mass spectrometric detection (MS), direct infusion mass 
spectrometry (DIMS), Fourier transform-infrared (FT-IR) and nuclear magnetic resonance 
spectroscopy (NMR). Since the metabolome comprehends a vast range of chemical species with 
diverse physical and chemical properties and those analytes occur in a wide concentration range, 
analytical procedures are quite challenging. With the recent progresses in analytical technologies 
and the possibility to combine more than one in the analytical platforms, metabolomics 
experiments gained a wider coverage in terms of the type and number of metabolites analysed. 
Currently, the most popular method for metabolomics analysis is GC/MS (Coucheney E et al., 
2008; Jonsson P et al., 2005; Kaspar H et al., 2008; Koek MM et al., 2006a; Kopka J, 2006; 
Pasikanti KK et al., 2008; Sajewicz M et al., 2009). In the GC equipment, a liquid sample is 
injected and rapidly vaporized and mixed with a carrier gas. Then, metabolites in the vaporized 
sample are separated on the GC column and follow to the MS device. Mass spectrometers 
operate in a three-step process: analytes are ionized in an ion source, either operating at 
atmospheric or vacuum pressures; ions are then separated according to the mass-to-charge 
(m/z) ratio in a mass analyser; and finally detected, either physically at a detector as an ion 
current or by the detection of orbital frequencies as image currents. Many advantages have been 
described for its application in metabolomic investigations, including its sensitivity (detection of 
μM concentrations) and the ability to identify metabolites through the fragmentation mass 
spectra. However, disadvantages like the requirement of chemical derivatization procedures, to 
convert some metabolites into less-polar, volatile and thermally stable derivatives before GC 
separation, are considerable. Chemical derivatization involves the substitution of active hydrogens 
in functional groups, such as –COOH, –OH, –NH, and –SH by other chemical groups via 
alkylation, acylation or silylation reactions. Silylation is the most traditional and results in stable 
derivatives with good reproducibility and wide range of metabolites that can be derivatized. 
However, it has been described as difficult to execute and time-consuming. Alkylation presents 
technical advantages compared to silylation, but the application range is limited. Nevertheless, 
important intermediates in the cellular metabolism, like carboxylic acids, amines, amino alcohols, 
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and amino acids, are likely to be converted to volatile derivatives with this chemical derivatization. 
These chemical processes allow the detection of many more metabolite classes in a single 
GC/MS run. Although, some degree of variability can be introduced in the metabolome data, 
mainly because sample derivatization is a multi-step process, generally manual, GC/MS 
applications in metabolomic investigations are valuable in the identification of metabolites of 
microbial, plant and mammalian systems. 
 
1.4.3 DATA ANALYSIS 
Since the start of metabolomics, software approaches to automated data interpretation have 
been scarce, and most efforts have been made in individual laboratories to support their own 
scientific investigations. Mass spectral libraries are the main example, since mass spectra vary 
with the performed analytical procedures. For example, different derivatization agents produce 
different metabolite derivatives, which consequently generate altered mass spectra. Collaboration 
projects should be encouraged to promote the construction of larger and more complete 
libraries. The computerized matching of an unknown spectrum with a database/library would 
provide a very rapid and useful tool in metabolic profiling procedures. The Automated Mass 
Spectral Deconvolution and Identification System (AMDIS) (Stein SE, 1999) from the National 
Institute of Standards and Technology (NIST) has been largely applied to match unknown spectra 
with libraries in order to identify most detected components.  
After identifying and quantifying the metabolome of a biological system, the main goal is to find 
relevant metabolites that discriminate between different phenotypic characteristics. By using 
statistical methods (e.g. multivariate data analysis or pattern recognition), differences between 
metabolomes can be identified and further contextualized to generate useful new knowledge. 
Most of the data analysis methods that have been applied in metabolomics, and also in many 
other omics data analyses, are based on unsupervised techniques, such as hierarchical cluster 
analysis (HCA) and principal component analysis (PCA) (Arbona V et al., 2009; Boroczky K et al., 
2006; Griffin JL, 2004; Llorach-Asuncion R et al., 2010; Pohjanen E et al., 2006). Supervised 
methods are usually more powerful as the classification is based on prior knowledge (e.g. Fisher 
discriminant analysis); however, they have the disadvantage of requiring a training data set, 
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which sometimes it is not easy to select and can overfit the model. Unsupervised methods, on 
the other hand, separate samples into classes without any training data set, but it is not always 
easy to interpret the basis for the generated clusters (Mendes P, 2002). Obviously, the most 
suitable data analysis method should be selected according to the aim of the study. 
Unsupervised methods are prioritized when prior information about the sample identity is 
unknown (e.g., in identification of a silent mutation phenotype) and the aim is sample 
classification. On the other hand, if sample identification is known and it is aimed to find 
characteristic metabolite profiles (e.g., search for groups of metabolites that define the phenotype 
of a microbial strain), supervised methods are ideal. Common statistical methods such as t-test 
or ANOVA, can also be used to find significant changes in the metabolite profiles. PCA analysis 
often uses only variables with significant changes tested by t-test or ANOVA. PCA analysis is 
mostly used for data visualization, where multivariate data is transformed into principal 
components and are projected on a 2D or 3D plots, facilitating data interpretation. An important 
aspect about this method is that PCA will emphasize variable components with high intensity 
levels, while lower metabolite levels are neglected, even if those are significant. Thus, data 
normalization is often performed before statistical analysis. Most books about chemometrics and 
statistics for analytical chemistry explore most of these subjects in detail, including data cleaning, 
normalization and transformation. 
But, besides all the challenges in technical, computational or statistical analysis, the 
interpretation of data is perhaps the paramount dilemma in metabolomics. As stated by 
Professor Henry Nix, co-chair of the Australian Wild Country Science Council: “Data does not 
equal information; information does not equal knowledge; and, most importantly of all, 
knowledge does not equal wisdom. We have oceans of data, rivers of information, small puddles 
of knowledge, and the odd drop of wisdom.” Thus, to keep pace with this flood of data, 
procedures for storage, analysis and interpretation of omics data must be developed. Meanwhile, 
few attempts have been made to build tools capable to expedite these processes (Table 1.4).  
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Table 1.4. List of bioinformatics tools for storing, reporting, analysing and interpreting 
metabolomics data.  
Tools Description References 
Databases   
Madison 
Metabolomics 
Consortium 
Database 
(MMCD)a 
Supports high-throughput NMR and MS data sets for the identification 
and quantification of metabolites present in biological samples. 
(Cui Q et al., 2008) 
Human 
Metabolome 
Databaseb 
The database covers more than 7900 metabolite entries with 
information about small molecule metabolites found in the human 
body. It contains three kinds of data: chemical data, clinical data and 
molecular biology/biochemistry data. 
(Wishart DS et al., 
2009) 
MassBankc Public repository of mass spectra of small chemical compounds for 
life sciences (<3000 Da). The database contains data for 2337 
authentic metabolites and for other synthetic compounds. 
(Horai H et al., 2010) 
METLINd Metabolite database for metabolomics containing over 15,000 
structures. Also, assists metabolite identification by providing public 
access to its repository of current and comprehensive mass spectral 
metabolite data. 
(Smith CA et al., 
2005) 
NISTe The 2008 version of the NIST/EPA/NIH Mass Spectral Library (NIST 
08) contains four libraries and a database of retention index values. 
Together they contain 220,460 spectra of 192,108 different 
chemical compounds. 
(Stein SE, 1995) 
Data analysis   
MetaboAnalystf Web-based tool for metabolomic data processing, data normalization, 
multivariate statistical analysis, graphing, metabolite identification 
and pathway mapping. 
(Xia J et al., 2009) 
MetaFINDg An application for 'post-feature selection' that aid metabolite signature 
elucidation, feature discovery and inference of metabolic correlations. 
(Bryan K et al., 2008) 
MSEAh A web-based tool to identify biologically meaningful patterns in 
quantitative metabolomic data. 
(Xia J and Wishart 
DS, 2010b) 
MEVi MeV is an application for the analysis, visualization and data-mining 
of large-scale data. It was developed for the analysis of microarrays, 
but is a versatile analytical tool. 
(Saeed AI et al., 
2006) 
Data 
visualization   
MetPAj A free and easy-to-use web application designed to perform pathway 
analysis and visualization of quantitative metabolomic data. 
(Xia J and Wishart 
DS, 2010a) 
MetExplorek A web server that offers the possibility to link metabolites identified in 
untargeted metabolomics experiments within the context of genome-
scale reconstructed metabolic networks. 
(Cottret L et al., 
2010) 
Metscapel A plug-in for Cytoscape, used to visualize and interpret metabolomic 
data in the context of human metabolic networks. 
(Gao J et al., 2010) 
ahttp://mmcd.nmrfam.wisc.edu/; bhttp://www.hmdb.ca/; chttp://www.massbank.jp/; dhttp://metlin.scripps.edu/; 
ehttp://chemdata.nist.gov/; fhttp://www.metaboanalyst.ca/, ghttp://mlg.ucd.ie/metafind; hhttp://www.msea.ca; 
ihttp://www.tm4.org/mev/; jhttp://metpa.metabolomics.ca/; khttp://metexplore.toulouse.inra.fr/; 
lhttp://metscape.ncibi.org/ 
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Databases for storing detailed metabolite profiles, including raw data and detailed metadata, are 
being created. However, the implementation of standard formats for recording and reporting 
metabolomics data is not yet commonly used (Sansone SA et al., 2007). Although some data 
analysis tools for metabolomics applications have became available in the last years, most 
researchers have found general software environments, like R or MATLAB, more versatile for 
statistical computing. Other software tools developed to analyse specific omics data, like 
MultiExperiment Viewer (MeV) for microarrays data (Saeed AI et al., 2006), can also be useful 
when analysing metabolomics data. As presented in Chapters 4 and 5, clustering algorithms 
from MeV were quite valuable when classifying samples with different phenotypic characteristics. 
Most recently, computational tools for elucidating and visualizing metabolome data have 
emerged, namely MetPA (Xia J and Wishart DS, 2010a), MetExplore (Cottret L et al., 2010) and 
Metscape (Gao J et al., 2010). The depiction of metabolome information into diagrams that 
provide an overview of the metabolite neighbourhood and relationships is one of the potentialities 
of these tools. The shift from roadmaps of metabolic pathways into the construction of 
comprehensive metabolic networks, where all biochemical entities and their relationships are 
represented (Bersini H et al., 2005; Borenstein E and Feldman MW, 2009; Jeong H et al., 2000; 
Jinq Z et al., 2006; Montanez R et al., 2010), was perhaps the driving force behind these 
initiatives.  
 
1.4.4 METABOLOMICS-DRIVEN ANALYSIS OF E. COLI 
The E. coli metabolism has been extensively characterised, but only in the last decade 
metabolomics approaches were applied to evaluate (simultaneously) the global metabolite 
profiles, both qualitatively and quantitatively. One of the first approaches was developed by 
Tweeddale and co-workers (Tweeddale H et al., 1998) and applied a two-dimensional thin-layer 
chromatography to analyse the slow growth metabolism of E. coli growing on glucose in minimal 
medium. Later on, metabolome analyses were performed using more sophisticated techniques, 
such as GC/MS or NMR, which have expanded our knowledge on E. coli metabolism (Koek MM 
et al., 2006b). For instance, the E. coli metabolome has been investigated to understand key 
metabolic processes, such as the central nitrogen metabolism (Yuan J et al., 2009) and glycolytic 
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activities under different growth rates (Schaub J and Reuss M, 2008), or cellular responses to 
carbon and nitrogen starvation (Brauer MJ et al., 2006). Other studies identified novel enzymatic 
activities, such as the hydroxybutyrate dehydrogenase that is involved in the metabolism of 
succinic semialdehyde, and other potentially toxic intermediates that may accumulate under 
stress conditions in E. coli (Saito N et al., 2009a). Thus, metabolomic approaches can reveal 
new cellular metabolic processes, or bring important insights into the physiology of E. coli. The 
evaluation of metabolite levels and further association to enzymatic reactions has been 
fundamental in the elucidation of many biochemical functions, as well as to characterize 
enzymatic properties.  
Often these biochemical reactions are organized into metabolic pathways as functional modules 
of organisms metabolic networks graph theory principles have been applied to study the structure 
and topological properties of these metabolic networks to dissect functional and behavioural 
features of many organisms (Almaas E, 2007; Barabasi AL and Oltvai ZN, 2004; Mazurie A et al., 
2010). As such, metabolic interpretations can be biased if the metabolic networks are incomplete 
or inaccurate. As stated (Montanez R et al., 2010) “a network is an abstraction of reality and its 
construction can determine the conclusions derived from it”. Therefore, computational 
approaches that evaluate the correlation between metabolite levels, in order to infer metabolic 
networks or even to discover novel pathways, have been explored in metabolomics-driven 
analysis (Steuer R et al., 2003). It is remarkable how metabolite levels can be repeatedly 
correlated and more significantly, how frequently these correlations are shown between 
metabolites that are not neighbours in a metabolic pathway, but, most likely, are involved in 
regulatory mechanisms. To exemplify the potential of this approach, the metabolic correlations 
between metabolites analysed by GC/MS in the extracellular medium of an E. coli fermentation 
(metabolome data from experiments analysed in Chapter 6) were determined (Figure 1.7).  
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Figure 1.7. Metabolic correlations between extracellular metabolites detected by GC/MS 
during a recombinant E. coli fed-batch fermentation. 
The relative concentrations of extracellular metabolites produced during a recombinant E. coli W3110 fed-batch 
fermentation were analysed by GC/MS (see Chapter 6 for details). Abbreviattions: acon-C – cis-aconitate; bnz – 
benzoate; cbm – carbamate; cit – citrate; gly – glycine; itcon – itaconate; succ – succinate. 
 
As demonstrated, there are seven extracellular metabolites that show, at some extent, correlated 
patterns between their relative levels measured during the fermentation process. It indicates that 
a degree of association is likely to exist between these metabolites. Several reasons can be 
deduced, but the most reasonable is the participation in the same metabolic process or closely 
related processes. It should be emphasized that these interpretations are based on the 
assumption that extracellular metabolite levels are closely related to their intracellular 
concentrations, i.e. extracellular metabolic changes might be envisioned as changes in the 
intracellular metabolism, thus reflecting phenotypic alterations. To further interpret these 
metabolic correlations, metabolites were depicted into the E. coli metabolic network from EcoCyc 
(Keseler IM et al., 2009) (Figure 1.8).  
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Figure 1.8. Diagram showing the neighbourhood of metabolites detected in the metabolite 
footprints. 
a) The E. coli metabolic network from EcoCyc (Keseler IM et al., 2009) was used to locate the metabolites found to 
have highly correlated profiles. b) Diagram showing the seven correlated metabolites; circles represent metabolites, 
in which the larger ones indicate those that were found to be correlated, while squares illustrate catalytic enzymes. 
Isolated metabolites have no links in the network associating these metabolites. Arrows indicate production (green) 
and consumption (orange) reactions. This exercise was performed using the MetExplore tool with a Cytoscape plug-in 
(Cottret L et al., 2010).  
 
As shown in Figure 1.8, at least three metabolites (citrate, cis-aconitate and succinate) are 
neighbours in the metabolic network, participating in the TCA cycle. Although cis-aconitate has a 
higher correlation coefficient with citrate than with succinate (i.e. its closest neighbour), it was 
shown that both are participants in the same metabolic pathway only two reactions distant. 
These reactions are connected through D-isocitrate that is an important node in the metabolic 
network, which has brought new considerations when examining the complete metabolite 
footprints studied in Chapter 6.  
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Figure 1.9. Clustering analyses of the E. coli W3110 endometabolome: (A) hierarchical and 
(B) K-means clustering.  
Intracellular metabolites extracted from E. coli cells grown in chemostat cultures at three dilution rates (0.05, 0.1 
and 0.2 h-1) were analysed by GC/MS. Metabolite clusters were determined using MeV algorithms (Saeed AI et al., 
2006) for hierarchical clustering (HCL) and K-means clustering based on the Pearson’s correlation metrics. 
Correlation coefficients (r) vary from 1 to -1 and coefficients higher than 0.8 indicate strong correlations between 
metabolite profiles. The dashed line delimits the correlation coefficient threshold below which metabolite profiles 
were considered uncorrelated.  
 
Other methods that can used to find and visualize metabolite correlations are the hierarchical 
and k-means clustering analysis. As demonstrated in Figure 1.9, metabolite profiles from the 
endometabolome of E. coli W3110 cells grown in chemostat culture, were classified into six 
clusters. These clusters represent the set of metabolites that showed similar metabolic patterns 
when the culturing conditions were changed. For example, it was clear that at lower dilutions 
rates (0.05 and 0.1 h-1) short chain fatty acids (hxa: hexanoate [n-C6:0], octa: octanoate [n-C8:0] 
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and dca:decanoate [n-C10:0]) and benzoate were present in low levels, but increasing the 
dilution rate a significant increase in their levels was verified. The opposite was seen for long 
chain fatty acids. However, one pattern was similar among four clusters. It seems that, in 
general, at a dilution rate of 0.1h-1 metabolite levels increase. This is analysed in detail in Chapter 
4. 
 
 
Figure 1.10. Pair-wise metabolite-metabolite correlations constructed from GC/MS 
measurements of intracellular metabolites from W3110 and ∆relA E. coli cultures.  
 
Metabolic correlations can also be explored for comparison of metabolite profiles produced by 
different E coli strains when growing in the same conditions (see Chapters 4 and 6). As 
exemplified in Figure 1.10, metabolic profiles of endometabolome samples from E. coli W3110 
and ∆relA cells were evaluated by pair-wise correlation coefficients (r), showing that almost half 
of the metabolites detected by GC/MS analysis showed strong correlated patterns (i.e. r above 
0.8). Some metabolites revealed negative correlations, which mean that the intracellular 
accumulation of these metabolites followed an opposite pattern in one of the E. coli cultures, e.g. 
malate (mal) with r equal to -0.3.  
As described, there are many ways to explore metabolome data and capture relevant metabolic 
patterns that explain some physiological characteristics observed during fermentation processes. 
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The fact that physiological responses to stimulus in microorganisms are often mediated by 
metabolic reactions entangled in intricate relationships in the metabolic network is pertinent. 
Moreover, alterations in quantitative levels of metabolites provide valuable information for 
understanding the dynamics of metabolic activities and the organizational principles underlying 
the metabolic networks. The access to metabolome data that can be further represented into 
large scale metabolic networks supports the holistic perspective of the metabolism that has been 
sustained by the systems biology view (Kitano H, 2002). However, it must be noted that 
interpretations are heavily shaped by the metabolomics approach performed to generated 
metabolome data and, consequently, the obtained metabolite coverage. For example, a 
metabolic footprinting approach is not capable to cover the same range of metabolites as an 
approach designed to measures intracellular metabolites. It is not expected that the entire set of 
metabolites produced under certain metabolic conditions are equally present inside and outside 
the cells. However, this approach offers several advantages, like technical simplicity, higher 
reproducibility and the possibility to find metabolic markers that could be used to monitor 
physiological alterations during bioprocesses that would not be otherwise detectable. 
Metabolomic measurements have also been used to elucidate the function of the unknown and 
novel genes (Forster J et al., 2002; Griffin JL, 2004; Raamsdonk LM et al., 2001). Although 
genome sequencing projects have been successfully applied in the functional genomics field, the 
potential of metabolomics to determine gene functions has also been considered (Bino RJ et al., 
2004). Still today, of 4460 E. coli genes, only 2650 (59.3%) have experimentally defined 
functions (Keseler IM et al., 2009), which denotes the necessity for new tools capable to uncover 
cellular functions of enzymes and other unassigned proteins. Although bioinformatics tools have 
been widely used to predict functional assignments, many metabolic activities are currently 
orphan. For example, metabolomics analysis presented in this thesis exposed that some 
metabolites detected by GC/MS in E. coli samples could not be linked to any known metabolic 
pathway. Metabolites, such as itaconate, malonate, 2-phenylglycine or benzoate, have no 
assigned metabolic reaction in the E. coli metabolic network, according to public databases, such 
as KEGG (Kanehisa M and Goto S, 2000) and EcoCyc (Keseler IM et al., 2009), or genome-scale 
metabolic models (e.g. iAF1260 model of E. coli K12 (Feist AM et al., 2007)). Yet, metabolome 
data confirmed that these metabolites are produced by E. coli cells and have characteristic 
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metabolic profiles that were correlated with other metabolites in the metabolic network (see 
Figure 1.8).  
Different approaches can be devised to confirm the role of these metabolites in the cellular 
metabolism. As detailed in Figure 1.11, metabolite profiling can be explored as a screening 
methodology to investigate and discover in vitro and in vivo activities of enzymes, by monitoring 
the changes in metabolite levels. Indeed, the 4-hydroxybutyrate dehydrogenase activity in E. coli 
was recently discovered using a metabolite profiling-based method (Saito N et al., 2009b).  
 
 
Figure 1.11. Schematic representation of metabolomics-driven approaches to identify new 
enzymatic functions (Saito N et al., 2010). 
There are two fundamental approaches that have been implemented: in vitro, where gene products with unassigned 
biochemical functions, often overproduced using recombinant systems with fusion tags to facilitate the purification, 
are added to a metabolome cocktail; and in vivo, where cells are genetically modified (target deletion of specific 
genes) or are exposed to environmental perturbations to observe metabolic changes. Mass spectrometry-based 
methods are used for metabolite identification and metabolic profiling allows for the verification of metabolite 
patterns that might explain phenotypic features. It is always advised further experimental validations for the new 
assigned functions.  
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In this thesis in vivo metabolite profiling-based methods were used to determine the metabolic 
status of E. coli cells under various environmental and genetic conditions:  
• Two E. coli strains were used. wild-type E. coli W3110 and the isogenic mutant ∆relA; 
• Both E. coli strains were cloned with a pTRC-His-AcGFP1 vector and were tested in 
producing and non-producing conditions; 
• Cells were grown in different fermentation modes: fed-batch and chemostat cultivations; 
• Several growth conditions were evaluated: from extremely low to excessive nutrient 
availability. 
 
Although a significant number of metabolites, known to participate in central metabolic pathways 
of E. coli, were not measured by the implemented GC/MS approach, the obtained metabolome 
data allowed for important discoveries that will be detailed in Chapters 4, 5 and 6. As previously 
mentioned several attempts to improve the performance of E. coli cells during recombinant 
bioprocesses have been presented in the last years. In particular, omics technologies have been 
applied with some success to derive new hypothesis to engineer host cells improving 
recombinant protein productivity. However, metabolomics is still the less used technology, 
certainly because the implementation of these methodologies is more difficult, and thus, any 
interpretation based on transcriptome or proteome data lacks the link to phenotypic 
characteristics. To enable predictive metabolic engineering, analytical approaches might not only 
incorporate experimental information from gene expression profiles or protein abundances, but 
primarily metabolic data that could be derived from metabolomics or/and fluxomics.  
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CHAPTER 2 
STRINGENT RESPONSE OF ESCHERICHIA COLI: 
REVISITING THE BIBLIOME USING LITERATURE MINING 
 
“Nearly 40 years ago two spots appeared on autoradiograms, as if by magic...”  
By K. Potrykus and M. Cashel in (p)ppGpp: Still Magical?,  
Annu. Rev. Microbiol. 2008. 62:35–51 
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2.1 ABSTRACT  
This work aims to present a novel approach to the large-scale compilation, 
processing, and analysis of literature on the stringent response in 
Escherichia coli. This cellular response consists of a range of (p)ppGpp-
induced cellular activities triggered by amino acid depletion, and involving a 
multitude of molecular components, namely genes, tRNAs, mRNAs, gene 
products and small molecules, that ensure a coordinated and effective 
response. Specialised controlled vocabulary supported the automatic 
recognition of molecular components whereas statistical co-occurrence 
analysis suggested the most likely to be biologically engaged. As a result, 
the cellular processes affected by the activity of (p)ppGpp nucleotides were 
identified and further investigated, complementing existing reviews on this 
pleiotropic cellular response. The RelA and SpoT enzymes that control the 
basal levels of (p)ppGpp nucleotides and the RNA polymerase to which 
these nucleotides bind, were the most represented components. However, 
the identification of less annotated components revealed that some 
(p)ppGpp-induced functional activities are still unclear or largely overlooked. 
The suggested literature mining approach offers a more comprehensive 
analysis of the stringent response in E. coli, enhancing the process of 
compiling and processing relevant literature, as well as enabling the 
incremental extension of the knowledge base, following up research 
breakthroughs. 
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2.2 INTRODUCTION  
The survival capacities of all living organisms are dependent on the ability to sense and 
respond to environmental changes. Organisms can face several stress conditions, such as 
nutritional and energetic starvation, excess of toxic substances and presence of inhibitory 
agents, all of which can affect normal growth (Nystrom T 1999; Mukherjee TK et al. 1998). 
The identification of the specific mechanisms involved in microbial survival under stress 
conditions is expected to provide insight into stress response systems across life forms. In 
particular, the stringent response of the E. coli serves as a paradigm for understanding global 
responses to sudden nutritional starvation (Chatterji D and Ojha AK 2001; Durfee T et al. 
2008). Moreover, there is an industrial motivation for understanding the mechanisms of the 
stringent response in E. coli, since it is sometimes triggered during recombinant protein 
production, leading to decreased productivities (Harcum SW 2002; Haddadin FT et al. 2009). 
In recent years, numerous publications have discussed the mechanisms involved in this 
response (Jain V et al. 2006; Battesti A and Bouveret E 2009; Srivatsan A and Wang JD 2008; 
Chang DE et al. 2002; Murray KD and Bremer H 1996; Xiao H et al. 1991). Studies indicate 
that the accumulation of unusual guanosine nucleotides, collectively called (p)ppGpp, is the 
hallmark of the stringent response of E. coli (Magnusson LU et al. 2005) (Figure 2.1). Such 
accumulation is known to be controlled by the activity of two enzymes, RelA and SpoT. Upon 
depletion of amino acids, the ribosome-bound RelA enzyme (ppGpp synthetase I) is induced to 
synthesise (p)ppGpp nucleotides when an uncharged tRNA binds to the acceptor site of the 
translating ribosome (Torok I and Kari C 1980). In turn, the bifunctional SpoT enzyme (ppGpp 
synthetase II), which also possesses weak synthetase activity, is responsible for maintaining 
the intracellular levels of (p)ppGpp nucleotides via enzymatic degradation (Johnson GS et al. 
1979).  
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Figure 2.1. The (p)ppGpp-mediated stringent response.  
(A) Low amino-acid concentrations lead to decreased charging of the corresponding tRNAs. (B) The translational 
machinery depends on the translocation along the mRNA whereby a new acetylated-tRNA is positioned in the 
ribosome. Whenever an uncharged tRNA binds to the ribosome, the elongation of the polypeptide chain is stalled. 
(C) The stringent factor RelA is then activated in the presence of the ribosomal protein L11, catalyzing the 
synthesis of (p)ppGpp nucleotides. (D) These nucleotides bind directly to the RNA polymerase and affect the 
binding abilities of sigma factors to the core RNA polymerase. (E) The co-factor DksA also binds to the RNA 
polymerase and augments the (p)ppGpp regulation of the transcription initiation at certain σ70-dependent 
promoters, functioning both as negative and positive regulators. (F) These regulators change the gene expression: 
(i) decreasing the transcription activity of genes involved in the translational activity; (ii) and increasing the 
transcription of stress-related operons and genes encoding for enzymes needed for the synthesis and the 
transport of amino acids.  
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The (p)ppGpp-mediated response involves the control of the genetic expression by direct 
interaction of the (p)ppGpp nucleotides with the RNA polymerase (RNAP) (Chatterji D et al. 
1998; Artsimovitch I et al. 2004). Typically, transcription depends on the recognition of the 
promoter elements by the complex RNAP-sigma (σ) factor and the DNA-binding activity of 
transcription factors. During stringent response (p)ppGpp nucleotides, in conjunction with the 
DksA protein, bind to RNAP activating the transcription of the genes coding for stress-
associated sigma factors and amino acid biosynthesis and inhibiting the transcription of stable 
RNAs (rRNA and tRNA) (Paul BJ et al. 2004). 
This (p)ppGpp-mediated scenario is quite complex and many fundamental details, such as the 
mechanisms underlying the activation of transcription by (p)ppGpp, remain unknown or 
uncertain (Potrykus K and Cashel M 2008; Wu J and Xie J 2009). Experimental results keep 
being produced, and therefore continuous and incremental literature review is required to gain 
a better understanding of the process. In this work, we propose the development of a literature 
mining approach that complements manual literature review. This semi-automatic information 
extraction approach aims at speeding up the review process, but, far more important, takes 
advantage of public database information and ontology assignments to provide for large-scale 
enrichment and contextualisation of textual evidences. Manual curation was on top of the 
automatic annotation process and addressed the validity and consistency of the extracted 
information.  
A corpus, i.e., a set of documents, related to the stringent response of E. coli (published till 
2009) was retrieved using NCBI PubMed tools. EcoCyc database (Keseler IM et al. 2009), a 
key resource for E. coli studies, provided for most of the controlled vocabulary used for the 
identification of relevant entities in the documents, namely genes, gene products and small 
molecules. Moreover, EcoCyc gene and gene product assignments to Gene Ontology (GO) 
(Ashburner M et al. 2000) and MultiFun ontology (Serres MH and Riley M 2000) enabled the 
annotation of biological processes and molecular functions. Additionally, the Proteomics 
Standards Initiative-Molecular Interactions (PSI-MI) ontology (Hermjakob H et al. 2004) 
supported the annotation of experimental techniques.  
The analysis of corpus annotations aimed at (i) corroborating existing knowledge about key 
players and processes involved in the stringent response of E. coli and (ii) unveiling knowledge 
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that has been overlooked in the existing reviews. Analysis was based on the assumption that 
entities, processes and functions of interest could be identified by finding those terms (i.e. the 
set of name variants that identify a given biological entity or experimental technique) that were 
significantly present among all terms found on the corpus. As such, the frequency and variance 
of term annotation supported the identification of key players, whereas GO and MultiFun 
assignments to gene products assisted on the inspection of the involved biological processes. 
Finally, a decade-by-decade retrospective analysis was performed to evaluate the influence of 
technology advances on these findings and to get a broader perspective on the current 
knowledge of the stringent response.  
 
2.3 EXPERIMENTAL PROCEDURES  
The semi-automatic information extraction approach designed to review existing literature on 
the stringent response of E. coli, which integrated automatic document retrieval and entity 
recognition processes, manual curation and corpus analysis, is shown in Figure 2.2.  
 
 
Figure 2.2. Semi-automatic information extraction approach.  
The first step encompasses the retrieval of relevant documents that are then processed to recognize biological 
entities and map ontological concepts. The corpus analysis enables the identification of key players or significant 
information by an incremental curation that can further deliver information for retrieving new relevant documents. 
Chapter 2 59 
 
 
2.3.1  SEMI-AUTOMATIC INFORMATION EXTRACTION APPROACH 
A keyword-based search in PubMed, using the query ((“Escherichia coli” OR “E. coli”) AND 
“stringent response”) was used to compile the set of documents analysed in this work. @Note 
(Lourenco A et al. 2009), a workbench for Biomedical Text Mining enabled the use of common 
literature mining techniques, namely dictionary and rule-based techniques, in the recognition 
and annotation of genetic components, gene products and small molecules. Its regular 
expression module enabled the identification of genes and proteins that adhere to standard 
gene and protein naming conventions for E. coli (e.g. three lower case letters followed by a 
fourth letter in upper case or a term consisting of four digits preceded by character ‘b’ are 
candidates for gene names).  
The annotated corpus was stored into XML files for enabling further computer processing. 
Manual curation was regarded as the second stage of annotation and aimed at validating 
automatic annotations and coping with automatic annotation flaws and limitations. Each XML 
file was manipulated by the curator using the @Note’s manual curation environment. The 
curator was able to add, remove and correct annotations, evaluating possible improvements in 
the entity recognition process, namely the refinement of the vocabulary and the adjustment of 
the set of regular expressions.  
 
2.3.2 CONTROLLED VOCABULARY  
EcoCyc database (version 13.0, released in March 2009) provided for most of the controlled 
vocabulary. It supported the automatic identification of genetic components, gene products and 
small molecules as follows: common names and extensive name variants (synonyms) were 
used for recognising all entities in the corpus; entity name variants were normalised by 
associating the corresponding database record identifier to the annotation; and database 
assignments to GO and MultiFun categories enabled the mapping of annotated terms to the 
associated molecular functions and biological processes. Additional vocabulary was extracted 
from PSI-MI ontology for the annotation of experimental techniques.  
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2.3.3 ANALYSIS METHODOLOGY 
The number of annotations of a term (or entity), the number of documents that contributed for 
those annotations and the number of documents composing the corpus constituted the 
baseline of the statistical metrics used in the analyses. Let D be the set of documents in the 
corpus and T be the set of annotated terms in D. For every Tti ∈ , the frequency, the mean, 
the standard deviation of annotation, and the variance-to-the mean ratio (or coefficient of 
dispersion) were computed as described in Table 2.1. 
 
Table 2.1. Annotation statistics used in the analysis. 
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The frequency of annotation, freqti, is the fraction of documents in D that refers to the term ti. In 
turn, the mean, µti, and the standard deviation, σti, weight the number of annotations of a term, 
#annotsti, in the documents in D that include those annotations, docsti, and measure the 
average or dispersion of the annotations, respectively. The mean indicates the 
representativeness of the term in the subset docsti whereas the standard deviation indicates the 
variability of annotation in the subset. The variance-to-mean ratio (also called index of 
dispersion), VMRti, is a quantitative measure of the degree of clustering of term annotations. A 
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ratio that is greater than 1 indicates a clustered distribution, i.e., term annotations are 
unevenly distributed in the subset docsti; less than 1 indicates an evenly dispersed distribution, 
i.e., term annotations are evenly distributed in the subset docsti; equal to 1, a random 
distribution; and, equal to 0, indicates a constant distribution, i.e., the number of term 
annotations is the same in all documents that refer to the term. Finally, the frequency of co-
annotation relates two different entities, assuming that entities that are often co-annotated (in 
the same document) are biologically engaged. The frequency of co-annotation was estimated 
and these interactions were illustrated using the Cytoscape biomolecular interaction viewer and 
analyser (Shannon P et al. 2003). 
The statistics of the ontology assignments of the annotated terms were studied for process and 
function analysis. The functions of the annotated gene products and the involved biological 
processes are reflected in their GO and MultiFun annotations and thus, processes and 
functions of interest were identified by finding statistically enriched terms (mainly by looking 
into the frequency of annotation). Similar assessments were taken over PSI-MI assignments 
towards the identification of the techniques that have contributed the most to the study of the 
stringent response. Apart from the systematic analysis of the set of annotations in corpus, a 
retrospective analysis of annotations per decade was also undertaken (i.e. frequency of 
annotation per decade). Such analysis aimed at looking into the evolving experimental 
techniques that contributed to the study of the stringent response over the decades and, in 
particular, evaluating the impact that the technological evolution had in the identification of 
molecular participants. 
Finally, a set of recent documents that review the literature on the subject were manually 
retrieved from PubMed. Their contents were evaluated in terms of annotations of genetic 
components, gene products and small molecules and further compared to the annotations 
retrieved from the corpus. 
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2.4 RESULTS  
Since the aim of this approach was to extract detailed information on the stringent response, 
the process of document retrieval was focused on full-texts. A keyword-based search on 
PubMed retrieved a total of 251 documents, from which 231 documents had full-texts available 
under different subscription policies. Open-access journals provided for 129 documents 
whereas 64 documents were retrieved using team’s institutional journal subscriptions. At the 
end, an overall of 193 full-text documents, most of which published in recent years, were 
available for annotation (Figure 2.3). 
 
 
Figure 2.3. Number of retrieved full-text publications per year (accumulated). 
 
The automatic identification of biological entities in the documents, so-called entity recognition, 
was based on EcoCyc controlled vocabulary for major biological classes and involved the 
recognition of genetic components (genes, RNA and DNA molecules), gene products (proteins, 
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including transcription factors and enzymes) and small molecules. Additionally, a hand-crafted 
dictionary supported the recognition of experimental techniques and their association to PSI-MI 
ontology concepts. The manual curation process consisted on reviewing document 
annotations, i.e., the text markups (XML tags) for recognised entities, to ensure the corpus 
quality and consistency. Errors of the automated recognition process such as the annotation of 
false entities (e.g. the words ‘release’ or ‘crease’ were annotated as enzymes based on 
common enzyme suffix ‘ase’), homonyms (e.g. the same term ‘elongation factor Tu’ to 
designate two different polypeptides ‘TufA’ and ‘TufB’) and PDF-to-text format conversion typos 
(e.g. ‘4azaleucine’ and ‘9galactosidase’ were corrected to ‘4-azaleucine’ and ‘β-galactosidase’, 
respectively) were manually curated. After manual curation, the corpus consisted of 93893 
annotations for 2474 entities.  
 
Figure 2.4. Corpus annotation contents.  
Overview of the extent of entities (A) and entity annotations (B) corresponding to each class. GO assignments (C) 
for molecular functions and biological processes mapped for each set of gene products (i.e. enzymes, 
transcription factors and other proteins) and MultiFun gene assignments (D) for different functional roles (BC-1 to 
Metabolism, BC-2 to Information transfer, BC-3 to Regulation, BC-4 to Transport, BC-5 to Cell processes, BC-6 to 
Cell structure, BC-7 to Location of gene products and BC-8 to Extrachromosomal origin) were recognized in the 
corpus.  
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Gene and gene products ontology assignments to MultiFun and GO were straightforward since 
all entries in the EcoCyc dictionary keep the corresponding database assignments to these 
ontologies. Similarly, ontology assignments to PSI-MI concerning laboratory techniques were 
enabled by the hand-crafted dictionary. Annotations were distributed as follows (Figure 2.4): (i) 
most of the annotated entities represent genetic components (50% of the entities), whereas 
small molecules accounted for the largest number of annotations (35% of the overall number of 
annotations); (ii) enzymes and proteins contributed to most GO assignments; and (iii) the 
MultiFun cellular function categories ‘Metabolism’(BC-1) and ‘Location of gene products’ (BC-
7) related to most of the annotated genes.  
The analysis of the corpus was based in the assumption that relevant entities could be 
identified by finding frequent terms. Thus, the analysis was primarily based on the number of 
documents where each entity was annotated and the number of entity annotations per 
document. First, the frequency of annotation (freqti) assessed the recurrent mention of an entity 
throughout the corpus and the mean (meanti) and standard deviation (stdti) of annotation 
showed its relevance in the discussion. Then, the variance-to-mean ratio (VMRti) indicated the 
existence of document clusters, which put emphasis on particular entities that are much less 
discussed on the rest of the documents. Additionally, the frequency of co-annotation (freqti,tj) 
was calculated for highly representative entities (entities with high frequency and mean) to 
identify those entities that were most probably engaged to them. 
To understand the evolving of the topic throughout the years, and in particular the impact of 
technology-driven advances, this analysis was extended to the study of annotations per decade. 
The analysis of gene and gene product assignments to MultiFun and GO ontologies pursued 
the comprehension of the molecular functions and biological processes involved in the 
stringent response of E. coli. 
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2.4.1  BIOLOGICAL ENTITIES 
The systems-level investigation of the stringent response involved the search for three main 
biological classes: genetic components (genes, RNA and DNA molecules), gene products 
(proteins, transcription factors and enzymes) and small molecules.  
 
Table 2.2. Annotations of the genetic components in the corpus.  
Individual genetic components (i.e. genes, DNAs and RNAs) were evaluated considering the number of documents 
where these entities were annotated and their number of annotations in the corpus. Statistical measurements are 
detailed in the Methods and Materials section. VMR: variance-to-mean; Std: standard deviation. 
Class Term 
Number of 
Annotations 
Number of 
Documents 
Frequency 
(%)Ψ 
M ean Std VM R  
Ge
ne
 
relA 3163 138 71.50 22.92 27.23 33.14 
spoT 1315 88 45.60 14.94 27.42 52.07 
lac 354 63 32.64 5.620 19.42 72.20 
lacZ 534 50 25.91 10.68 17.16 28.90 
thi 91 47 24.35 1.940 0.050 4.000 
rel 523 47 24.35 11.13 20.68 36.36 
recA 82 39 20.21 2.100 1.810 0.5000 
rpsL 95 36 18.65 2.640 3.530 4.500 
thr 84 36 18.65 2.330 3.760 4.500 
rpsG 103 34 17.62 3.030 7.250 16.33 
leu 98 34 17.62 2.880 6.800 18.00 
rpoS 205 33 17.10 6.210 10.83 16.67 
kan 308 33 17.10 9.330 16.61 28.44 
glnV 42 31 16.06 1.350 0.7400 0 
rpoB 389 30 15.54 12.97 17.60 24.08 
ptsG 240 30 15.54 8.000 21.54 55.13 
trp 144 25 12.95 5.760 14.73 39.20 
carA 60 20 10.36 3.000 3.810 3.000 
hsdR 23 19 9.840 1.210 0.5600 0 
DN
A 
DNA 1839 137 70.98 13.42 16.31 19.69 
plasmid DNA 193 36 18.65 5.360 12.31 28.80 
chromosomal DNA 63 24 12.44 2.630 2.440 2.000 
cDNA 125 23 11.92 5.430 5.820 5.000 
RN
A 
RNA 4193 140 72.54 29.95 38.21 49.79 
uncharged tRNA 1168 117 60.62 9.980 19.64 40.11 
rRNA 1116 97 50.26 11.51 25.97 56.82 
a mRNA 999 91 47.15 10.98 19.52 36.10 
rrnA 911 87 45.08 10.47 22.51 48.40 
stable RNA 430 87 45.08 4.940 8.030 16.00 
a charged tRNA 140 43 22.28 3.260 4.200 5.330 
rrnB 301 26 13.47 11.58 19.30 32.82 
rrn 321 26 13.47 12.35 30.42 75.00 
16s-rRNAs 156 25 12.95 6.240 9.090 13.50 
ΨA threshold of 10% of the frequency of annotation was set for each genetic component category.   
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The analysis of the frequency of annotation of genetic components (see Table 2.2) evidenced 
that entities like the relA gene and the RNA and DNA molecules were annotated in more than 
70% of the documents. Though the representativeness of such entities in these documents was 
considerably high (i.e. high mean of annotation), the annotations were over-dispersed (VMR>1). 
For example, the relA gene has a mean of over 22 annotations per document and a VMR of 
over 33, meaning that a small part of the documents presents a very high number of 
annotations, which suggests that these are focused on the discussion of the role of this gene in 
the stringent response. 
Similarly, the analysis of gene product annotations (see Table 2.3) exposed RelA, RNAP and 
ribosomes as highly annotated entities (present in over than 50% of the documents) with a 
considerable degree of over-dispersion (VMR>1). More interesting, the Fis transcriptional dual 
regulator, which modulates several cellular processes, such as the transcription of stable RNA 
(PMID: 2209559; PMID: 9973355)1
 
 (Ross W et al. 1990; Walker KA et al. 1999), presented a 
low frequency of annotation (less than 10% of the documents), but was highly annotated in the 
associated documents (with a mean of almost 50 annotations per document). An extremely 
high value of VMR (over 150) pointed out that some of these documents are really devoted to 
the discussion of this biological entity. 
 
 
 
 
 
 
                                            
1 The PubMed Unique Identifiers (PMIDs) indicate which documents from the corpus supported the evidences. 
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Table 2.3. Annotations of the gene products in the corpus.  
Individual gene products (i.e. enzymes, transcription factors and other proteins) were evaluated considering the 
number of documents where these entities were annotated and their number of annotations in the corpus. 
Statistical measurements are detailed in the Methods and Materials section.  
Class Term 
Number of 
Annotations 
Number of 
Documents 
Frequency 
(%)Ψ 
Mean Std VM R  
Pr
ot
ei
ns
 
Ribosome 1643 128 66.32 12.84 23.57 44.08 
Rel 1021 62 32.12 16.50 36.60 81.00 
LacZ 543 53 27.46 10.30 17.44 28.90 
Sigma 38 factor 392 42 21.76 9.330 15.40 25.00 
Sigma factor 112 35 18.13 3.200 5.870 8.330 
UvrD 56 35 18.13 1.600 1.300 1.000 
RpoB 252 35 18.13 7.200 11.50 17.29 
RecA 99 31 16.06 3.190 4.260 5.330 
EF-Tu 223 26 13.47 8.580 17.32 36.13 
Der 51 25 12.95 2.040 2.140 2.000 
Sigma 70 factor 134 21 10.88 6.380 11.19 20.17 
Tr
an
sc
ri
pt
io
n 
fa
ct
or
s 
Fis  888 18 9.330 49.33 86.88 150.9 
Fur 56 13 6.740 4.310 9.260 20.25 
CRP 279 12 6.220 23.25 36.28 56.35 
DnaA 121 11 5.700 11.00 23.00 48.09 
H-NS 73 11 5.700 6.640 10.73 16.67 
LexA 101 10 5.180 10.10 18.32 32.40 
IHF 54 9 4.660 6.000 5.250 4.170 
En
zy
m
es
 
RelA 4138 152 78.76 27.22 31.16 35.59 
RNAP 1873 117 60.62 16.01 28.08 49.00 
SpoT 1024 60 31.09 17.07 42.19 103.8 
EcoRI 215 53 27.46 4.060 4.970 4.000 
β-galactosidase 294 47 24.35 6.260 6.550 6.000 
BamHI 149 43 22.28 3.470 5.870 8.330 
HindIII 114 41 21.24 2.780 2.160 2.000 
RNase 109 36 18.65 3.030 4.280 5.330 
YbcS 50 23 11.92 2.170 2.620 2.000 
Reverse 
transcriptase 
34 21 10.88 1.620 1.050 1.000 
tRNA synthetase 54 20 10.36 2.700 2.630 2.000 
Endonuclease I 29 20 10.36 1.450 1.400 1.000 
ΨA threshold of 10% of the frequency of annotation was set for enzymes and other proteins, whereas a threshold 
of 5% was set for transcription factors. VMR: variance-to-mean; Std: standard deviation. 
 
The analysis of the annotation of small molecules (see Table 2.4) revealed that, though almost 
83% of the documents discussed the general role of amino acids and nucleotides, the mean of 
annotation of specific nucleotides and amino acids was quite low (less than 10 annotations per 
document in most cases). The two exceptions were the nucleotides ppGpp and (p)ppGpp (the 
collective reference for ppGpp and pppGpp). A high frequency of annotation (75% and 37%, 
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respectively) and a high mean of annotation (29 and 43, respectively) confirm that these 
nucleotides are central in the stringent response in E. coli. Indeed, during amino acid 
starvation (p)ppGpp nucleotides coordinate several cellular activities by influencing gene 
expression. As a result, further analysis based on the frequency of co-annotation of these 
nucleotides (and also the related pppGpp nucleotide) with gene products was issued to support 
the identification of more key players (Figure 2.5). 
 
Table 2.4. Annotations of the small molecules in the corpus.  
Individual small molecules were evaluated considering the number of documents where these entities were 
annotated and the number of annotations in the corpus. Statistical measurements are detailed in the Methods 
and Materials section.  
Term 
Number of 
Annotations 
Number of 
Documents 
Frequency (%)Ψ Mean Std VM R  
Amino acids 1557 160 82.90 9.730 13.83 18.78 
Nucleotides 1230 145 75.13 8.480 9.290 10.13 
ppGpp 4159 145 75.13 28.68 31.00 34.32 
β-D-glucose 792 123 63.73 6.440 10.63 16.67 
Pi 662 113 58.55 5.860 12.60 28.80 
Guanosine 407 112 58.03 3.630 3.540 3.000 
ATP 587 100 51.81 5.870 7.410 9.800 
GTP 748 91 47.15 8.220 13.85 21.13 
AMP 598 90 46.63 6.640 10.09 16.67 
PPi 447 87 45.08 5.140 5.180 5.000 
H2O 210 83 43.01 2.530 2.430 2.000 
Tris 261 82 42.49 3.180 2.800 1.330 
Carbon 288 80 41.45 3.600 4.850 5.330 
Chloramphenicol 435 77 39.90 5.650 8.250 12.80 
pppGpp 632 74 38.34 8.540 13.61 21.13 
(p)ppGpp 3127 72 37.31 43.43 56.00 72.93 
NaCl 189 67 34.72 2.820 2.790 2.000 
L-lactate 413 65 33.68 6.350 20.84 66.67 
Glycerol 145 65 33.68 2.230 1.850 0.5000 
Ethanol 189 65 33.68 2.910 4.400 8.000 
Na+ 145 63 32.64 2.300 2.100 2.000 
Ampicillin 321 62 32.12 5.180 12.74 28.80 
EDTA 142 60 31.09 2.370 1.680 0.5000 
L-methionine 248 59 30.57 4.200 6.670 9.000 
L-histidine 183 59 30.57 3.100 5.410 8.330 
L-valine 396 57 29.53 6.950 11.90 20.17 
Formate 136 57 29.53 2.390 2.360 2.000 
ΨA threshold of 30% of the frequency of annotation was set for compounds. VMR: variance-to-mean; Std: standard 
deviation.   
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Figure 2.5. Proteins co-annotated with ppGpp, pppGpp and the collective (p)ppGpp 
entities.  
Edges indicate the proteins co-annotated with these core nucleotides and nodes represent proteins with frequency 
of co-annotation higher than 10%. Highly co-annotated proteins are represented by nodes with a larger size 
(frequencies of co-annotation greater than 50%). Pink nodes represent the proteins that were co-annotated with 
the three entities, while green and yellow nodes indicate the proteins that are co-annotated with only two and one 
of the nucleotides, respectively. 
 
The (p)ppGpp nucleotides were found to be considerably co-annotated with highly 
representative proteins, namely: the RelA and SpoT enzymes that control the basal levels of the 
nucleotides (around 93% and 67%, respectively); ribosomes that are affected by the nucleotides 
activity (around 79%); RNAP (around 64%); and the RpoS, the alternative sigma factor σ38 that 
acts as the master regulator of the general stress response (around 40%) (PMID: 9326588) 
(Shiba T et al. 1997). Some proteins were co-annotated with only one or two of the terms. For 
instance, the Gpp enzyme that converts pppGpp into ppGpp (PMID: 8531889; PMID: 
6130093) (Condon C et al. 1995; Hara A and Sy J 1983) was essentially co-annotated with 
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pppGpp. In turn, the RecA protein, which catalyses DNA strand exchange reactions (PMID: 
17590232) (Manganelli R 2007), and the tRNA synthetase were co-annotated with (p)ppGpp 
and ppGpp with a frequency higher than 10%, whereas other proteins were mainly co-
annotated with (p)ppGpp and pppGpp: the elongation factor (EF) G, known to facilitate the 
translocation of the ribosome along the mRNA molecules (PMID: 8531889) (Condon C et al. 
1995); the RplK (or 50S ribosomal subunit protein L11) that was reported to be essential when 
the 30S ribosomal initiation complex joins to the 50S ribosomal subunit and in the EF-G-
dependent GTPase activity (PMID: 17095013; PMID: 12419222) (Wendrich TM et al. 2002; 
Jenvert RM and Schiavone LH 2007); and the enzyme PhoA known to be involved in the 
acquisition and transport of phosphate (PMID: 9555903) (Rao NN et al. 1998). Additionally, 
results pointed out potentially interesting associations with less represented proteins, such as: 
the Fur transcriptional activator that controls the transcription of genes involved in iron 
homeostasis (PMID: 15853883) (Vinella D et al. 2005); the HN-S transcriptional dual regulator 
that is capable of condensing and supercoiling DNA (PMID: 10966109) (Johansson J et al. 
2000); the DnaA protein implicated in the chromosomal replication initiation (PMID:1690706) 
(Chiaramello AE and Zyskind JW 1990); the DinJ-YafQ complex involved in the inhibition of 
protein synthesis and growth (PMID:12123445) and the MazE antitoxin of the MazF-MazE 
toxin-antitoxin system involved in translation inhibition processes (PMID:12123445) (Chang DE 
et al. 2002).  
 
2.4.2 ONTOLOGY TERM ENRICHMENT 
Recent developments in the functional annotation of genomes using biological ontologies 
provided the means to contextualise literature mining outputs, i.e. to disclose the biological 
meaning behind the annotated entities. The automatic mapping of annotated entities to 
ontology concepts was possible because EcoCyc supports the assignment of MultiFun and GO 
ontology concepts to genes and gene products in its curation procedures. MultiFun ontology 
classifies gene products according to their cellular function, namely: metabolism, information 
transfer, regulation, transport, cell processes, cell structure, location, extra-chromosomal 
origin, DNA site, and cryptic gene. In turn, GO embraces three separate ontologies: cellular 
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components, i.e. the parts of a cell or its extracellular environment; molecular functions, i.e. 
the basic activities of a gene product at the molecular level, such as binding or catalysis; and 
biological processes, i.e. the set of molecular events related to the integrated functioning of 
cells, tissues, organs or organisms.  
Here, the analysis of ontology assignments was focused on MultiFun cellular functions and GO 
biological processes (Table 2.5 and Table 2.6). The aim was to identify the processes and 
functions to which annotated entities contributed the most. As such, the frequency of ontology 
assignment represented the fraction of documents in the corpus that included entities with 
assignments to the concept. The frequency of assignment estimated the particular contribution 
of an entity to the overall assignment of the ontology concept and the frequency of annotation 
of the entity indicated the number of documents in which that entity was annotated. Since one 
entity can be associated to several ontology concepts and the representation of an ontology 
concept depends on the number of annotations of the embraced entities, the frequency of 
assignment evaluated the most contributing entities to ontology concepts whereas the 
frequency of annotation provided indication of whether those entities are considerably 
discussed in the corpus or not. 
The analysis of MultiFun cellular function assignments (Table 2.5) evidenced gene functions 
related to central metabolism processes, post-transcriptional processes and transcription 
related functions (covered by over 50% of the documents). The most assigned MultiFun cellular 
functions, namely metabolic functions related to nucleotide and nucleoside conversions (BC-
1.7.33) and proteolytic cleavage of compounds (BC-3.1.3.4), derived from the highly annotated 
relA and spoT genes. The lacZ gene, another highly annotated gene (26% of the documents), 
that encodes the β-galactosidase enzyme responsible for the hydrolysis of β-galactosides into 
monosaccharides, contributed significantly (almost 50% of assignments) to the annotation of 
cellular functions implicated in the metabolism of carbon compounds (BC-1.1.1). The gene fis 
that encodes the Fis transcriptional dual regulator and the gene rpoB coding for the β subunit 
of the RNAP, contributed the most to the annotation of transcriptional related functions (BC-
2.2.2). Similarly, genes like dksA that encodes the DksA protein, rplK that encodes the 50S 
ribosomal subunit L11, and rpsG and rpsL coding for the 30S ribosomal subunitsS7 and S12, 
respectively, contributed the most to the annotation of transcription related processes (BC-
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2.3.2). By looking into the frequency of annotation of the corresponding encoded products, it 
was verified that there is a discrepancy of annotation between the genes contributing to 
enriched ontology terms and the corresponding gene products. Therefore, the use of the 
MultiFun ontology not only pointed out relevant gene function assignments, but also disclosed 
the participation of several gene products that, even though presenting extremely low 
frequency of annotation, were highlighted by functional association. Some examples are 30S 
ribosomal subunit protein S12 and 30S ribosomal subunit protein S7 encoded by rpsL and 
rpsG, respectively. 
On the other hand, the analysis of GO biological process assignments (Table 2.6) highlighted 
metabolic and genetic information transfer processes as the most frequent in the corpus (over 
50% of the documents). Although the general concept of metabolic process had the highest 
frequency (89% of the documents), two particular metabolic processes: the nucleobase, 
nucleoside and nucleotide interconversion (GO:0015949) and the guanosine tetraphosphate 
metabolic (GO:0015969) processes, had high frequencies (around 80% of the documents) as 
well. The gene product that contributed the most to the annotation of metabolic-related 
processes was the RelA enzyme, with over 80% of the assignments. Regarding genetic 
information transfer, transcription (GO:0006350), DNA-dependent transcription regulation 
(GO:0006355) and translation (GO:0006412) were the most represented processes (56%, 52% 
and 40% of the documents, respectively). The σ38 factor, the CRP transcriptional dual regulator, 
known to participate in the transcriptional regulation of genes involved in the degradation of 
non-glucose carbon sources (PMID: 10966109) (Johansson J et al. 2000) and the Mfd protein, 
found to be responsible for ATP-dependent removal of stalled RNAPs from DNA (PMID: 
7968917) (Selby CP and Sancar A 1994), contributed similarly to the annotation of 
transcription and DNA-dependent transcription regulation processes, ranging between 10% and 
20% of the assignments. Translation process assignments were derived from the RplK (or 50S 
ribosomal subunit protein L11) and the DksA proteins, with 28% of the assignments each, and 
the Elongation Factor Tu (EF-Tu), which mediates the entry of the aminoacyl tRNA into the 
ribosome, with 13% of the assignments.  
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In terms of stress-specific ontology annotations, responses to stress (GO: 0006950), starvation 
(GO: 0042594), osmotic stress (GO: 0006970) and DNA damage stimulus (GO:0006974) 
were the most frequently assigned cellular response processes (present in almost 40% of the 
documents). The response to stress was mostly assigned by the RecA regulatory protein, the 
RelB transcriptional repressor and the transcription antitermination protein NusA (frequencies 
of assignment of 20%, 16% and 10%, respectively). In the response to starvation, SpoT enzyme 
detached from other contributing gene products (almost 70% of the assignments). The σ38 
factor and the EF-Tu protein were the main contributors to the assignment of osmotic stress 
responses (59% and 34% of the assignments, respectively), while the response to DNA damage 
stimulus was derived from the annotation of proteins Mfd, RecA and RecG (28%, 11% and 11% 
of the assignments, respectively). The process of restoring DNA after damage, called DNA 
repair (GO:0006281), was also assigned by the aforementioned annotated entities.  
Since results evidenced significant assignment of stress-related processes, it was considered 
interesting to explore in detail the functional annotations of gene products related to E. coli 
stress responses (Table 2.7). A decade-by-decade analysis was performed to evaluate the 
extent of documents that study entities associated with these functional annotations. As shown, 
the response to starvation (GO:0042594) was mostly evidenced in the last decade, being 
assigned in almost 70% of the documents of this decade. The response to DNA damage 
stimulus (GO:0006974) and osmotic stress (GO:0006970) were also considerably assigned in 
the last decade (50% of the documents). On the contrary, the defense response to bacterium 
(GO:0042742) was less assigned in the documents from the last two decades (less than 10% 
of the documents) and the stringent response (GO:0015968) was poorly assigned in the last 
decade, probably because GO only associates this biological process to the 50S ribosomal 
subunit protein L11, which only recently has been studied in the context of this stress. 
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Table 2.7. Assignment of GO concepts related to stress responses.  
The frequency of annotation of stress response-related concepts was estimated for documents published in the 
four decades analysed (from 1970 to 2009). 
GO Concept GO Description 
Frequency of Ontology 
Annotation 
1970 1980 1990 2000 
Response to 
starvation 
A change in state or activity of a cell or an 
organism as a result of a starvation stimulus, 
deprivation of nourishment. 
- 15% 28% 68% 
Response to DNA 
damage stimulus 
A change in state or activity of a cell or an 
organism as a result of a stimulus indicating 
damage to its DNA. 
7% 26% 31% 50% 
Response to osmotic 
stress 
A change in state or activity of a cell as a result 
of an increase or decrease in the concentration 
of solutes outside the cell. 
21% 28% 35% 50% 
Response to stress A change in state or activity of a cell or an 
organism as a result of a disturbance in 
organismal or cellular homeostasis. 
- 31% 46% 46% 
Response to oxidative 
stress 
A change in state or activity of a cell or an 
organism as a result of oxidative stress. 
- 3% 20% 45% 
SOS response An error-prone process for repairing damaged 
microbial DNA. 
- 23% 30% 45% 
Response to antibiotic A change in state or activity of a cell or an 
organism as a result of an antibiotic stimulus. 
- 23% 30% 15% 
Response to drug A change in state or activity of a cell or an 
organism as a result of a drug stimulus.  
- 15% 35% 11% 
Response to 
temperature stimulus 
A change in state or activity of a cell or an 
organism as a result of a temperature stimulus. 
- - 9% 11% 
Defense response to 
bacterium 
Reactions triggered in response to the presence 
of a bacterium that act to protect the cell or 
organism. 
14% 26% 9% 8% 
Stringent response A specific global change in the metabolism of a 
bacterial cell as a result of starvation. 
- 13% 7% 6% 
Response to heat A change in state or activity of a cell or an 
organism as a result of a heat stimulus. 
- 3% 13% 5% 
Response to cold A change in state or activity of a cell or an 
organism as a result of a cold stimulus. 
- - - 3% 
Response to toxin A change in state or activity of a cell or an 
organism as a result of a toxin stimulus. 
- - - 3% 
Cellular response to 
starvation 
A change in state or activity of a cell as a result 
of deprivation of nourishment. 
- - - 1% 
Response to copper 
ion 
A change in state or activity of a cell or an 
organism as a result of a copper ion stimulus. 
- - - 1% 
Response to 
desiccation 
A change in state or activity of a cell or an 
organism as a result of a desiccation stimulus. 
- - 4% - 
Response to 
methotrexate 
A change in state or activity of a cell or an 
organism as a result of a methotrexate stimulus.  
- - 2% - 
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2.4.3  EXAMINING LESS-REPORTED ENTITIES 
In the present corpus, most of the biological entities identified as major participants in the E. 
coli stringent response, were also extensively cited in recent reviews (Wu J and Xie J 2009; 
Srivatsan A and Wang JD 2008; Potrykus K and Cashel M 2008; Jain V et al. 2006; 
Magnusson LU et al. 2005). As illustrated in Figure 2.6, biological entities considered to be key 
components in the important reviews, namely the enzymes RelA and SpoT and the RNAP, were 
also evidenced by the semi-automatic information extraction approach.  
 
Figure 2.6. Venn diagram comparing annotations from corpus and selected reviews. 
This diagram indicates the number of entities per class that were retrieved from the corpus and from the latest 
reviews considered to be relevant in this subject. The intersecting zone gives the number of entities that were 
simultaneously reported in the two set of documents.  
 
However, when examining the extent of annotations from the selected reviews and the corpus, 
it was evident that many biological entities have been disregarded or less reported in the 
reviews. Biological entities, such as transcriptional factors and other gene products like stress-
related proteins, were not described in the selected reviews. As exemplified in Table 2.8, the 
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role of some biological entities that are directly (or indirectly) associated with the stringent 
response, is often underestimated by most literature revisions.  
 
Table 2.8. Some examples of less-reported entities (namely in recent reviews), which are 
relevant in the E. coli stringent response. 
Biological 
entities 
Freq 
(%) 
Details References 
DnaJ - chaperone 
with DnaK 
3.11 Chaperone protein that assists the DnaJ/DnaK/GrpE system of E. coli. 
The overproduction of ppGpp has shown to induce the accumulation of 
these chaperones. 
(Jones PG et al. 
1992) 
ClpB chaperone 1.55 ClpB, together with the DnaJ/DnaK/GrpE chaperone system, is able to 
resolubilize aggregated proteins.  
(Mogk A et al. 
2003) 
GroEL-GroES 
chaperonin complex 
0.52 GroEL and GroES are both induced by heat and when ppGpp is 
overproduced in E. coli. 
(Jones PG et al. 
1992) 
RuvB - repair 
helicase 
1.55 Component of the RuvABC enzymatic complex that promotes the 
rescue of stalled (often formed by ppGpp) or broken DNA replication 
forks in E. coli. 
(Shinagawa H et 
al. 1988) 
CsrA - carbon 
storage regulator 
1.04 Regulator of carbohydrate metabolism, which activates UvrY, 
responsible for the transcription of csrB that, in turn, inhibits the CsrA 
activity. 
(Sabnis NA et al. 
1995) 
uvrY 0.52 Encodes the UvrY protein that has been shown to be the cognate 
response regulator for the BarA sensor protein. This regulator 
participates in controlling several genes involved in the DNA repair 
system (e.g. CsrA) and carbon metabolism.  
(Pernestig AK et 
al. 2001) 
cstA 0.52 Gene encoding the CstA peptide transporter, which expression is 
induced by carbon starvation and requires the CRP-cAMP 
transcriptional regulator. The CstA translation is regulated by the CsrA 
that occludes ribosome binding to the cstA mRNA. 
(Dubey AK et al. 
2003) 
CspD - DNA 
replication inhibitor 
0.52 CspD is a toxin that appears to inhibit the DNA replication. ppGpp is 
one of the positive factors for the expression of cspD. 
(Yamanaka K and 
Inouye M 1997) 
FabH - β-ketoacyl-
ACP synthase III 
0.52 A key enzyme in the initiation of fatty acids biosynthesis that is 
stringently regulated by ppGpp. 
(Podkovyrov SM 
and Larson TJ 
1996) 
FadR transcriptional 
dual regulator 
1.55 Regulates the fatty acid biosynthesis and fatty acid degradation at the 
level of transcription. ppGpp has been shown to be also involved in the 
regulation of these pathways 
(Podkovyrov SM 
and Larson TJ 
1996) 
NtrC-Phosphorylated 
transcriptional dual 
regulator 
1.04 Regulatory protein involved in the assimilation of nitrogen and in slow 
growth caused by N-limited condition. It was reported that ppGpp levels 
increase upon nitrogen starvation. 
(Peterson CN et 
al. 2005) 
dps 2.59 Gene encoding the Dps protein that is highly abundant in the 
stationary-phase and is required for the starvation responses. It was 
found to be regulated by ppGpp and RpoS. 
(Gong L et al. 
2002) 
psiF  2.07 Gene induced during phosphate starvation that has been associated 
with the accumulation of ppGpp. 
(Rao NN et al. 
1998) 
chpR 2.07 Encodes the MazE antitoxin, a component of the MazE-MazF system 
that causes a "programmed cell death" in response to stresses, 
including starvation. Genes mazE and mazF are located in the E. coli 
rel operon and are regulated by ppGpp. 
(Aizenman E et 
al. 1996) 
mazG 0.52 Encodes the MazG nucleoside pyrophosphohydrolase that limits the 
detrimental effects of the MazF toxin under nutritional stress conditions. 
Overexpression of mazG inhibits cell growth and negatively affects 
accumulation of ppGpp. 
(Gross M et al. 
2006) 
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The recognition of these proteins in the corpus was invaluable, allowing to uncover various 
stress-responsive proteins that are normally associated with other stress responses, such as 
chaperones (e.g. DnaJ, ClpB or the GroEL-GroES chaperonin complex) and toxin-antitoxin 
systems (e.g. protein encoded by chpR). The description of such entities as participants in the 
stringent response discloses a more insightful overview of the complexity of these entangled 
cellular processes. For example, the identification of entities related to certain metabolic 
pathways, like the fatty acids biosynthesis (e.g. FabH and FabR), or DNA processes, like DNA 
replication (e.g. CspD) and DNA repair (e.g. uvrY), expanded the characterization of stringently 
regulated activities that were not evident in most reviews analysed.  
 
2.4.4 EVOLUTION OF TECHNOLOGY 
The evolution of experimental techniques was expected to intersect points of turnover on the 
study of the stringent response. This assumption was confirmed by comparing the number of 
annotations of biological entities (genetic components, gene products and small molecules) 
and experimental techniques (grouped into major PSI-MI classes) per decade (Figure 2.7).  
The analysis evidenced that the repertoire of experimental techniques has been growing 
significantly and the study is ever more dedicated to genetic components. In particular, results 
showed the use of an ever-growing number of experimental interaction detection methods 
(MI:0045) and a considerable number of experimental participant identification (MI:0661) and 
experimental feature detection (MI:0659) methods.  
The analysis of the frequency of annotation (Table 2.9) evidenced that the chromatography 
technology (MI:0091), experimental feature detection (MI:0657), genetic interference 
(MI:0254) and primer specific polymerase chain reaction (PCR) (MI:0088) techniques were 
annotated in more than 40% of the documents. Most techniques were referred roughly two 
times per document, but primer-specific PCR (MI:0088) and array technology (MI:0008) 
presented a considerable mean of annotation (with over 10 and 8 annotations per document, 
respectively) and high VMR values (22.5 and 6.13, respectively), which indicated that these 
techniques were essentially discussed in a given set of documents. 
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Figure 2.7. Comparison of the expansion of knowledge to the applied experimental 
techniques. 
Bars represent the number of biological entities (left Y axis) found for the three major biological classes, i.e., 
genetic components (genes, RNAs and DNAs), gene products (proteins, transcription factors and enzymes) and 
small molecules. Lines plot the number of experimental techniques (right Y axis) associated to the annotated PSI-
MI classes.  
 
Also, a detailed look into the frequency of annotation per decade points out that some of the 
techniques used in early studies have a reduced application today and highlights the increasing 
influence of high-throughput technologies in recent studies. For instance, experimental 
interaction detection methods (MI:0045) such as the scintillation proximity assay (MI:0099), 
the molecular sieving (MI:0071), the filter trap assays (MI:0928) and the cosedimentation 
through density gradient (MI:0029) showed a higher frequency of annotation in the first decade 
(1970-1980) whereas the comigration in gel electrophoresis (MI:0807) and enzymatic studies 
(MI:0415) experienced an increase in the frequency of annotation throughout the decades.  
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Table 2.9. PSI-MI assignments to annotated experimental techniques.  
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2.5 DISCUSSION  
The aim of this work was to use literature mining to complement manual curation in the 
revision, systematisation and interpretation of current knowledge on the stringent response of 
E. coli. Literature mining was expected to speed up the retrieval of relevant literature and help 
on the identification of important biological players and their molecular functions. The 
controlled vocabulary extracted from EcoCyc repository (GO and MultiFun assignments) and 
PSI-MI ontology was expected to support large-scale information processing and biological 
contextualisation.  
At present, manual curation can extract more detailed information from literature than it is 
possible by mining approaches, and more accurately define the participants and their roles. 
However, to achieve a broad coverage, both approaches can efficiently complement each 
other. Results suggested that: (i) automatic literature retrieval is able to provide documents of 
interest whereas controlled vocabulary from publicly available databases can support the 
identification of relevant entities; (ii) database ontology assignments enable entity 
contextualisation into cellular functions and biological processes, delivering a more 
comprehensive and biologically meaningful scenario; and (iii) statistical analysis identifies 
biological entities of interest and facilitates document indexing for additional manual curation. 
Ultimately, the literature mining approach presented clues on entities and associations of 
interest and suggested which documents in the corpus should be further inspected for details 
on given entities or processes. 
The analysis evidenced the (p)ppGpp nucleotides as some of the most annotated biological 
entities: the ppGpp nucleotide was annotated in 75% of the documents, and the term (p)ppGpp 
exhibited the highest average of annotations per document (Table 2.4). The extensive number 
of documents supporting these annotations evidenced that the role of (p)ppGpp nucleotides in 
the stringent response has been extensively studied. Corpus analysis disclosed that the 
synthesis of ppGpp was first associated in 1970 to the activity of relA gene product (PMID: 
4315151) (Cashel M and Kalbache B 1970), which, during amino acid deprivation, promotes 
the accumulation of this nucleotide above the basal levels. Later, in 1980, the ppGpp level was 
found to be controlled by the SpoT enzyme via GTP hydrolysis activity (PMID: 6159345) 
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(Lagosky PA and Chang FN 1980). From then on, studies have been detailing the role of these 
entities on the (p)ppGpp-mediated response.  
Most studies have been focused on the activity of the relA gene and its product RelA (over 70% 
of the documents), while a fewer set of documents (roughly 30% of the documents) has 
reported the activity of the spoT gene and the SpoT enzyme (see Tables 2.2 and 2.3). In part, 
because RelA was the first enzyme discovered to be involved in the stringent response, but 
mostly because it is the first biological entity to respond to the amino acid starvation. 
Accordingly, nucleobase, nucleoside and nucleotide metabolic processes emerged as the most 
assigned functional class associated with the metabolic response to amino acid starvation. The 
lacZ gene was also highly annotated in the corpus, but it was surmised to be associated with 
the involvement of this gene in most genetic manipulation procedures described in many 
studies. 
Transcriptional and translational processes were also highlighted by the analysis. The 
acknowledgment that (p)ppGpp nucleotides manipulate gene expression, so that gene products 
with important roles in the starvation survival are favoured at the expense of those required for 
growth and proliferation, has been widely reported (PMID:12123445; PMID:10809680) 
(Chang DE et al. 2002; Liang ST et al. 2000). In vitro studies demonstrated that (p)ppGpp bind 
directly to the RNAP, affecting the transcription of many genes (PMID:4553835) (Irr JD 1972). 
Also, studies hypothesised that the configuration of the RNAP is altered, decreasing the affinity 
of the housekeeping sigma factor (i.e. σ70) to RNAP and thus, allowing other sigma factors to 
compete and influence promoter selectivity (PMID:12023304) (Jishage M et al. 2002). As 
covered by the corpus analysis, besides RNAP (annotated in over 60% of the documents), four 
of the existing sigma factors in E. coli were also annotated: the σ38 that acts as the master 
regulator of the general stress response (annotated in 22% of the documents); the σ70 that is 
the primary sigma factor during exponential growth (annotated in 11% of the documents); the 
σ54 that controls the expression of nitrogen-related genes (annotated in 4% of the documents); 
and the σ32 that controls the heat shock response during log-phase growth (annotated in 3% of 
the documents). Although the regulation of transcription initiation is not yet fully understood, 
current knowledge suggests that these four sigma factors may interact with the RNAP during 
stringent control.  
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Further inspection of the functional annotations of transcription-related processes helped in the 
characterisation of other annotated entities to understand their roles in this scenario, namely: 
the β subunit of the RNAP (RpoB) to which (p)ppGpp nucleotides bind (PMID:9501189) (Zhou 
YN and Jin DJ 1998); the CRP transcriptional dual regulator that is activated in response to 
starvation conditions (PMID:10966109) (Johansson J et al. 2000); the Fis transcriptional dual 
regulator, whose gene promoter is inhibited during the transcription initiation by the (p)ppGpp-
bound RNAP polymerase (PMID:2209559; PMID:9973355) (Ross W et al. 1990; Walker KA et 
al. 1999); and the Mfd protein that releases the arrested RNAP-DNA complexes after (p)ppGpp 
nucleotides induce the transcription elongation pausing, protecting genome integrity during 
transient stress conditions (PMID:7968917) (Selby CP and Sancar A 1994). In resume, 
(p)ppGpp nucleotides not only modulate the RNAP activity, either by reducing the expression of 
genes like fis (which in turn modulates the expression of the crp gene) or increasing the 
expression of the σ38 gene, but also mediate the inhibition of the RNAP replication-elongation, 
which afterwards requires the Mfd protein to remove the stalled RNAPs (PMID:16039593; 
PMID:7968917) (Selby CP and Sancar A 1994; Trautinger BW et al. 2005). Although most 
studies have focused on the influence of the (p)ppGpp nucleotides on the mechanisms that 
regulate transcription initiation activities, their regulatory effects on the elongation of DNA 
transcription are also important. The combined control of the DNA transcription initiation and 
elongation are central to a prompter cellular response to nutritional starvation (Srivatsan A and 
Wang JD 2008). 
Similarly, (p)ppGpp also influence certain translation-related processes. Studies showed that 
(p)ppGpp inhibits translation by repressing the expression of ribosomal proteins and also 
potentially inhibiting the activity of the particular proteins (PMID:7021151; PMID:11673421; 
PMID:6358217) (Yang X and Ishiguro EE 2001; Pingoud A and Block W 1981; Pingoud A et al. 
1983). Corpus analysis evidenced the annotation of ribosomal proteins, such as the 50S 
ribosomal subunit protein L11 and the 30S ribosomal subunit proteins S7 and S12, as well as 
the EF-Tu and the non-ribosomal DksA protein. The 50S ribosomal subunit protein L11 has 
been indirectly implicated in the feedback inhibition of (p)ppGpp, because ribosomes lacking 
this protein are unable to stimulate the synthesis of these nucleotides (PMID:11673421; 
PMID:17095013) (Jenvert RM and Schiavone LH 2007; Yang X and Ishiguro EE 2001). The 
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involvement of the DksA protein in translation processes was inferred through the inspection of 
functional assignments. As reported (PMID:16824105) (Nakanishi N et al. 2006), DksA 
regulates the posttranscriptional stability of σ38 factor, which increases dramatically when 
(p)ppGpp levels are high. Although these are the main (p)ppGpp interactions at the 
translational level, the impact of these nucleotides in the translation apparatus was further 
analysed based on the frequency of co-annotation of gene products with (p)ppGpp nucleotides 
that unveiled additional participants at this level. As a result, it was possible to perceive the 
relevance of specific translation GTPases known to be inhibited by (p)ppGpp nucleotides, 
namely: the Der protein that stabilises the 50S ribosomal subunit and the EF-G that facilitates 
the translocation of the ribosome along the mRNA molecules (PMID:8531889) (Condon C et 
al. 1995).  
Apart from identifying and contextualising numerous biological participants in the stringent 
response, the proposed analysis (in particular, the analysis of GO functional assignments) 
suggested that some of the biological entities involved in the stringent response may also 
participate in other stress responses. Responses to starvation, DNA damage and osmotic, 
oxidative and SOS stresses, which are gaining increasing attention in the last decades, are 
some examples of stress responses that were also evidenced in the analysis of the corpus 
(over 30% of the documents). Yet, it was striking to notice that the stringent response concept 
was barely assigned, probably because few biological entities are currently associated with this 
GO concept. In fact, the 50S ribosomal subunit protein L11 was the only entity in this corpus 
associated with the concept. Nevertheless, several biological entities that interplay between 
different responses to stress were identified. For example: the link between the stringent 
response and the response to osmotic and oxidative stresses was demonstrated via the 
involvement of the σ38 factor and EF-Tu protein; the response to DNA damage stimulus was 
assigned by the RecA, RecG and Mfd proteins that intervene in the early dissociation of the 
elongation complex stalled by ppGpp (PMID: 16039593) (Trautinger BW et al. 2005); and 
finally, the RecA regulator and the UvrABC nucleotide excision repair complex have been 
implicated in the DNA repair process and SOS response (Bichara M et al. 2007).  
With the extensive list of biological players retrieved from the corpus it was possible to 
recognize and investigate most of the (p)ppGpp induced cellular processes. The basic 
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participants in the stringent response were highlighted by their frequency of annotation and 
their representativeness in the corpus. The (p)ppGpp nucleotides and the RelA and SpoT 
enzymes that control (p)ppGpp basal levels, along with the RNAP, were pointed as the most 
significant entities in the corpus. Nonetheless, corpus analysis also revealed the involvement of 
entities that have been disregarded or less reported in most recent revisions (Wu J and Xie J 
2009; Srivatsan A and Wang JD 2008; Potrykus K and Cashel M 2008; Jain V et al. 2006; 
Magnusson LU et al. 2005). In most cases, this is due to the fact that the reviews are not 
focused on the detailed description of the molecular mechanisms involved in the stringent 
response. They reflect the current state of knowledge, including the different levels of cellular 
processes that are triggered during this stress response, but do not specify which biological 
entities are involved in these processes. However, researchers often need to compile this 
information, not only for experimental purposes, but also for computational modelling or to 
better understand the complexity of the response. Hence, in this study, the stringent response 
was broadly described considering the large variety of biological entities that were directly or 
indirectly affected by the (p)ppGpp within specific metabolic, transcriptional and translational 
processes.  
Following a retrospective analysis, the remarkable advances accomplished in the investigation 
of the (p)ppGpp-induced starvation response in E. coli became evident. The (p)ppGpp 
metabolism has been investigated since the 70s, as well as the transcriptional, translational 
and DNA replication control by these nucleotides. Technological developments have promoted 
the discovery of many new entities and have clarified their roles in the stringent response. At 
the early stage of the study of the stringent response, some traditional experimental techniques 
were considered decisive in the identification of the main metabolic participants (see Figure 
2.7 and Table 2.9). Yet, in the last decades, research efforts have been focused on the newest 
molecular biology techniques, namely high-throughput detection methods. In particular, 
techniques based on array technology have addressed the rapid screening of biological entities 
as well as molecular interactions (PMID: 18039766; PMID: 17233676) (Durfee T et al. 2008; 
Chatterji D et al. 2007). DNA microarrays have been used to inspect the genome-wide 
transcriptional profiles of E. coli (PMID: 18039766) (Durfee T et al. 2008). This technology has 
also provided information on transcriptional regulation, determining negatively controlled 
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promoters (typically involved in cell growth and DNA replication) and positively controlled 
promoters (the amino acid biosynthesis, the transcription factors, and/or alternative sigma 
factor genes). Although the reconstruction of the transcriptional regulatory structure of the 
stringent response is far from complete, these recent advances have brought a closer view of 
the pleiotropic nature of the response. 
Finally, results showed that it is possible to scale-up conventional manual curation coping with 
the ever-increasing publication rate and, at the same time, provide automatic means of 
identifying and contextualising participants of interest. Beyond the accomplishments of the 
approach on this particular study, its extension to the analysis of other stress responses 
and/or organisms is fairly easy and interesting. Adaptation to other scenarios implicates the 
compilation of sets of related documents and eventually other controlled vocabularies (when 
considering other organisms). As future work, the incorporation of an automatic relation 
extraction process is foreseen as a most valuable support to the inspection and understanding 
of involved interactions.  
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3.1 Abstract  
A hybrid modelling approach, combining a stoichiometric model of the 
E. coli metabolic network and kinetic-based descriptions for the 
production of the recombinant protein, cell growth and ppGpp 
synthesis, was applied to describe metabolic bottlenecks associated 
with recombinant processes. The model represents the triggering of the 
stringent response upon the deprivation of amino acids caused by the 
additional drainage of biosynthetic precursors for the production of 
recombinant proteins. The equation for ppGpp synthesis allows to 
estimate the accumulation of this molecule above its basal levels once 
amino acid shortages occur. The capability to predict these stress-
responsive events might be crucial in the design of optimal cultivation 
strategies. 
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3.2 Background 
The production of recombinant proteins can challenge cells with different levels of stress and 
metabolic burden (Hoffmann F and Rinas U, 2004; Schweder T et al., 2002). The cellular 
processes for plasmid DNA replication and expression require the drainage of biosynthetic 
precursors, energy and other cellular resources that are shared with the host cell’s metabolic 
processes. Consequently, the competition for a limited pool of cellular resources will provoke 
serious perturbations in metabolism (Bentley WE et al., 1990; Glick BR, 1995). Typically, it 
promotes the reduction of cellular growth and protein productivity in recombinant cells (Glick BR, 
1995). In particular, the metabolic load imposed by the overexpression of recombinant proteins, 
with an amino acid composition that is often different from the average composition of biomass 
proteins, leads to the imbalance of the cellular metabolism resulting in the over-accumulation of 
some metabolites and shortage of others, like some amino acids. In the past few years, the 
association of this metabolic burden with other cellular events, like the stringent response, has 
been demonstrated (Andersson L et al., 1996; Chao YP et al., 2002; Haddadin FT et al., 2009; 
Hoffmann F and Rinas U, 2004; Schweder T et al., 1995) and the understanding of the whole 
scenario underlying these cellular events in recombinant bioprocesses is fundamental for 
productivity purposes. For example, the stringent response has been characterized by the down-
regulation of stable RNAs (i.e., tRNA and rRNA) and protein synthesis, and the simultaneous up-
regulation of protein degradation (Ferullo DJ and Lovett ST, 2008; Jain V et al., 2006; 
Magnusson LU et al., 2005), which results in considerable losses during recombinant 
bioprocesses.  
The unusual accumulation of a guanosine nucleotide, termed GDP 3’-diphosphate or GTP 3’-
diphosphate, collectively called (p)ppGpp, was identified as one of the key factors that provide 
bacteria the ability to survive under hostile conditions (Chatterji D and Ojha AK, 2001; Jain V et 
al., 2006; Magnusson LU et al., 2005; Mukherjee TK et al., 1998; Torok I and Kari C, 1980; Wu 
J and Xie J, 2009), such as the lack of amino acids. The discovery that these unusual guanosine 
nucleotides are accumulated in response to starvation was followed by extensive studies on the 
downstream pathways of the stringent response, which suggested that accumulating ppGpp is an 
important link between nutritional stress and bacterial adaptation (Cashel M and Kalbache B, 
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1970; Chatterji D and Ojha AK, 2001; Foster PL, 2005; Mukherjee TK et al., 1998; Nystrom T, 
2004b; Nystrom T, 2002).  
It was initially proposed (Haseltin WA and Block R, 1973) that the ratio of aminoacylated transfer 
RNAs (tRNAs) to free tRNAs is one of the critical parameters that regulate the synthesis of ppGpp. 
When free tRNA is encountered at the A-site of the 50S ribosome, protein synthesis is delayed, 
resulting in an idling reaction in which ribosome-bound RelA is activated to synthesize ppGpp 
(pppGpp is produced first and then it is converted to ppGpp). Thus, an increase in the population 
of free tRNA during starvation leads to an accumulation of ppGpp (Chatterji D and Ojha AK, 
2001). The ppGpp levels are controlled by two enzymes, RelA and SpoT. RelA is the major ppGpp 
synthase (also known as ppGpp synthetase I) whose activity occurs in the presence of Mg2+, 
whereas the SpoT protein mainly carries out a pyrophosphate hydrolase activity in the presence 
of Mn2+, although it has also mild synthetic activity (ppGpp synthetase II). 
The pleiotropic effects of the intracellular accumulation of ppGpp have been explored and major 
alterations in the transcription of many stringently controlled genes were found (Magnusson LU et 
al., 2005; Nystrom T, 2004a; Srivatsan A and Wang JD, 2008). In general, genes involved in cell 
proliferation and growth are negatively regulated by ppGpp, whereas genes implicated in 
maintenance and stress defence are positively regulated by this regulator. 
 
3.3 Modelling amino acid shortages towards the 
synthesis of ppGpp 
The view of ppGpp primarily as a regulator of gene transcription has been expanded and it is now 
clear that the response controlled by ppGpp is crucial for cell survival during the adaptation to 
stressful conditions (Magnusson LU et al., 2005). To understand the impact of recombinant 
processes in metabolism it is crucial to capture the molecular basis of the ppGpp synthesis in 
response to metabolic stimuli, like the deprivation of amino acids. However, this stress-
responsive process is still poorly understood, though it is acknowledged that during recombinant 
processes the accumulation of this regulator above a threshold level promotes the stringent 
response.  
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Here we propose a model to examine two fundamental events: the amino acid deprivation 
caused by the unbalanced drainage of biosynthetic resources imposed by the recombinant 
protein production; and the consequent induction of the ppGpp synthesis. A deterministic 
mathematical modelling approach based on a hybrid system, i.e. a system in which discrete 
events are combined with kinetic expressions, was implemented to capture the behaviour of 
these cellular phenomena.  
 
3.3.1 Model description 
Our aim is to analyse the initial steps of the E. coli stringent response by creating a modelling 
structure that acts as a basis to analyse the impact of the synthesis of heterologous proteins on 
the cellular behaviour, specifically in the intracellular accumulation of ppGpp. A combined 
modelling approach was developed to represent the key metabolic bottlenecks in the E. coli 
metabolism during recombinant processes and, subsequently, the induction of the ppGpp 
biosynthetic pathway (Figure 3.1).  
First, the genome-scale metabolic model of E. coli iJR904 (Reed JL et al., 2003) was used for 
simulations using Flux Balance Analysis (FBA) (Price ND et al., 2003; Schilling CH et al., 1999; 
Varma A and Palsson BO, 1994) to determine the metabolic fluxes leading to the biosynthesis of 
amino acids. This approach simulates the E. coli metabolic network under steady-state 
conditions, based on the mass balance of metabolites constrained by stoichiometry and 
thermodynamics, and estimates the optimal metabolic flux distribution subjected to an objective 
function. Details about the mathematical formulations were presented in Chapter 1. In this work, 
the FBA simulation was performed using the OptFlux tool (Rocha I et al., 2010) defining the 
maximization of biomass formation (µ) as the objective function. The predicted amino acid 
biosynthetic fluxes (raa) were then included in the dynamic model that was used for simulations 
using the Systems Biology Toolbox 2 (Schmidt H and Jirstrand M, 2006) implemented in 
MATLAB (version 2009b, The Mathworks, Inc). The ODE model is presented in Appendix A. 
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Figure 3.1. Proposed modelling approach that combines Flux Balance Analysis (FBA) with 
the genome-scale metabolic model of E. coli iJR904 (Reed JL et al., 2003) and dynamic 
rate equations for the intracellular pools: amino acids (aa), biomass, recombinant protein 
(PR) and ppGpp (G4P).  
The amino acid reactions (raa) are depicted as boundary reactions linking the stoichiometric model and the dynamic 
model.  
 
Variables considered in this model are presented in Table 3.1. 
Table 3.1. Variables included in the model. 
Model variables Units 
Biomass (X) gX.L-1 
Carbon source (S) gS.L-1 
Recombinant protein (PR) gPR.gX-1 
Amino acids (aa) gaa.gX-1 
ppGpp (G4P) pmolG4P.gX-1 
Amino acid reactions (raa) gaa.gX-1.h-1 
Biomass-associated stoichiometric coefficients (γaa) gaa.gX-1 
Recombinant protein-associated stoichiometric coefficients (φaa) gaa.gPR-1 
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Differential mass balance equations for amino acid biosynthesis reaction rates were based on the 
previously developed model by Bentley and Kompala (Bentley WE and Kompala DS, 1989): 
( ) ( )PRDPRaaaaaa rrrdt
aad
−−×−= φγµ][  (1) 
Changes in the intracellular amino acids pool were calculated by subtracting the term associated 
with the consumption of a specific amino acid (aa) for biomass formation (µ×γaa) and the term 
associated with the consumption of that amino acid for recombinant protein polymerization 
(φaa×rPR) and its degradation (φaa×rPRD), to the amino acid synthesis flux (raa). The stoichiometric 
coefficients (γaa and φaa) describe the mass requirements of that amino acid for the production of 
the biomass-associated proteins and recombinant AcGFP1 protein (given in Table 3.2). The raa 
term represents the reaction fluxes for each amino acid pool predicted by the FBA approach, 
which were also designated as boundary reactions. Amino acid biosynthesis fluxes were 
calculated by subtracting fluxes that account for the consumption of a particular amino acid (e.g. 
glutamate is often used as a precursor in other reactions) from those that lead to the production 
of that amino acid (in Table 3.3 the values of these fluxes are given for a wild-type strain under 
the conditions detailed in (Reed JL et al., 2003)). All rates are specific for biomass concentration, 
i.e., they are expressed per grams of biomass. 
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Table 3.2. Stoichiometric coefficients of amino acids in the reactions leading to biomass (X) 
and recombinant protein (PR) formation, calculated on the basis of the amino acids 
composition based on (Neidhardt FC et al., 1990) and on AcGFP data, respectively. 
Amino acid (aa) γaa (g.gX-1) φaa(g.gPR-1) 
A-Ala 0.0434 0.0366 
R-Arg 0.0489 0.0417 
N-Asn 0.0302 0.0678 
D-Asp 0.0305 0.0774 
C-Cys 0.0105 0.0083 
Q-Gln 0.0365 0.0350 
E-Glu 0.0368 0.0755 
G-Gly 0.0437 0.0642 
H-His 0.0140 0.0849 
I-Ile 0.0362 0.0673 
L-Leu 0.0561 0.0808 
K-Lys 0.0476 0.0900 
M-Met 0.0218 0.0408 
F-Phe 0.0290 0.0735 
P-Pro 0.0242 0.0433 
S-Ser 0.0215 0.0611 
T-Thr 0.0287 0.0693 
W-Trp 0.0110 0.0070 
Y-Tyr 0.0237 0.0744 
V-Val 0.0470 0.0601 
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Table 3.3. Amino acid biosynthesis reactions based on the metabolic model of E. coli 
iJR904 (Reed JL et al., 2003) and their flux, calculated for a wild-type strain. 
Amino acid Producing reactions Consuming reactions 
Overall synthesis flux 
(g.gX-1.h-1) 
A-Ala rALATA_L rALAR rVPAMT rUAMAS  0.0400 
R-Arg rARGSL  0.0451 
N-Asn rASNS2  0.0279 
D-Asp 
rASPTA 
 
rASNS2 
rARGSS 
rASPO3 
rASP1DC 
rADSS 
rPRASCS 
rASPCT 
rASPK 
0.0281 
C-Cys rCYSS rPPNCL2 rSHSL1   0.0097 
Q-Gln 
rGLNS 
 
rGF6PTA 
rADCS 
rIG3PS 
rGMPS2 
rGLUPRT 
rPRFGS 
rCTPS2 
rANS 
0.0337 
E-Glu 
rGF6PTA 
rADCS 
rGLUDy 
rIG3PS 
rGMPS2 
rGLUPRT 
rPRFGS 
rCTPS2 
rANS 
rALATA_L 
rASPTA 
rUNK3 
rACGS 
rACOTA 
rGLU5K 
rGLUR 
rDHFS 
rGLNS 
rPSERT 
rHSTPT 
rSDPTA 
rTYRTA 
rPHETA1 
rILETA 
rLEUTAi 
0.0339 
G-Gly rGHMT2 rPRAGSr 0.0760 
H-His rHISTD  0.0129 
I-Ile rILETA  0.0333 
L-Leu rLEUTAi  0.0517 
K-Lys rDAPDC  0.0439 
M-Met rUNK3 rMETS  rMETAT 0.0201 
F-Phe rPHETA1  0.0268 
P-Pro rP5CR  0.0223 
S-Ser rPSP_L rSERAT rGHMT2 rPSSA_EC  0.0198 
T-Thr rTHRAr rTHRD_L 0.0264 
W-Trp rTRPAS2  0.0102 
Y-Tyr rTYRTA  0.0219 
V-Val rVPAMT  0.0434 
 
 
 
 
 
 
104 A systematic modelling approach: the stringent response in recombinant E. coli systems 
 
This model describes cellular growth and recombinant protein production in a batch fermentation 
mode with constant volume, where the only available carbon source is glucose and maintenance 
coefficients were not considered. The specific growth rate (µ) for the recombinant bacteria was 
estimated as a function of the substrate concentration (S) based on the Monod equation: 
SK
S
s +
×= 0µµ  
(2) 
where µ0 is referred to the maximum specific growth rate of the wild-type cells predicted by the 
FBA simulation and Ks is the Monod affinity constant corresponding to an approximated value 
from recombinant E. coli growth measurements. The mass balance equations for biomass (X) 
and substrate (S) concentrations were defined as: 
X
dt
dX
×= µ  (3) 
SXY
X
dt
dS
/
×−= µ
 
(4) 
where YX/S is the biomass yield on substrate for recombinant E. coli cells. 
The recombinant protein formation was induced at time 0 and the rates of synthesis  and 
degradation are described using the following expressions based on (Palaiomylitou MA et al., 
2002): 
PRK
PRKr
t
ePR +
×=  (5) 
PRKr PRDPRD *=
 
(6) 
where PR is the recombinant protein concentration, Ke is the maximal rate of protein synthesis, 
incorporating the rate constants for transcription and translation and Kt is the saturation 
constant, which depends on the host-plasmid system used. For protein degradation, the protein 
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denaturation rate constant (KPRD) is given independently of the growth rate. The mass balance 
equation for the recombinant protein concentration was given by the protein synthesis rate and 
an empirical function of the intracellular recombinant protein concentration: 
PRDPR rrdt
dPR
−=  (7) 
At last, the model describes the accumulation of ppGpp or G4P in response to the shortage of 
any amino acid pool (eqs. 8 to 11). The intracellular concentration of ppGpp is given by the rates 
of degradation (rG4PD) and synthesis (rG4P). The ppGpp synthesis rate was defined as a function 
of the intracellular levels of amino acids given by f(aa) and the parameter KG4P. 
PDGPG rrdt
PdG
44
4
−=  (8) 
PGKr PDGPDG 444 ×=
 
(9) 
( )aafKr PGPG ×= 44
 
(10) 
( ) aaEeaaf ×−×= 412.0
 
(11) 
The terms KG4P and KG4PD refer to parameters for the synthesis and degradation of ppGpp. The 
accumulation of ppGpp was empirically described as an exponential function that defines a 
relation f between the stimulus (i.e., levels of aa) and the expected value of the response (i.e., 
levels of ppGpp or G4P) (Torok I and Kari C, 1980).  
All model parameters are given in Table 3.4. 
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Table 3.4. Model parameters. 
Parameter Value References 
µ0 (h
-1) 0.36 Inferred from experimental data 
Ks (g L
-1) 0.05 (Harcum SW, 2002) 
YX/S (gX gS
-1) 0.40 Inferred from experimental data 
Ke (gPR gX
-1 h-1) 4.09 Adapted from (Bentley WE and Kompala DS, 1989; Palaiomylitou MA et al., 2002) 
Kt (gPR gX
-1) 5.39 Adapted from (Bentley WE and Kompala DS, 1989; Palaiomylitou MA et al., 2002) 
KPRD (h
-1) 0.04 Adapted from (Bentley WE and Kompala DS, 1989; Palaiomylitou MA et al., 2002) 
KG4P (h
-1) 0.2 Adapted from (Dedhia N et al., 1997; Torok I and Kari C, 1980) 
KG4PD (h
-1) 0.002 Adapted from (Dedhia N et al., 1997; Torok I and Kari C, 1980) 
 
3.4 Simulation results 
This model can be used to estimate amino acid shortages caused by recombinant processes and 
the consequent activation of the ppGpp synthesis. The systematic evaluation of the deprivation of 
amino acids during the translation process gives a preliminary recognition of potential metabolic 
bottlenecks that ultimately lead to the activation of the stringent response. The stoichiometric 
coefficients associated with biomass and recombinant protein formation requirements were 
fundamental to estimate the mass balance dynamics for each amino acid pool. Information on 
these parameters and kinetic data on the synthesis of biomass (µ) and recombinant protein (rPR) 
formation, allowed estimating the evolution over time of the intracellular amino acid levels. To 
simulate the stringent response, a function determining the relation of ppGpp accumulation and 
decreasing levels of amino acids, as well as an expression (or event) defining the delay on the 
formation of biomass and recombinant protein were implemented in the computation.  
 
3.4.1 Amino acids deprivation 
In this model, the abundance of amino acids was estimated over time (eq. 1) to detect at what 
extent the withdrawn of amino acids for biomass and recombinant protein formation exceeds the 
biosynthetic capacities of E. coli cells. To illustrate the impact of recombinant protein production, 
the concentration of amino acids was allowed to become negative in this exercise (although, 
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clearly, this has no biological meaning). As shown in Figure 3.2, it is clear that the deprivation of 
most amino acids would be extensive, if cells were not capable to counteract these events.  
 
 
Figure 3.2. Dynamics of the intracellular concentrations of amino acids.  
Dashed lines indicate those amino acid pools that seem not to be deprived over time. Concentrations below zero 
indicate that amino acids consumption exceeds the synthesis rate.  
 
3.4.2 ppGpp biosynthesis 
To simulate the triggering of the stringent response caused by the deprivation of amino acids 
shown above, the dynamics of ppGpp was included in the simulation (eqs 8 to 11). In Figure 3.3, 
the cellular response to perturbations in the amino acids pools is demonstrated by the increasing 
levels of ppGpp (G4P) when histidine (H) reached concentration levels close to zero. The 
synthesis of this signalling molecule is described as a function of the first amino acid to be 
depleted in the intracellular pool (eq. 10 and 11). In these particular conditions, histidine (H) was 
the first amino acid to reach levels close to zero, determining the exponential increase in ppGpp 
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levels. At high levels, the concentration of the ppGpp regulator is controlled by the degradation 
rate (eq. 9) of the SpoT enzyme. 
 
 
Figure 3.3. Intracellular pool concentrations of amino acids and ppGpp (G4P).  
The arrow indicates when histidine (H) concentration level falls to zero. 
 
To illustrate the impact of the ppGpp accumulation in the biomass and recombinant protein 
formation, an event was defined, i.e. an expression to simulate discrete state changes when a 
given condition is fulfilled. A simple syntax expression was used to determine that when the 
histidine (H) pool falls below zero, the parameters for the degradation of ppGpp (KG4PD), 
maximum specific growth rate (µ0) and the transcription and translation rate saturation constant 
(Kt) were set to 0.02, 0.2 and 100, respectively (Eq. 12). 
event = lt(H,0.0),KG4PD,0.02, µ0,0.2, Kt,100 (12) 
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The results of the addition of this event are shown in Figure 3.4.  
 
 
Figure 3.4. Intracellular concentrations of histidine (H), ppGpp (G4P), recombinant protein 
(PR), and biomass (X) accumulation during the recombinant bioprocess simulation.  
Basal levels for ppGpp are maintained until the amino acid histidine (H) drops to zero. At that point, the biomass 
formation and the recombinant protein production are stalled (see eq. 12). 
 
3.5 Discussion 
Our current understanding on the behaviour of recombinant systems is based on empirical 
descriptions that disregard the involvement of cellular events, like stress-responsive mechanisms. 
As observed in most cellular systems, in particular in recombinant E. coli cells (Sanden AM et al., 
2003; Tedin K and Bremer H, 1992), stimulus-responses (e.g. amino acid shortages) are 
fundamental to sense and react to metabolic perturbations.  
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The proposed model aims at providing a systematic approach capable to predict amino acid 
shortages based on the biosynthetic capabilities of the E. coli metabolism when induced to 
produce recombinant proteins. A combined modelling approach based on the FBA simulation of 
the E. coli metabolic network and a kinetics-based dynamic method to simulate the behaviour of 
the intracellular amino acids pools during the recombinant bioprocess were implemented. The 
definition of amino acid biosynthetic reactions as boundary reactions was central to follow the 
dynamics of amino acids concentrations, which may constitute metabolic bottlenecks during 
recombinant bioprocess. The existence of one or more bottlenecks is expected to affect most 
cellular processes, including the synthesis of recombinant products, if cells are deprived of 
mechanisms capable to circumvent and respond to such events.  
The accumulation of ppGpp during recombinant bioprocesses has been pointed as a 
consequence of amino acid shortages due to the overexpression of recombinant proteins. As the 
amino acids composition of these proteins is frequently different from the average composition of 
biomass proteins, the unbalanced drainage of these biosynthetic resources is often indicated as 
the major cause for the commonly observed amino acid shortages. In the proposed model, 
stoichiometric coefficients determining the amount of amino acids that are drained from the 
intracellular pools toward biomass and recombinant protein formation, establish the basis for 
estimating possible metabolic bottlenecks in recombinant process. The dynamic equations for 
the amino acid intracellular pools describe the time evolution of their concentrations and, once 
one amino acid reaches concentration levels close to zero, the model estimates the accumulation 
of ppGpp above its basal levels. This stimulus-response model integrates an expression that 
outlines the production of ppGpp as a negative exponential function of the intracellular 
concentration of amino acids. When cells sense the depletion of amino acids, the activity of the 
RelA enzyme is sharply increased. Normally, it is the ratio of aminoacylated transfer RNAs 
(tRNAs) to free tRNAs that triggers the synthesis of ppGpp. Yet, to simplify the model 
representation, we did not include this ratio as the triggering factor for the stringent response, 
given that the limiting substrate in any tRNA charging reaction is its specific amino acid. The 
depletion of the amino acids results, logically, in the increase of free tRNAs that will bind to the 
ribosome and induce the accumulation of ppGpp. The pleiotropic effects of this global regulator 
have been described (Chang DE et al., 2002; Durfee T et al., 2008; Traxler MF et al., 2006), but 
the most significant in recombinant bioprocesses are growth and protein synthesis decline. Thus, 
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the kinetic parameters used to describe these reaction rates were changed to reproduce such 
effects.  
The possibility to predict such dynamic phenomena provides an important advantage when 
designing recombinant fermentation processes. The optimization of cultivation processes to 
produce recombinant proteins is still a difficult task. Despite the advances in novel expression 
systems, it is acknowledged that culture control procedures have a significant impact in the 
productivity of the bioprocess. And thus, it is fundamental to achieve a finer balance between the 
expression levels of the desired protein, along with the tight control of the culture performance. In 
order to predict the process dynamics that hinders the productivity of the recombinant process, 
the development of systematic modelling approaches capable to describe these systems is 
central. Most of the modelling strategies used for optimization and control of bioprocesses are 
based on empirical models that do not sufficiently reflect these dynamic processes. The design of 
optimal recombinant cultivation processes should, however, consider the complexity behind 
these cellular processes to enhance protein productivity.  
 
3.6 Future work 
Studies in the E. coli stringent response have been disclosing the complexity of the mechanisms 
underlying this stress response. The role of ppGpp in microbial cells has been expanded from the 
coordination of cellular activities to cope with amino acid starvation, to many other cellular 
processes, like the coordination of processes associated with pathogenesis, virulence, 
sporulation, etc (Chatterji D and Ojha AK, 2001; Wu J and Xie J, 2009).  
The representation of the dynamics of the overall processes leading to the ppGpp activity and 
subsequent coordinated activities is still complex, but the development of modelling approaches 
capable to describe at least some parts of the system, is hoped to bring major advances. The 
proposed modelling scheme, combining a large scale stoichiometric network simulated by FBA 
and kinetic-based equations, shows some advantages when describing the dynamic behaviour of 
several metabolic variables with limited information on kinetic parameters. However, it is still 
limited to the early stages of the stringent response and transcriptional, translational and post-
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transcriptional events were not included. The inclusion of regulatory information that, finally, will 
reflect alterations in the metabolic flux distributions, is foreseen. Some approaches have already 
been described, like the implementation of Boolean logic rules (Covert MW et al., 2001), 
structure-oriented analyses based on network topology (Stelling J et al., 2002) or the 
representation of dynamic descriptions for metabolic reactions and gene regulation (Varner JD, 
2000). Whilst the dynamic mathematical modelling offers detailed descriptions of the system’s 
behaviour, the lack of data and unknown kinetic parameter values, limits its application. 
However, the combination of mathematical approaches that integrate stoichiometry, kinetics and 
gene regulation seems a promising strategy to analyse large scale models.  
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3.8 Appendix A 
********** MODEL NAME 
Stringent response in recombinant E. coli systems  
********** MODEL NOTES 
 
********** MODEL STATES 
d/dt(Sg) = -miu*X/Yxs                      
d/dt(X) = miu*X                            
d/dt(PR) = rPR-rPRD                        
d/dt(G4P) = rG4P-rG4PD                     
d/dt(A) = rA-(miu*gamaA)-fiA*(rPR-rPRD)    
d/dt(R) = rR-(miu*gamaR)-fiR*(rPR-rPRD)    
d/dt(N) = rN-(miu*gamaN)-fiN*(rPR-rPRD)    
d/dt(D) = rD-(miu*gamaD)-fiD*(rPR-rPRD)    
d/dt(C) = rC-(miu*gamaC)-fiC*(rPR-rPRD)    
d/dt(Q) = rQ-(miu*gamaQ)-fiQ*(rPR-rPRD)    
d/dt(E) = rE-(miu*gamaE)-fiE*(rPR-rPRD)    
d/dt(G) = rG-(miu*gamaG)-fiG*(rPR-rPRD)    
d/dt(H) = rH-(miu*gamaH)-fiH*(rPR-rPRD)    
d/dt(I) = rI-(miu*gamaI)-fiI*(rPR-rPRD)    
d/dt(L) = rL-(miu*gamaL)-fiL*(rPR-rPRD)    
d/dt(K) = rK-(miu*gamaK)-fiK*(rPR-rPRD)    
d/dt(M) = rM-(miu*gamaM)-fiM*(rPR-rPRD)    
d/dt(F) = rF-(miu*gamaF)-fiF*(rPR-rPRD)    
d/dt(P) = rP-(miu*gamaP)-fiP*(rPR-rPRD)    
d/dt(S) = rS-(miu*gamaS)-fiS*(rPR-rPRD)    
d/dt(T) = rT-(miu*gamaT)-fiT*(rPR-rPRD)    
d/dt(W) = rW-(miu*gamaW)-fiW*(rPR-rPRD)    
d/dt(Y) = rY-(miu*gamaY)-fiY*(rPR-rPRD)    
d/dt(V) = rV-(miu*gamaV)-fiV*(rPR-rPRD)    
                                           
Sg(0) = 10                                 
X(0) = 0.20000000000000001                 
PR(0) = 0.002                              
G4P(0) = 1.0000000000000001e-005           
A(0) = 0.00023729999999999999              
R(0) = 0.000232                            
N(0) = 0.00022000000000000001              
D(0) = 0.00059409999999999997              
C(0) = 8.0699999999999996e-005             
Q(0) = 0.0002433                           
E(0) = 0.00024499999999999999              
G(0) = 0.00020000000000000001              
H(0) = 0.0001033                           
I(0) = 0.00021829999999999999              
L(0) = 0.0003057                           
K(0) = 0.00022389999999999999              
M(0) = 4.9700000000000002e-005             
F(0) = 0.00022000000000000001              
P(0) = 0.0001917                           
S(0) = 0.00024499999999999999              
T(0) = 0.0013844                           
W(0) = 0.000136                            
Y(0) = 0.00042230000000000002              
V(0) = 0.000234 
 
********** MODEL PARAMETERS 
miuwt = 0.36000000000000004                
ks = 0.05                                    
Yxs = 0.4                                  
ke = 4.0999999999999988                    
kt = 5.3999999999999995                    
kPRD = 0.050000000000000002                
kg4p = 0.20000000000000001                 
kg4pd = 0.002 
 
********** MODEL VARIABLES 
rA = 0.04004199                            
rR = 0.04507818                            
rN = 0.02786916                            
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rD = 0.02807896                            
rC = 0.00970541                            
rQ = 0.03365008                            
rE = 0.03388203                            
rG = 0.0759915                             
rH = 0.0128619                             
rI = 0.03333426                            
rL = 0.05169129                            
rK = 0.0438803                             
rM = 0.0200554                             
rF = 0.0267729                             
rP = 0.02226515                            
rS = 0.019845                              
rT = 0.02644061                            
rW = 0.01015716                            
rY = 0.02185937                            
rV = 0.04336254                            
fiA = 0.036580604000000003                 
fiR = 0.041718328999999998                 
fiN = 0.067817974000000003                 
fiD = 0.077442646000000004                 
fiC = 0.0082888630000000005                
fiQ = 0.035005034999999997                 
fiE = 0.075524562000000003                 
fiG = 0.064221565999999994                 
fiH = 0.084943724999999998                 
fiI = 0.067304200999999994                 
fiL = 0.080765041999999995                 
fiK = 0.090012946999999996                 
fiM = 0.040827790000000003                 
fiF = 0.073469471999999994                 
fiP = 0.043328150000000003                 
fiS = 0.061138931000000001                 
fiT = 0.069290788000000006                 
fiW = 0.0069873060000000004                
fiY = 0.074394262000000003                 
fiV = 0.060111386000000003                 
gamaA = 0.0434                             
gamaR = 0.0489                             
gamaN = 0.0302                             
gamaD = 0.0305                             
gamaC = 0.0105                             
gamaQ = 0.0365                             
gamaE = 0.0368                             
gamaG = 0.0437                             
gamaH = 0.0140                             
gamaI = 0.0362                             
gamaL = 0.0561                             
gamaK = 0.0476                             
gamaM = 0.0218                             
gamaF = 0.0290                             
gamaP = 0.0242                             
gamaS = 0.0215                             
gamaT = 0.0287                             
gamaW = 0.0110                             
gamaY = 0.0237                             
gamaV = 0.0470 
 
********** MODEL REACTIONS 
miu = miuwt*Sg/(ks+Sg)                     
rPR = ke*PR/(kt+PR)                        
rPRD = kPRD*PR                             
rG4P = kg4p*f(H)                           
rG4PD = kg4pd*G4P 
 
********** MODEL FUNCTIONS 
f(x) = 0.2*exp(-10000*x) 
 
********** MODEL EVENTS 
event = lt(H,0.0),kg4pd,0.02,miuWT,0.2,kt,100 
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Metabolic profiling of the E. coli relA mutant 
under nutrient-limited growth conditions 
 
“Being exposed to stress has become an everyday experience...” 
By G. Storz and R. Hengge-Aronis in Bacterial stress responses,  
ASM Press, 2000 
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4.1 Abstract  
The bacterial stringent response was found to be triggered by the 
ribosome-associated RelA enzyme in response to nutrient deprivation 
conditions. Here a metabolic profiling analysis of E. coli W3110 and 
the isogenic ∆relA mutant cells is proposed to characterize the activity 
of this enzyme under different growth conditions. Metabolic profiles 
evaluated by gas chromatography–mass spectrometry (GC-MS) 
revealed that there were significant differences in metabolic activities 
between E. coli strains and predominantly among different growth 
conditions. Major differences were detected in the relative 
concentration levels of most metabolites when cells were grown at a 
dilution rate of 0.1 h-1, for which higher levels were obtained, though 
the accumulation of fatty acids was more significant at a dilution rate of 
0.05 h-1. These metabolic differences were less pronounced in the 
∆relA mutant cells, denoting that RelA must be involved in such 
metabolic activities. This suggests that under nutrient limiting 
conditions the RelA-dependent stringent response promotes key 
changes in the E. coli metabolism. 
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4.2 Introduction 
Under low nutrient conditions cells engage a multitude of cellular processes allowing for survival 
until growth can restart. Typically, the coordination of these cellular responses involves the global 
regulator guanosine-3',5'-bis-pyrophosphate (ppGpp), a core molecule that triggers the stringent 
response (Chatterji D and Ojha AK, 2001; Haseltin WA and Block R, 1973; Jain V et al., 2006; 
Magnusson LU et al., 2005). In E. coli, the stringent control mediated by ppGpp is a key 
regulatory process governing gene transcription, but also protein translation, enzyme activation 
and growth arrest (Artsimovitch I et al., 2004; Dennis PP et al., 2004; Paul BJ et al., 2004). This 
phenomenon is mainly triggered by the activation of the ribosome-associated enzyme encoded by 
the relA gene, which catalyzes the conversion of cellular GTP to ppGpp (Torok I and Kari C, 
1980). Although the synthesis of ppGpp has been mainly associated with the activity of the RelA 
enzyme in response to amino acid starvation, studies indicate that ppGpp also accumulates 
during carbon starvation (Traxler MF et al., 2006). A second ppGpp synthetase, SpoT, has been 
described to be involved in the ppGpp accumulation during carbon starvation, but its activity was 
shown to be much weaker than the RelA enzyme (Xiao H et al., 1991). Hypotheses indicate that 
these two phenomena might be strictly related and the exhaustion of carbon often results in the 
rapid limitation of amino acids availability (Traxler MF et al., 2006). Thus, it is expected that RelA, 
directly or indirectly, interferes in the definition of cellular responses to carbon starvation 
conditions. Otherwise, in the absence of the relA gene, bacterial cells would respond just as the 
wild-type strain to such environmental conditions. To dissect the role of the RelA enzyme in the E. 
coli responses to nutrient-limited growth conditions, a metabolomics approach was applied in this 
study. The intracellular metabolite profiles measured by gas chromatography–mass spectrometry 
(GC-MS) were exploited to characterize the main metabolic differences when cells are grown at 
different dilution rates.  
So far, studies have been focused on the gene expression profiling to investigate the RelA activity 
in response to environmental growth perturbations. For instance, changes in the transcriptome 
during glucose-lactose diauxic conditions were investigated in the wild-type E. coli and ∆relA 
mutant cells (Traxler MF et al., 2006), revealing that cells lacking the relA gene show a delayed 
diauxie and a deficient induction of RpoS and Crp regulons. Other studies (Durfee T et al., 2008; 
Haddadin FT et al., 2009) evaluated gene expression profiles of E. coli cells after treatment with 
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“artificial” inducers that mimic amino starvation (e.g. serine hydroxymate) leading to the 
induction of the stringent response. Results of this study showed that ∆relA mutant 
transcriptional responses are consistent with the “relaxed” phenotype of double null mutant 
(∆relA/∆spoT) and fail to adapt their physiology to the new conditions.  
In general, gene expression patterns revealed that the accumulation of ppGpp can occur either 
during carbon or amino acid starvation conditions in wild-type strains and that the RelA is 
involved in cellular adaptation responses to both conditions. From transcriptome data, some 
common features were observed, like the downregulation of the translational apparatus, including 
rRNAs, tRNAs and ribosomal genes and induction of the RpoS-dependent general stress 
response. As a result, stringent response promotes the rapid decay of cellular growth, since the 
translational apparatus is significantly reduced, and invokes a manifold of cellular survival 
mechanisms that limits most processes for cell division and reproduction. 
It has been proposed (Dedhia N et al., 1997) that E. coli strains with relaxed phenotypes (e.g., 
∆relA mutants) can be quite useful as host strains in the synthesis of recombinant proteins. In 
fact, some successful applications of ppGpp-defective strains in recombinant bioprocesses have 
been reported (Dedhia N et al., 1997; Sanden AM et al., 2003), showing that these recombinant 
systems can limit ppGpp accumulation, thus reducing growth arrest and productivity losses. 
However, our understanding on the ppGpp effects in the organization of the metabolic network 
under nutrient-limiting conditions is still incomplete. Some studies have used microarrays to 
profile the ppGpp effects on gene expression and then infer metabolic alterations (Chang DE et 
al., 2002; Durfee T et al., 2008), but the unbiased determination of metabolite levels can bring 
better insights to unveil the mechanism of stringent response in the metabolism. For that reason 
our goals in this study are twofold: to investigate the metabolic behaviour of E. coli W3110 strains 
at different growth conditions; and to elucidate how the relA gene mutation affects these 
metabolic behaviours.  
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4.3 Material and Methods 
4.3.1 Bacterial strains and growth conditions 
E. coli K12 W3110 (F-, LAM-, IN[rrnD-rrnE]1, rph-1) and the isogenic mutant ∆relA (obtained 
from M. Cashel (Xiao H et al., 1991)) were grown under controlled conditions in a chemostat 
culture at 37ºC, pH 7 and dissolved oxygen above 30%. The minimal medium consisted of 5 g.kg-
1 of glucose, 6 g.kg-1 of Na2HPO4, 3 g.kg-1 of KH2PO4, 0.5 g.kg-1 of NaCl, 1 g.kg-1 of NH4Cl, 0.015 
g.kg-1 of CaCl2, 0.12 g.kg-1 of MgSO4.7H2O, 0.34 g.kg-1 of thiamine, 2 mL.kg-1 of trace-element 
solution (described elsewhere (Rocha I and Ferreira EC, 2002)) and 2 mL.kg-1 of vitamins solution 
(described elsewhere (Rocha I and Ferreira EC, 2002)). The minimal medium supplemented with 
20 mg.kg-1 of L-isoleucine was used to grow the W3110 strain, while the same medium with 
further addition of 20 mg L-1 L-valine and 25 mg L-1 kanamycin was used to grow the ∆relA 
mutant strain.  
Chemostat cultivations were operated in a 3 L fermentor (BioFlo 3000, New Brunswick Scientific, 
USA) with a working volume of 1.5 L. The described minimal medium was continuously fed, at 
least for five residence times, at a given dilution rate (0.05, 0.1 and 0.2 h−1), and the working 
volume was kept constant by withdrawing the culture broth through level control. Steady-state 
conditions were verified by constant optical density and glucose measurements. The pH of the 
culture was maintained at 7.0 by adding 2.0 M NaOH and 2.0 M HCl. Dissolved oxygen was 
maintained above 30% saturation through a cascade mode controlling the agitation speed and 
airflow.  
 
4.3.2 Analytical techniques 
Biomass was determined by measuring culture turbidity (OD600nm) and cell dry weight (CDW). In 
order to determine CDW, 10 mL of broth were filtered with 0.2 µm filters and the filtrate was 
dried in the microwave to a constant weight. For glucose and acetate analysis, culture broth was 
centrifuged at 8000 rpm for 15 min to remove the cell debris and the supernatant was collected. 
The glucose concentration in the culture broth was determined by the dinitrosalicylic acid (DNS) 
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colorimetric method (Miller GL, 1959). The concentrations of acetic acid in the culture broth were 
determined with an enzymatic test kit (R-Biopharm AG, Germany).  
 
4.3.2.1 Quenching and metabolite extraction 
For metabolomics analysis, samples (50 mL) were taken quickly from the fermentor and 
immediately quenched, to halt cellular metabolism, in 200 mL of glycerol/saline solution (60%, 
v/v) at -23 °C, followed by quick homogenization. Samples were centrifuged at 10,000 rpm for 
20 min at -20 ºC using a refrigerated centrifuge. The supernatants were discarded and the cell 
pellets were resuspended in 2 mL of cold glycerol/saline solution (50%, v/v) at -23 ºC, followed 
by a second centrifugation at 8,000 rpm for 30 min at -20 ºC. The supernatants were again 
discarded and the cell pellets were dissolved in 2.5 mL of cold methanol/water solution (50%, 
v/v) at -30 ºC and stored at -80ºC for subsequent intracellular metabolite extraction. For that, 
samples were subjected to three freeze–thaw cycles with 1 min of vigorous mixing using a vortex 
between each cycle. After the third cycle, samples were centrifuged at 8,000 rpm for 30 min at -
20 ºC and the supernatants were collected and stored at -80 ºC. The extracted pellet was then 
resuspended in another 2.5 ml of cold methanol/water solution (50%, v/v) and centrifuged at 
8,000 rpm for 30 min at -20 ºC. The supernatant was collected and pooled with the first one and 
kept at -80 ºC and, afterwards lyophilized. 
 
4.3.2.2 Derivatization and GC-MS analysis 
For GC-MS analysis samples were further treated as follows. The dried intracellular metabolite 
extracts were resuspended in 200 µL of sodium hydroxide (1 M) and derivatized using the methyl 
chloroformate (MCF) method (Smart KF et al., 2010). The derivatized samples were then 
analyzed with a GC-MS systems - GC7890 coupled to a MSD5975 (Agilent Technologies, Inc., 
Santa Clara, CA, USA) equipped with a ZB-1701 GC capillary column, 30m x 250mm id x 0.15 
mm (film thickness) with a 5 m guard column (Phenomenex, Inc., Torrance, CA, USA) at a 
constant flow rate of 1.0 mL/min of helium. The oven temperature was initially held at 45ºC for 
2 min. Thereafter the temperature is raised with a gradient of 9ºC/min until 180ºC. This 
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temperature (180ºC) is held for 5 min. Then the temperature is raised with a gradient of 
40ºC/min until 220ºC. The temperature is again held for 5 min. Then the temperature is raised 
with a gradient of 40ºC/min until 240ºC and this temperature is held for 11.5 min. Finally the 
temperature is raised with a gradient of 40ºC/min until 280ºC, which is held for 2 min. The 
temperature of the inlet is 290ºC, the interface temperature 250ºC, and the quadrupole 
temperature 200ºC. Sample (1 µL) was injected onto the column under pulsed splitless mode 
(1.8 bars until 1 min, 20 mL/min split flow after 1.01 min) and the detector was set with a scan 
interval of 1.47 seconds and m/z range of 38-650.  
 
4.3.3 Statistical analysis 
Data from GC-MS analyses were deconvoluted using the AMDIS spectral deconvolution software 
(Stein SE, 1999) to identify the compounds through matching with a library constructed by using 
analytical chemical standards. Peak intensity values corresponding to each identified compound 
were corrected for the recovery of the internal standard (D-4-alanine) and normalized with respect 
to biomass concentration. The corrected and normalized peak intensity values were thereafter 
transformed into Z-scores, by subtracting the average peak intensity corresponding to a 
metabolite k among all the n samples (including replicates) in the set of experiments, from the 
peak intensity value (IMK) of that metabolite in one sample, and dividing that result by the standard 
deviation (SDM1..Mn) of all measured n peak intensities, according to: 
( )
nMkMk
n
SD
ImeanI
kscoreZ MkMkMk
...1
1...,
−
=−  
Further data processing and statistical analysis were performed with MATLAB (version 2009b, 
The Mathworks, Inc) and MultiExperiment Viewer (MeV) (Saeed AI et al., 2003). The 
nonparametric two-way method, Mack-Skillings test, was used for testing the null hypothesis (H0) 
of no differences among experiments and to look for the main differences between metabolic 
profiles that are related to either of the two factors: strain (Factor A) and dilution rate (Factor B). 
As exemplified by Table 4.1, this two factor design allows the combination of one or more 
observations for each factor with an uneven number of replicates per observation. p-values were 
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calculated to determine if the null hypothesis, which establishes that metabolic profiles are not 
affected neither by factors A and/or B, is rejected. Thus, metabolites with p-value lower than 
0.01 show statistically significant differences (with 99% of confidence) in their relative 
concentration between different experimental conditions when considering factors A or B. 
 
Table 4.1. Mack-Skillings test for two factor design.  
The design matrix captures the disproportionate number of replicates (either 3 or 4) in the group of experiments 
performed in this study. 
 
Factor B 
0.05 0.1 0.2 
Factor A 
W3110 4 3 4 
∆relA 3 3 4 
 
Hierarchical clustering (HCL) was used to cluster samples and metabolites that showed 
significant changes according to the Mack-Skillings test. The construction of hierarchical trees 
was based on the Pearson correlation metrics. Pearson's correlation coefficients (r) were also 
used to evaluate the degree of association between the metabolite profiles produced by the 
W3110 and ∆relA E. coli cultures. p-values associated with each Pearson correlation coefficient 
was calculated using a Student's t distribution to test the null hypothesis (H0) of no significant 
correlation between the metabolite profiles from the two cultures, against the alternative 
hypothesis (H1) that establishes a significant correlation between the profiles.  
 
4.4 Results  
This study aimed at evaluating the impact of different dilution rates (0.05, 0.1 and 0.2 h-1) in the 
metabolome in a wild-type and a relaxed strain of E. coli. Assuming that ppGpp accumulates 
under very slow growth conditions and the RelA enzyme is involved in the ppGpp-induced 
response, metabolic patterns of the E. coli W3110 and the isogenic ∆relA mutant were analysed 
to explore the metabolic activities influenced by the ppGpp-induced response.  
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4.4.1 Growth parameters of E. coli W310 wild-type and ∆relA 
cells under different dilution rates 
Chemostat cultures of E. coli W3110 and the isogenic ∆relA mutant were run at different dilution 
rates (0.05, 0.1, and 0.2 h-1) and growth parameters were determined (Table 4.2). It was 
observed that only at higher dilution rates residual concentrations of glucose and acetate were 
detected in the extracellular medium. Biomass yields increased with the dilution rate and the 
mutant strain exhibited a biomass yield slightly higher than that of the W3110 strain in the same 
conditions.  
 
Table 4.2. Growth parameters of the W3110 and ∆relA mutant E. coli strains in aerobic 
glucose-limited continuous culture. 
 W3110 ∆relA mutant 
Dilution rate (h-1) 0.05 0.10 0.20 0.05 0.10 0.20 
Biomass yield (g g-1) 0.36±0.056 0.44±0.15 0.55±0.10 0.46±0.063 0.46±0.064 0.67±0.3 
Biomass (g L-1) 1.8±0.28 2.2±0.34 2.7±0.43 2.3±0.31 2.3±0.32 3.3±0.45 
Glucose (g L-1) (1) 0.029±0.0086 0.040±0.0033 (1) (1) 
0.023±0.0
10 
qGlucose (g g-1 h-1) 0.14±0.021 0.23±0.076 0.36±0.063 0.11±0.015 0.22±0.030 0.30±0.13 
Acetate (g L-1) (1) (1) 0.34 (1) (1) 0.02 
qAcetate (10-3)(g g-1 h-1) - - 25±3.8 - - 1.1±0.15 
(1) Undeterminable traces.  
 
4.4.2 Metabolic profiling of E. coli  
In this work, the E. coli metabolic profiles were determined through the analysis of intracellular 
chemical molecules detected by GC-MS. The chemical derivatization procedure was chosen in 
order to quantify the main amino acids and their precursors generated in the central carbon 
metabolism and fatty acid biosynthesis. The overall list of detected metabolites is presented in 
Table 4.3.  
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Table 4.3. List of the intracellular metabolites detected by GC-MS.  
The metabolites abbreviations are discriminated inside brackets.  
TCA cycle 
Fatty acids and derivatives 
biosynthesis 
Amino acid biosynthesis Others 
2-ketoglutarate 
(akg) 
cis-Aconitate 
(acon-C) 
Citrate (cit) 
Fumarate (fum) 
Malate (mal) 
Succinate (succ) 
Hexanoate (hxa) 
Octanoate (octa) 
Decanoate (dca) 
Tetradecanoate (ttdca) 
10,13-Dimethyltetradecanoate (1013mlt) 
Pentadecanoate (pdca) 
14-Methylpentadecanoate (14mpdca) 
Octadecanoate (ocdca) 
Octadecenoate (ocdcea) 
9-cis,12-cis-Octadecadienoate (ocdcin) 
Aspartate (asp) 
Isoleucine (ile) 
Lysine (lys) 
Threonine (thr) 
Alanine (ala) 
Leucine (leu) 
Valine (val) 
Glycine (gly) 
Serine (ser) 
Glutamate (glu) 
Proline (pro) 
Phenylalanine (phe) 
(2S)-2-isopropylmalate (3c3hmp) 
N-Acetyl-L-glutamate (acglu) 
BenzoateΨ (bnz) 
NADP(H) 
Nicotinate (nac) 
Phosphoenolpyruvate 
(pep) 
5-oxo-D-prolineψ (pyrglu) 
Malonateψ (mlt) 
Itaconateψ (itcon) 
Lactate (lac) 
Ψ Metabolites unknown to be synthesized by E. coli 
 
Metabolomic analysis showed that the metabolite profiles were largely influenced by the growth 
rate conditions and the genetic characteristics of the bacteria (i.e., relA gene deletion). 
Nevertheless, Mack-Skillings test demonstrated that the amount of metabolites whose profiles 
were significantly changed with the dilution rate is greater than the ones that are different among 
the different strains (i.e. E. coli W3110 and ∆relA mutant). As illustrated in Figure 4.1, only 15 
metabolites (20% of the total metabolites detected by GC-MS) changed significantly with the 
alteration of the strain, while 20 metabolites were found to be considerably changing their profile 
with the alteration of the dilution rate.  
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Figure 4.1. Hierarchical tree representing metabolites that were significantly changed (p-
value <0.01) with both experimental factors: strain or dilution rate.  
 
4.4.2.1 The impact of the dilution rate in the E. coli metabolome 
Before analysing the metabolic differences between E. coli W3110 and ∆relA mutant cultures, 
the metabolic states of the non-relaxed cells were examined in detail. This analysis was 
performed in order to verify if the RelA-modulated stringent response is triggered at any of the 
growth conditions evaluated and how this stress response affects E. coli metabolic activities. In 
this analysis, only those metabolites that presented p-values less than 0.01 in the Mack-Skillings 
test were considered.  
Hierarchical clustering (HCL) analysis was used to group metabolites into different clusters that 
congregate those metabolites that behave in a similar manner under different growth conditions 
(Figure 4.2), and that are most likely engaged in similar metabolic processes. The overall trend of 
metabolite profiles was characterized by a maximum accumulation at the dilution rate of 0.1 h-1 
and decreased levels below and above this dilution rate, except for fatty acids (clusters 1 and 2). 
Medium- and long-chain fatty acids (included in clusters 1 and 2, respectively) presented higher 
relative concentrations at lower dilution rates when compared with high dilution rates. This seems 
to indicate that those compounds are associated with key metabolic activities when cells are 
growing at nutrient-limiting conditions and are less required when increasing the availability of 
nutrients.  
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Figure 4.2. Metabolite profiles of the E. coli W3110 strain exhibited under three dilutions 
rates (0.05, 0.1 and 0.2 h-1) were clustered by HCL analysis.  
For abbreviations see Table 4.3. 
 
On the other hand, clusters 4 and 5 grouped most of the TCA metabolites, amino acids, 
including amino acid derivatives like, 5-oxo-D-proline (pyrglu) and (2S)-2-isopropylmalate 
(3c3hmp) and the NAD salvage pathway intermediaries, nicotinate (nac) and NADP(H), 
presenting higher levels at the dilution rate of 0.1 h-1. The third cluster presented slightly higher 
relative metabolite concentrations at the dilution rate 0.05 h-1, compared to the fourth and fifth 
clusters, but the overall metabolic patterns were similar. Most likely, these clusters are at some 
extent linked and biochemical reactions involving these metabolites may be synchronized.  
To understand how these alterations in the relative metabolite concentrations are related with 
changes in biochemical activities, metabolites detected in the E. coli metabolome were 
represented into a metabolic map (Figure 4.3). 
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Figure 4.3. Metabolic map representing the metabolome of the E. coli W3110 according to 
the clusters obtained.  
Grey boxes represent those metabolites that were not detected by the GC-MS analysis and the coloured boxes 
display the sets of metabolites that were clustered according to the HCL analysis (each colour corresponds to a 
cluster, according to Figure 4.2) and that were statistically significant for the dilution rate factor. Non-coloured boxes 
represent those metabolites that were detected by the GC-MS analysis, but were not significantly changed with the 
dilution rate. Red dashed lines indicate enzymatic inhibition activities performed by various metabolites. 
 
As illustrated in Figure 4.3, the strong correlation between medium-chain fatty acids, 
pentadecanoate (pdca) and tetradecanoate (ttdca), seems derived from their proximity in the 
metabolic network (i.e. pentadecanoate is produced via saturated fatty acid elongation cycle that 
uses tetradecanoate as an intermediary). Likewise, amino acids, leucine (leu), isoleucine (ile) and 
valine (val) were also clustered together and are participants in the two pathways that are highly 
correlated. As depicted, the pathway of isoleucine biosynthesis is subject to regulation by valine 
and leucine, whereas the first step in the pathway of valine biosynthesis is also regulated by 
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isoleucine. Although it is not illustrated, several enzymes are simultaneously involved in the 
synthesis of the three amino acids. In addition, amino acids, fumarate (fum) and the NADP(H) 
molecules were also clustered with these metabolites, but not all presented clear metabolic 
associations. For instance, serine (ser) and proline (pro) are not neighbours in the metabolic 
network, but glutamate is a common participant in both biosynthetic pathways (i.e. glutamate is 
the amino donor in the biosynthesis of serine and the biosynthesis of proline involves the 
reduction of L-glutamate). 
 
4.4.2.2 The impact of the ∆relA mutation in the E. coli metabolome 
Having evaluated the metabolic states exhibited by E. coli W3110 cells, the metabolic profiles 
exhibited by the two strains at different dilution rates were compared. Here the aim was to 
determine the key metabolic activities that were influenced by the relA gene mutation under the 
tested growth conditions. Although the relative concentrations of most metabolites were 
significantly changed (see Appendix A), when comparing the metabolite profiles between the two 
E. coli strains, it was found that their trend were similar in some cases. Therefore, pairwise 
correlation coefficients were calculated for each metabolite that was found to be significant by the 
Mack-Skillings test (Figure 4.4). As illustrated, almost half of the metabolites showed poorly 
correlated patterns (i.e. r below 0.8). Moreover, some metabolites revealed to have negatively 
correlated profiles, which means that the intracellular accumulation of these metabolites follows 
an opposite pattern in one of the cultures, e.g. succinate (succ) with r equal to -0.3.  
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Figure 4.4. Representation of the pairwise correlation coefficients (r) determined between 
metabolite profiles generated in the W3110 and ∆relA E. coli cultures.  
Only metabolites that presented significant changes according to the Mack-Skillings test for the strain factor were 
considered. Dashed line delimits the correlation coefficient threshold below which metabolite profiles produced by 
the two strains were considered uncorrelated. 
 
Profiles of those uncorrelated metabolites are then shown in Figure 4.5. In general, relative 
concentrations were significantly different at lower dilutions rates and have a tendency to become 
similar as the dilution rate increases. For example, octadecanoate (ocdca), tetradecanoate 
(ttdca), pentadecanoate (pdca) and 10,13-dimethyltetradecanoate (1013mlt) presented quite 
divergent trends when the dilution rate was lower. In contrast, metabolites like succinate (succ), 
threonine (thr) and lactate (lac) showed particularly asymmetrical metabolic patterns, which 
indicate that metabolite accumulation in E. coli mutant cells was quite different compared to the 
W3110 strain. 
Other interesting differences between strains are represented by five metabolites that, although 
using the Mack-Skillings test were not considered significant, were uniquely detected in the 
W3110 culture at a dilution rate of 0.1 h-1 (see Appendix B): N-acetyl-L-glutamate (acglu), lysine 
(lys), malate (mal), 2-ketoglutarate (akg) and the two inhibitors of the isocitrate lyase, itaconate 
(itcon) and malonate (mlt). It is worth to notice that each one of these metabolites is somehow 
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related to the TCA cycle, in particular the 2-ketoglutarate (akg), itaconate (itcon) and malonate 
(mlt), which are directly linked to the isocitrate node, which is a key metabolic valve that controls 
the carbon flux through the TCA cycle or the glyoxylate shunt depending on the metabolic 
requirements.  
 
 
Figure 4.5. Metabolic profiles of the metabolites that were uncorrelated between E. coli 
strains. 
 
4.5 Discussion 
The growth rate-dependent regulation of the metabolism is fundamental to fine-tune the fuelling 
and biosynthetic reactions, in such a way that cells can rapidly adapt to the existing 
environmental conditions. The effect of nutrient-limiting conditions on the balance of the catabolic 
and anabolic fluxes and energetic efficiency of the E. coli cells has been the focus of previous 
investigations (Farmer IS and Jones CW, 1976; Ko Y-F et al., 1994; Neijssel OM et al., 1990; 
Russell JB and Cook GM, 1995) and it was confirmed that several key metabolic activities are 
systematically activated under those conditions. In this study, it was aimed to analyse this growth 
rate-dependent behaviour and observe how it is affected by the deletion of the relA gene, which 
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encodes a ppGpp synthetase described as a key element for the cellular responses to nutrient 
limiting conditions. 
First, the physiological parameters of E. coli W3110 and the isogenic ∆relA mutant were 
assessed. Apparently, biomass yields are lower as the dilution rate decreases and the biomass 
yields of the mutant strain were consistently higher compared to the E. coli strain W3110, in 
particular at lower dilutions rate (D=0.05 h-1). Indeed, it was expected that at lower dilution rates 
the metabolic and physiological behaviour of these two strains would be different, since it is 
assumed that part of the maintenance energy is spent in cellular processes to counteract 
nutritional limitations, typically through RelA-dependent processes. To understand how these 
cellular processes impact the E. coli metabolism, a metabolic profiling approach was applied to 
study the intracellular metabolome of E. coli W3110 and ∆relA mutant cells growing at three 
different dilution rates.  
It was verified that metabolite pools were strongly affected by the dilution rate and the 
accumulation of most metabolites was higher at a dilution rate of 0.1 h-1, which is in good 
agreement with other studies performed in glucose-limited chemostat experiments (Nanchen A et 
al., 2006; Prasad MR et al., 2005; Sauer U et al., 1999). According to Nanchen et al (Nanchen A 
et al., 2006), at a dilution rate of 0.1 h-1, large flux variations are verified in the metabolic 
network, in particular at the oxaloacetate node where two anaplerotic reactions converge. The 
carbon flux through the glyoxylate cycle (i.e. an anaplerotic pathway that converts isocitrate to 
succinate or to malate via glyoxylate) is maximum at this dilution rate and decreases at higher 
dilution rates (Fischer E and Sauer U, 2003; Nanchen A et al., 2006; Prasad MR et al., 2005). It 
was proposed (Fischer E and Sauer U, 2003; Nanchen A et al., 2008; Sauer U and Eikmanns 
BJ, 2005) that at nutrient starvation conditions the cAMP-mediated catabolite repression of 
enzymes in the glyoxylate cycle is limited and the activity of the competing enzyme, i.e. the 
isocitrate dehydrogenase, is decreased. As such, it is believed that anaplerotic reactions are 
stimulated in hungry E. coli cells and, at higher dilution rates, are restrained as a consequence of 
the increasing glucose concentrations and the catabolite repression.  
This phenomenon has been associated with the stringent response induced by the ppGpp 
accumulation that should require the activity of the RelA enzyme (Ozkan P et al., 2005; Pao CC 
and Dyess BT, 1981; Traxler MF et al., 2006). The levels of this global regulator, ppGpp, 
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increase rapidly when cells are grown in nutrient-deprived conditions, which potentiates the 
expression of several stress response genes, namely the transcriptional regulator cAMP receptor 
protein (Crp) that governs the catabolite repression (Traxler MF et al., 2006). Thus, it was 
expected that ∆relA mutants would be less effective to increase metabolic activities at a dilution 
rate of 0.1h-1. Although it seemed that the catabolite derepression was invoked in both E. coli 
strains, it was clear that it was induced to a much lesser extent in ∆relA mutant cells, as the 
relative concentrations of most metabolites were much lower (see Appendix A). Besides the 
overall relative metabolite concentrations at these conditions, the absence of the isocitrate lyase 
inhibitors is indicative of a less effective ppGpp-induced catabolite derepression of anaplerotic 
activities. It is believed that anaplerotic functions in “less stringent” phenotypes are limited, and 
for that reason enzymatic inhibitors, such as isocitrate lyase inhibitors, are not needed to control 
such metabolic activities. In contrast, these inhibitors were found to be overproduced in the 
W3110 E. coli strain under this particular dilution rate (0.1 h-1), which denotes that they can be 
physiologically determinant for the regulation of enzymes at the metabolic branch-point at 
isocitrate under nutrient-limiting conditions. Although it is only an hypothesis, the failure to induce 
the catabolite derepression of isocitrate lyase (i.e. anaplerotic enzyme) and the concomitant 
absence of isocitrate lyase inhibitors, suggest that “relaxed” phenotypes are less effective to 
stimulate anaplerotic functions under nutrient limiting conditions. 
At dilutions rates lower than 0.1 h-1, the strong dependence of metabolic activities on carbon 
source availability was evidenced by generally lower relative concentrations of most metabolites, 
even when anaplerotic reactions were derepressed. However, a group of metabolites were highly 
accumulated at these conditions (D=0.05 h-1). Fatty acids, like the tetradecanoate (ttdca), 
pentadecanoate (pdca), octadecenoate (ocdcea) and 9-cis,12-cis-octadecadienoate (ocdcin), were 
highly accumulated in the intracellular milieu of the E. coli W3110 cells suggesting the 
involvement of key metabolic changes in the structure of cell membranes. Fatty acids 
biosynthesis was definitely the most significant change occurred at these growth conditions (0.05 
h-1) and represented the utmost opposite metabolic behaviour between the E. coli W3110 and 
∆relA cells. While fatty acids were highly accumulated in starved E. coli W3110 cells, the 
opposite was observed in the ∆relA mutant cells. As such, it is clear that the RelA activity is 
fundamental to define the cellular response during extreme starvation conditions. It is known that 
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fatty acid biosynthetic genes (e.g. fabHDG and fabA) are stringently controlled by the ppGpp and 
the alternative sigma factor, RpoS (Dong T and Schellhorn HE, 2009). Since the activity of RpoS 
is augmented by high levels of ppGpp, it is expected that in the absence of the RelA, the RpoS-
transcriptional control of these genes is reduced. Thus, the accumulation of fatty acids at lower 
dilution rates might be associated with the nutrient starvation responses and apparently is lessen 
in ∆relA mutant cells.  
One of the most reported effects provoked by the stringent response (Chatterji D and Ojha AK, 
2001; Durfee T et al., 2008; Jain V et al., 2006; Jishage M et al., 2002; Magnusson LU et al., 
2005; Mukherjee TK et al., 1998; Traxler MF et al., 2006) is the overexpression of genes coding 
for enzymes that participate in amino acid biosynthetic pathways. Although the curtailment of 
most amino acids was not observed in the intracellular milieu, ∆relA mutant cells showed some 
changes in metabolic profiles related with the biosynthesis of amino acids. For example, it was 
identified that lysine (lys) and N-acetyl-L-glutamate (acglu) were not detected in E. coli ∆relA 
mutant at a dilution rate of 0.1 h-1, but relative concentration levels of these amino acids were 
determined in the E. coli W3110 strain. The only common feature between these metabolites is 
the connectivity to glutamate, one of the most required amino donors in the metabolism, whose 
relative concentration levels were found to be much lower in the E. coli ∆relA mutant strain. 
Furthermore, 2-ketoglutarate (akg), the metabolic precursor of glutamate, was also undetected in 
this mutant strain at the same conditions, which indicates the relative concentrations of these 
metabolites were severely reduced in mutant cells. This may suggest that E. coli ∆relA mutant 
cells present a “relaxed” phenotype that may have led to important shortages in certain 
metabolites.  
 
4.6 Conclusions 
Even with detailed knowledge about the overall metabolic reactions and their regulation, the 
interpretation of metabolic patterns is still not a trivial task. Analytical limitations in the detection 
of the whole set of metabolites within the cellular milieu, are still a problem to fully characterize 
the metabolic system. For example, key metabolic nodes like the isocitrate (icit), oxaloacetate 
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(oaa) or glyoxylate (glx), would be helpful in the verification if anaplerotic functions were indeed 
activated under catabolite derepression. However, it was possible to unveil crucial metabolic 
alterations in response to different nutrient-limiting conditions, and more importantly to confirm 
that the RelA activity is fundamental in the coordination of several cellular responses, like 
anaplerosis and fatty acid biosynthesis. These two metabolic activities were associated with the 
most remarkable differences between the two E. coli strains and exposed some limitations that 
“less stringent” phenotypes might exhibit. Nevertheless, there are no evidences suggesting that 
the relA mutation leads to impaired metabolic performances and are entirely devoid of survival 
mechanisms. In fact, it was observed that biomass yields were higher in ∆relA mutant cells. It 
can be hypothesized that ppGpp synthesized by SpoT guarantees the most basic responses to 
maintain cell growth and survival and the activity of RelA would be involved in the reorganization 
of the global network that operates in response to several environmental perturbations entailing a 
multitude of cellular processes, namely cellular metabolism.  
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4.8 Appendix A 
Z-scores of metabolites that presented significant changes according to the strain factor. R-values 
indicate the correlation between the relative concentrations of these metabolites in the two 
cultures: E. coli W310 (WT) and E. coli ∆relA (RelA). 
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4.9 Appendix B 
Relative concentrations of metabolites that were undetected in chemostat cultures, except in the 
E. coli W3110 grown at a dilution rate of 0.1 h-1. 
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4.10 Appendix C 
Relative concentrations of metabolites detected by GC/MS analysis. 
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thr 0.481 0.45 0.396 0.311 1.446 2.556 1.931 0.173 0.277 0.154 0.151 0.347 0.263 0.355 0.311 0.205 0.255 0 0 0 0
ser 0.054 0.046 0.086 0.061 0.627 0.852 0.689 0.077 0.066 0.067 0.075 0.137 0.117 0.14 0.21 0.172 0.17 0 0 0 0
pyrglu 5.492 5.684 3.737 4.476 13.55 22.39 19.35 1.929 3.061 2.475 1.647 2.332 4.713 6.82 13.45 7.732 7.546 1.077 0.744 1.203 0.793
cit 5.712 6.975 3.812 4.559 46.65 56.75 44.29 1.016 1.816 1.305 1.075 1.065 1.262 2.12 2.051 1.388 1.222 1.721 1.191 1.69 1.683
asp 24.25 24.17 15.79 19.49 76.57 115.8 92.02 8.035 9.259 6.551 5.691 5.018 15.24 22.08 27.17 18.25 16.03 2.887 2.635 3.623 2.951
ttdca 15.02 21 18.18 19.1 15.04 13.62 12.56 6.298 6.82 5.33 5.958 3.776 5.77 5.761 9.464 6.297 5.908 3.454 4.267 5.013 2.653
glu 22.45 22.21 17.01 18.69 51.86 74.65 63.19 7.581 10.91 6.954 5.493 4.813 15.59 18.95 28.64 19.15 22.49 3.76 2.314 2.917 3.115
pdca 8.86 10.42 9.546 9.542 8.074 7.048 6.271 2.657 2.592 1.915 2.618 1.32 2.297 2.225 5.309 3.494 3.186 0.93 0.401 1.409 0.824
acglu 0 0 0 0 0.307 0.306 0.252 0 0 0 0 0 0 0 0 0 0 0 0 0 0
1013mlt 38.87 50.12 47.21 46.58 49.98 40.81 42.42 39.68 43.15 28.91 34.71 11.19 19.09 19.46 35.82 25.6 24.09 21.03 23.8 26.32 13.81
phe 1.023 0.684 0.67 0.714 1.052 1.201 1.033 0.542 0.481 0.447 0.359 0.466 0.347 0.431 0.524 0.453 0.3 0.35 0.386 0.534 0.325
14mpdca 13.4 18.95 17.03 17.8 21.72 20.55 17.81 10.93 13.33 9.216 12.17 2.626 4.151 4.301 23.05 14.82 17.03 0.951 0.878 0.965 0.686
ocdcea 36.1 58.15 48.74 49.75 50.68 45.52 46.23 5.992 5.801 5.467 4.333 10.29 14.13 15.75 24.28 15.27 15.16 6.703 5.557 9.307 4.329
ocdcin 14.25 23.69 19.9 20.61 20.31 18.63 18.84 0 0 0 0 4.086 5.74 6.54 9.686 6.084 6.085 0 0 0 0
ocdca 2.803 4.205 3.862 3.566 3.428 2.943 3.075 2.714 3.622 2.542 2.243 1.682 1.784 1.77 2.029 1.747 2.019 1.479 1.323 1.999 0.759
lys 0 0 0 0 0.846 1.396 1.078 0 0 0 0 0 0 0 0 0 0 0 0 0 0
mlt 0 0 0 0 0.795 1.01 0.979 0 0 0 0 0 0 0 0 0 0 0 0 0 0
hxa 2.311 2.184 2.149 2.61 2.9 1.518 2.298 2.697 3.869 2.907 3.027 9.296 5.364 8.235 3.34 2.926 2.574 3.375 2.702 5.059 2.386
fum 0.838 0.897 0.739 0.826 1.831 3.254 2.766 0.894 0.973 0.96 1.262 0.363 0.416 0.481 0.809 0.688 0.535 1.537 0.802 1.111 1.096
succ 1.971 1.693 1.228 1.486 3.619 3.46 3.196 1.685 2.05 1.56 1.872 4.095 2.379 3.066 4.162 4.126 1.563 4.48 3.161 3.158 5.691
lac 12.63 10.22 9.531 9.327 12.66 13.04 13.1 8.811 10.72 9.275 11.35 12.34 5.69 9.907 9.138 8.563 6.313 8.384 4.376 6.727 5.15
mal 0 0 0 0 1.244 2.258 1.758 0 0 0 0 0.349 0.344 0.442 0 0 0 0 0 0 0
octa 3.245 2.877 2.787 3.266 3.817 2.212 2.895 4.924 5.268 4.022 5.277 6.978 3.782 6.377 3.971 3.733 2.528 4.533 3.22 4.973 3.351
itcon 0 0 0 0 12.46 12.6 12.82 0 0 0 0 0 0 0 0 0 0 0 0 0 0
nac 1.594 1.78 1.629 1.865 3.123 2.98 2.353 0.955 0.945 0.687 1.004 1.429 0.951 1.24 2.747 2.114 1.592 0.734 0.861 0.933 0.72
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5.1. ABSTRACT  
The expression of foreign DNA in bacterial cells has been explored by 
using recombinant plasmids. The impact of the expression and 
maintenance of these plasmids in cells is often associated with the 
metabolic burden phenomenon, which consists in the additional 
drainage of cellular resources that often leads to metabolic imbalances. 
We observed that Escherichia coli growth yields and metabolic changes 
were significant in cells harbouring the plasmid pTRC-AcGFP1. The GC-
MS metabolome analysis showed that the intracellular amino acid pool 
was significantly lower, except for unsaturated long-chain fatty acids. 
Less pronounced changes were observed when cells were induced to 
express the recombinant protein, but the expression levels were not 
considerable. However, significant changes in the relative 
concentrations of fatty acids were verified. Some amino acids and TCA 
metabolites levels were also altered. 
Here we demonstrated that metabolic profiling represents a useful 
method to observe metabolic imbalances caused by plasmids 
maintenance and expression. Alterations in the metabolic state of host 
cells harbouring plasmids are significant and might impair important 
cellular functions. 
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5.2. INTRODUCTION 
Recombinant DNA technology offers today the ability to produce foreign proteins in several 
microorganisms, such as the bacterium Escherichia coli. The introduction of a plasmid into 
bacterial cells to express genes from other sources can perturb the host cellular functions at 
many levels. The adjustment of most metabolic activities, to cope with the additional biosynthetic 
requirements, and the consequent adaptation of the transcriptional regulation, to fine-tune the 
levels of catabolic enzymes, interfere with the physiology of the host cell. Most notably, drastic 
changes in the specific growth rate can occur when the recombinant protein synthesis is 
induced. This physiological perturbation is often associated with the metabolic burden that has 
been defined as “the portion of host cell’s resources – either in the form of energy such as ATP 
or GTP, or raw materials such as nucleotides and amino acids – that is required to maintain and 
express foreign DNA in the cell” (Hoffmann F and Rinas U, 2004). Cellular growth and expression 
of foreign gene products in recombinant cells compete for the use of intracellular resources, such 
as amino acids, nucleic acids and metabolic energy. To overproduce these recombinant proteins, 
cellular resources are extensively consumed and a shortage of even one of these resources can 
cause alterations in the cellular metabolism, a condition known as starvation. Since protein 
synthesis, or more specifically the polymerization of amino acids, is the biggest energy-
consuming process in the cell, with more than 50% of the ATP consumption for biosynthetic 
purposes (Stouthamer AH, 1973), energy generation may become critical in recombinant-protein 
overproducing cells.  
Besides metabolic burden, several other consequences of the production of heterologous 
proteins have been referred, like the triggering of various stress responses. The transcription of 
various stress-encoded proteins might be stimulated when cells are exposed to sudden disturbing 
conditions, like the abnormal protein synthesis (Bukau B, 1993; Harcum SW and Bentley WE, 
1999) or the accumulation of inclusion bodies (Ho JGS and Middelberg APJ, 2004; Jurgen B et 
al., 2000; Panda AK et al., 1999), as well as the shortage of biosynthetic precursors, such as 
amino acids (Andersson L et al., 1996; Harcum SW and Bentley WE, 1999). In the last case, if 
the composition of the recombinant protein considerably differs from the average composition of 
E. coli proteins, then, at some point, the intracellular pool of certain amino acids might get 
depleted and the ratio of charged to uncharged tRNAs decreases. This increases the possibility of 
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an unchaged tRNA binding to a translating ribosome, which induces the activity of the RelA 
enzyme (Haseltin WA and Block R, 1973). RelA synthesizes an unusual nucleotide, ppGpp, which 
in a process called stringent response, reprograms gene expression towards the transcription of 
genes involved in amino acids biosynthesis and stress proteins and inhibits the majority of stable 
RNAs (rRNA and tRNA) (Chatterji D and Ojha AK, 2001; Irr J and Gallant J, 1969; Jain V et al., 
2006; Magnusson LU et al., 2005; Srivatsan A and Wang JD, 2008). It also interferes with the 
control of plasmid DNA replication (Potrykus K et al., 2000), although the molecular mechanisms 
of this ppGpp-mediated inhibition of replication remains unclear (Herman A et al., 1994; Wegrzyn 
G, 1999). Thus, the overall alteration in metabolism is the result of a series of cellular processes 
triggered to respond to the metabolic load imposed by the production of heterologous proteins, 
which ultimately leads to the arrest of cellular growth and to the reduction of the recombinant 
protein productivity (Bentley WE et al., 1990).  
In this study, the isogenic mutant ∆relA of E. coli W3110 was chosen as the host cell to study the 
impact of the metabolic burden caused by plasmid DNA maintenance and expression without the 
interference of other subsequently elicited cellular processes. Mutants in the relA gene do not 
contain functional RelA (ppGpp synthetase I), which will limit the ppGpp-induced responses, 
namely the transcriptional activation of stress-regulons associated with cellular mechanisms to 
survive starvation conditions. As detailed above, regulatory responses induced by the ppGpp-
stringent control might be a common problem during recombinant protein overproduction 
(Dedhia N et al., 1997; Sanden AM et al., 2003) and the use of relaxed mutants (∆relA) may 
overcome some of these issues and isolate the metabolic burden phenomenon.  
To better understand and control recombinant cultures, it is important to have a more profound 
knowledge of how the cell couples energy generation and carbon supply in the catabolic 
pathways with the anabolic requirements at different growth rates under producing and non-
producing conditions. Continuous cultivation has been demonstrated (Kim E et al., 1992; 
Maresova H et al., 2001; Vaiphei ST et al., 2009; Zhang WH et al., 2004) to be a useful 
bioprocess tool to study the kinetics of recombinant cultures and to identify the primary 
metabolic bottlenecks associated with the recombinant protein expression. Thus, continuous 
cultivation of the host strain (E. coli W3110 ∆relA) and plasmid-bearing cells (E. coli W3110 
∆relA/pTRC-AcGFP1) were performed in a glucose-limited chemostat at a dilution rate of 0.2 h-1. 
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We aimed to investigate the metabolic profiles at steady-state conditions to evaluate the effects of 
plasmid DNA maintenance and recombinant protein expression in the absence of stress 
responses. A GC/MS-based metabolomics approach to measure the intracellular levels of 
metabolites associated with central metabolic pathways, such as amino and fatty acids, was 
applied.  
 
5.3. EXPERIMENTAL PROCEDURES 
5.3.1. BACTERIAL STRAINS AND GROWTH CONDITIONS 
The ∆relA251 mutant E. coli strain (obtained from M. Cashel (Xiao H et al., 1991)) was 
transformed with the cloned pTRC-HisA vector (Invitrogen Corporation and Applied Biosystems 
Inc, USA) carrying a gfp gene amplified from the pAcGFP1 plasmid for the green fluorescent 
protein AcGFP1, a derivative of GFP from Aequorea coerulescens (Clontech, Takara Bio 
Company, USA). The pTRC-AcGFP1 contains a trc promoter for high-level expression of the fusion 
protein and an ampicillin resistance gene for propagation and selection in E. coli.  
Three different experiments were performed in a minimal medium consisting of 5 g.kg-1 of 
glucose, 6 g.kg-1 of Na2HPO4, 3 g.kg-1 of KH2PO4, 0.5 g.kg-1 of NaCl, 1 g.kg-1 of NH4Cl, 0.015 g.kg-1 
of CaCl2, 0.12 g.kg-1 of MgSO4.7H2O, 0.34 g.kg-1 of thiamine, 2 mL.kg-1 of trace-element solution 
(described elsewhere (Rocha I and Ferreira EC, 2002)) and 2 mL.kg-1 of vitamins solution 
(described elsewhere (Rocha I and Ferreira EC, 2002)). The minimal medium was further 
supplemented with 20 mg.kg-1 of L-isoleucine, 20 mg.kg-1 of L-valine, 100 mg kg-1 of ampicillin 
and 25 mg kg-1 of kanamycin. The first experiment was conducted with the strain E. coli W3110 
(∆relA), while E. coli W3110 (∆relA)/pTRC-AcGFP1) was used in the second and the third one. In 
this last one, induction of AcGFP1 production was performed with 1.5 mM IPTG (isopropyl b-D-
thiogalactoside) when the culture optical density (OD600nm) reached a constant value. 
Chemostat cultivations were operated at 37°C in a 3 L fermenter (BioFlo 3000, New Brunswick 
Scientific, USA) with a working volume of 1.5 L. The described minimal medium was 
continuously fed into the vessel, at least for five residence times, at a dilution rate of 0.2 h−1, and 
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the working volume was kept constant by withdrawing the culture broth through a level control 
system. The pH of the culture was maintained at 7.0 by adding 2.0M NaOH and 2.0M HCl. 
Dissolved oxygen was maintained above 30% saturation through a cascade mode, controlling the 
agitation speed and airflow.  
 
5.3.2. ANALYTICAL TECHNIQUES 
Biomass was determined by measuring culture turbidity (OD600nm) and cell dry weight (CDW). In 
order to determine CDW, 10 mL of broth were filtered by 0.2 µm filters and the filtrate was dried 
in the microwave to a constant weight. For glucose and acetate analysis, culture broth was 
centrifuged at 8000 rpm for 15 min to remove the cell debris and the supernatant was collected. 
The glucose concentration in the culture broth was determined by the dinitrosalicylic acid (DNS) 
colorimetric method (Miller GL, 1959). The concentrations of acetic acid in the culture broth were 
determined with an enzymatic test kit (R-Biopharm AG, Germany).  
The expression level of AcGFP1 was determined by fluorescence measurements at a 2104 
EnVision® Multilabel Reader (PerkinElmer, USA) with excitation and emission wavelengths of 
475 and 505 nm, respectively, and a bandwidth of 8 nm. His-Tag purification of the AcGFP1 was 
performed with HiTrap columns (GE Healthcare Bio-Sciences AB, Sweden) and the concentration 
was determined by the Bradford method using BSA as standard. Plasmids from cell samples 
were isolated using the Illustra™ plasmid Prep Mini Spin Kit (GE Healthcare UK Limited, UK) and 
quantified by a Quant-it assay (Invitrogen Corporation and Applied Biosystems Inc, USA). 
 
5.3.2.1. QUENCHING AND METABOLITE EXTRACTION 
For metabolomics analysis, samples (50 mL) were taken quickly from the fermentor and 
immediately quenched, to halt cellular metabolism, in 200 mL of glycerol/saline solution (60%, 
v/v) at -23 °C, followed by quick homogenization. Samples were centrifuged at 10,000 rpm for 
20 min at -20 ºC using a refrigerated centrifuge. The supernatants were discarded and the cell 
pellets were resuspended in 2 mL of cold glycerol/saline solution (50%, v/v) at -23 ºC, followed 
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by a second centrifugation at 8,000 rpm for 30 min at -20 ºC. The supernatants were again 
discarded and the cell pellets were dissolved in 2.5 mL of cold methanol/water solution (50%, 
v/v) at -30 ºC and stored at -80ºC for subsequent intracellular metabolite extraction. For that, 
samples were subjected to three freeze–thaw cycles with 1 min of vigorous mixing using a vortex 
between each cycle. After the third cycle, samples were centrifuged at 8,000 rpm for 30 min at -
20 ºC and the supernatants were collected and stored at -80 ºC. The extracted pellet was then 
resuspended in another 2.5 ml of cold methanol/water solution (50%, v/v) and centrifuged at 
8,000 rpm for 30 min at -20 ºC. The supernatant was collected and pooled with the first one and 
kept at -80 ºC and, afterwards lyophilized. 
 
5.3.2.2. DERIVATIZATION AND GC-MS ANALYSIS 
For GC-MS analysis samples were further treated as follows. The dried intracellular metabolite 
extracts were resuspended in 200 µL of sodium hydroxide (1 M) and derivatized using the methyl 
chloroformate (MCF) method (Villas-Boas SG et al., 2003). The derivatized samples were then 
analyzed with a GC-MS systems - GC7890 coupled to MSD5975 (Agilent Technologies, Inc., 
Santa Clara, CA, USA) equipped with a ZB-1701 GC capillary column, 30m x 250mm id x 0.15 
mm (film thickness) with a 5 m guard column (Phenomenex, Inc., Torrance, CA, USA) at a 
constant flow rate of 1.0 mL/min of helium. The oven temperature was initially held at 45ºC for 
2 min. Thereafter the temperature is raised with a gradient of 9ºC/min until 180ºC. This 
temperature (180ºC) is held for 5 min. Then the temperature is raised with a gradient of 
40ºC/min until 220ºC. The temperature is again held for 5 min. Then the temperature is raised 
with a gradient of 40ºC/min until 240ºC and this temperature is held for 11.5 min. Finally the 
temperature is raised with a gradient of 40ºC/min until 280ºC, which is held for 2 min. The 
temperature of the inlet is 290ºC, the interface temperature 250ºC, and the quadrupole 
temperature 200ºC. Sample (1 µL) was injected onto the column under pulsed splitless mode 
(1.8 bars until 1 min, 20mL/min split flow after 1.01min) and the detector was set with a scan 
interval of 1.47 seconds and m/z range of 38-650. The mass fragmentation spectrum was 
analysed in The Automated Mass Spectral Deconvolution and Identification System (AMDIS) 
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(Stein SE, 1999) to identify the compounds through matching with a library constructed by using 
analytical chemical standards. 
 
5.3.3. STATISTICAL ANALYSIS 
The mass fragmentation spectrum was analysed using the Automated Mass Spectral 
Deconvolution and Identification System (AMDIS) (Stein SE, 1999) to identify the compounds 
through matching with a library constructed using analytical chemical standards. The peak 
intensity values from the AMDIS analysis were refined and corrected and normalized for the 
recovery of the internal standard (D-4-alanine) and the corresponding biomass concentration. 
Values were then transformed into Z-scores, by subtracting the average peak intensity 
corresponding to a metabolite k among all the n samples (including replicates) in the set of 
experiments, from the peak intensity value (IMK) of that metabolite in one sample, and dividing that 
result by the standard deviation (SDM1..Mn) of all measured n peak intensities, according to: 
( )
nMkMk
n
SD
ImeanI
kscoreZ MkMkMk
...1
1...,
−
=−  
Data analysis was carried out in MATLAB 7.1 (Mathworks, USA). Normality of the data and 
homogeneity of variance were studied using Kolmogorov-Smirnov (KS) and Levene’s tests, 
respectively. One-way ANOVA was applied to compare the means of the relative metabolite 
concentrations, where each sample was representing a particular experimental condition: 
(A) Chemostat cultivation of E. coli W3110 (∆relA) grown at a dilution rate of 0.2 h-1; 
(B) Chemostat cultivation of E. coli W3110 (∆relA)/pTRC-AcGFP1 grown at a dilution rate of 
0.2 h-1; 
(C) Chemostat cultivation of E. coli W3110 (∆relA)/pTRC-AcGFP1 grown at a dilution rate of 
0.2 h-1 and IPTG-induced to express AcGFP1. 
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5.4. RESULTS 
5.4.1. PHYSIOLOGICAL PARAMETERS 
Three aerobic glucose-limited continuous steady-state cultures were performed with the E. coli 
W3110 (∆relA) strain and the plasmid-bearing E. coli W3110 (∆relA)/pTRC-AcGFP1 strain. 
Initially, cells were grown in a batch mode and then the culture was fed at the rate of 300 mL.h-1 
to achieve the desired dilution rate of 0.2 h-1. When the cultivation system reached a steady state 
(i.e., when OD600 becomes constant) samples were collected to determine the cell dry weight 
(CDW), AcGFP1 protein, pTRC-AcGFP1 plasmid, glucose and acetate concentrations. Steady-state 
parameters determined for each culture are summarized in Table 5.1. 
 
Table 5.1. Comparison of the physiological parameters of E. coli W3110 (∆relA) strains 
during glucose-limited chemostats using a dilution rate of 0.2h-1.  
The three E. coli cultures are identified as: (A) W3110 (∆relA) host cells; (B) W3110 (∆relA) harbouring the pTRC-
AcGFP1 plasmid; and W3110 (∆relA)/pTRC-AcGFP1 induced with IPTG 1.5 mM. 
 Strains 
 
 W3110 (∆relA)/pTCR-AcGFP1 
(A) W3110 (∆relA) (B) Non IPTG-induced (C) IPTG-induced 
Dilution rate (h-1) 0.2 0.2 0.2 
CDW (g.L-1) 3.33±0.45 2.69±0.46 2.29±0.39 
YX/G (g.g-1) 0.67±0.30 0.54±0.19 0.46±0.12 
Glucose (g.L-1) 0.023±0.01 0.031±0.0093 0.059±0.011 
qG (g.g-1.h-1) 0.3±0.13 0.37±0.13 0.43±0.11 
AcGFP1 (g.L-1) - - 0.18±0.02 
qAcGFP1 (×10-6) (g.g-1.h-1) - - 15.78±3.21 
Plasmid (mg.L-1) - 21.7±0.28 38.4±1.67 
Acetate (g.L-1) 0.020 0.18±0.0077 0.52±0.024 
qA (×10-3) (g.g-1.h-1) 1.08±0.15 13.15±2.31 45.86±8.14 
CDW, cell dry weight; qG, specific glucose consumption rate (the maintenance coefficient was not considered); qA, 
specific acetate consumption rate; qAcGFP1, specific AcGFP1 production rate; YX/G, mass yield coefficient of 
biomass/glucose. 
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It was observed that:  
− biomass concentration of E. coli host cells is higher than of the plasmid-bearing strain 
(W3110 (∆relA)/pTCR-AcGFP1);  
− the specific glucose consumption rate (qG) increased for plasmid-bearing and producing 
cells;  
− acetate accumulation increased approximately fifty times in the AcGFP1 producing 
culture;  
− intracellular concentration of the pAcGFP1 is higher when cells are induced to express 
the recombinant protein. 
 
5.4.2. EFFECTS OF PLASMID AND ACGFP1 BIOSYNTHESIS ON THE E. 
COLI METABOLISM 
To analyse effects of plasmid DNA maintenance and recombinant protein production on the 
metabolism of E. coli, intracellular metabolites were extracted and analysed by GC-MS. In the 
present study, fatty acids and the main amino acids and their precursors generated in the central 
carbon metabolism were measured in order to evaluate the main metabolic changes imposed by 
the recombinant bioprocess in the host cell. Metabolite profiles corresponding to each chemostat 
culture are depicted in Figure 5.1.  
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Figure 5.1. Comparison of metabolite profiles during chemostat cultures with a dilution rate 
of 0.2h-1 with the following E. coli strains: (A) W3110 (∆relA) host cells; (B) W3110 (∆relA) 
harbouring the pTRC-AcGFP1 plasmid; and (C) W3110 (∆relA)/pTRC-AcGFP1 induced with 
IPTG 1.5 mM.  
Metabolite relative concentrations were normalized into Z-scores and are shown as the average of three 
measurements with the standard deviations. Metabolites that presented significant changes (p-values≤0.05) between 
experiments A/B and B/C are indicated with (∗) and (¥), respectively. Abbreviations: Fatty acids – 14mpdca, 14-
methylpentadecanoate; dca, decanoate; hxa, hexanoate; ocdca, octadecanoate; ocdcea, octadecenoate; octa, 
octanoate; pdca, pentadecanoate; ttdca, tetradecanoate. Amino acids – asp, aspartate; glu, glutamate; gly, glycine; 
ile, isoleucine; leu, leucine; phe, phenylalanine; pro, proline; val, valine. Others – acon-C, cis-aconitate; bnz, 
benzoate; cit, citrate; fum, fumarate; lac, lactate; succ, succinate. 
156 Mapping metabolic-induced changes in recombinant E. coli 
 
To investigate the differences between the three experiments (A, B and C), a one-way ANOVA 
analysis was performed (Figure 5.2). Normality (KS test) and homogeneity of variances (Levene’s 
test) were tested before using ANOVA and both tests returned that the null hypotheses (i.e., data 
come from normal distributions with the same variance) cannot be rejected at the 5% significance 
level (p-values were 0.37 and 0.17, respectively). 
 
 
Figure 5.2. One-way ANOVA analysis (p-value of 5.2E-13). 
 
It was found that metabolic profiles from cells harbouring the recombinant plasmid (B and C) and 
host cells (A) show a significant difference (p-value less than 0.05). However, differences between 
the IPTG induced culture (C) and non-induced were not significant. It can be inferred that plasmid 
burden overlaps the extent of the metabolic load imposed by the expression of the recombinant 
protein. To further investigate these metabolic changes, the intracellular metabolite pools 
produced in culture A were compared to culture B to evaluate the impact of the plasmid 
maintenance in the host cell, and metabolite pools from culture B were compared to culture C to 
determine the solely impact of the expression of the recombinant protein in the cellular 
metabolism.  
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Figure 5.3. Metabolic map illustrating the metabolic changes between the metabolite 
profiles analysed by GC/MS.  
Alterations in the intracellular metabolite concentrations are depicted by a green arrow pointed up, if the ratio of 
metabolite levels of culture B to culture A (first arrow) and culture C to culture B (second arrow) are superior to 1, 
and a red arrow pointed down, if ratios are less than 1. Metabolites that presented significant changes (p-
values≤0.05) between experiments A/B and B/C are indicated with (∗) and (¥), respectively. Acetate was also 
represented as an extracellular metabolite (acex). Abbreviations: g6p, glucose-6-phosphate; 3pg, 3-phospho-D-
glycerate; pep, phosphoenolpyruvate; pyr, pyruvate; accoa, acetyl-CoA; ac, acetate; icit, isocitrate; akg, α-
ketoglutarate; glx, glyoxylate; mal-L, L-malate; oaa, oxaloacetate. For other abbreviations see Figure 5.1. 
 
As illustrated in Figure 5.3, most of the metabolite pools were significantly decreased for the cells 
harbouring the pTRC-AcGFP1 plasmid, except for unsaturated long-chain fatty acids. However, 
when comparing metabolite pools from cultures B and C, it appears that some metabolites 
presented higher levels when cells are induced to express the recombinant protein. Though these 
changes were not significant (p-values higher than 0.05), which poses some uncertainties 
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regarding these variations, differences in the amino acid pools provide important information 
about the metabolic load associated with the protein biosynthetic process. As shown, only two of 
the detected amino acids (aspartate and glycine) presented lower levels when cells were 
producing the recombinant protein, which may indicate that amino acid pools are increased to 
balance the additional biosynthetic requirements. Fatty acids levels were also significantly 
changed when cells were induced with IPTG. For example, octanoate and pentadecanoate 
presented significant lower levels in the protein producing culture. A detailed inspection of Figure 
5.1 reveals that, although not significant, most fatty acids presented lower levels during 
recombinant protein production. 
 
5.5. DISCUSSION 
Continuous culture in a chemostat is a practical way to study the state of host cells during the 
production of recombinant proteins under defined growth conditions. The physiological effects of 
the plasmid burden on the metabolism and the maximum biosynthetic capacity of the host cells 
can be evaluated during a continuous growth for many generations, which present some 
advantages compared to other cultivation modes (Maresova H et al., 2001; Zhang WH et al., 
2004).  
In the present investigation, the estimated physiological parameters, such as qG, qA and qAcGFP1, 
revealed that culture performance by cells harbouring the pAcGFP1 plasmid is quite different 
from the chemostat culture with host cells. Besides the higher qG, the accumulation of the 
metabolic by-product acetate in the plasmid-bearing cultures was significant. It has been 
described (Holms H, 1996; Majewski RA and Domach MM, 1990) that when increasing the 
consumption of glucose, carbon flux through the glycolysis pathway exceeds the TCA capabilities 
and acetyl-CoA is over-accumulated, resulting in the excretion of acetate. Indeed, it is expected 
that to cope with the additional biosynthetic requirements, cells enhance their ability to uptake 
the carbon source (e.g. glucose). As a consequence, glucose overflow leads to the accumulation 
of certain metabolic by-products, like acetate, that are afterwards excreted to the extracellular 
medium. This not only represents a diversion of carbon that might otherwise have been used for 
biomass or recombinant protein synthesis, but, at certain levels a toxicity agent for cells. 
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Reduction of the growth yields and protein expression has been indicated as a result of this 
metabolic state. In fact, biomass concentration decreased from 3.33±0.45 g.L-1 in the host E. coli 
culture (A) to 2.69±0.46 g.L-1 and 2.29±0.39 g.L-1 in non-induced (B) and IPTG-induced (C) 
plasmid-bearing chemostat cultures, respectively. Moreover, acetate levels in the IPTG-induced 
culture reached toxic levels (0.52±0.02 g.L-1), which may be deleterious for cells. The specific 
acetate production rate (qA) increased almost 45 times compared to the culture with host cells.  
This metabolic imbalance was also observed in the metabolite profiles of plasmid-bearing 
chemostat cultures. Metabolic profiling demonstrated that most metabolites from the host cell 
culture (A) presented significantly different levels from those analysed in the plasmid-bearing 
cultures (B and C). These differences were stronger in the amino acids pool, where aspartate, 
isoleucine, leucine, phenylalanine, proline and valine presented lower levels for the plasmid-
bearing culture (between 20-70% less). It seems that either amino acid biosynthesis decreased, 
or the drainage of metabolic resources for plasmid maintenance was superior to their synthesis. 
Plasmids are non-essential DNA molecules, which require additional intracellular resources and 
energy to be maintained in host cells, including for DNA replication and expression of resistance 
gene products (e.g. proteins encoded by an antibiotic resistance marker gene). Several studies 
(Flores S et al., 2004; Ozkan P et al., 2005; Wang ZJ et al., 2006) indicate that the presence of 
plasmids significantly influences various metabolic pathways in the host cells, e.g. glycolysis and 
the pentose phosphate (PP) pathway. On another study, however, TCA enzymatic activities at a 
dilution rate of 0.2 h-1 did not change significantly between plasmid-bearing and non-bearing 
cultures (Wang ZJ et al., 2006). Nevertheless, in the present experiments, the level of TCA 
intermediaries in cultures harbouring the pAcGFP1 plasmid decreased, and more significantly for 
citrate, cis-aconitate and succinate. This might be associated with the drainage of amino acid 
precursors to fulfil the extra requirement for the expression of resistance gene products, which 
are not completely replenished by anaplerotic reactions.  
By combining metabolic flux analyses and DNA microarrays, another study found that the 
phosphotransferase system for glucose uptake and glycolytic and PP pathway genes were up-
regulated in a plasmid-bearing culture when compared with host cells (Wang ZJ et al., 2006). 
These pathways are involved in the generation of NADPH for biosynthetic pathways, recruiting 
essential metabolites for nucleic acids, amino acids and vitamins, and the generation of 
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ingredients of the cell lipopolysaccharide layer (Wang ZJ et al., 2006). Therefore, to supply cells 
for the additional biosynthetic processes, metabolic fluxes through these pathways are probably 
up-regulated. The increased carbon uptake is channelled to the glycolysis and PP pathway and, 
although no experimental data was obtained in our study to confirm this, metabolome data 
indicate that plasmid-induced changes up-regulate certain metabolic enzymes in recombinant 
cells, which could in turn lead to the atypical increase of flux in some pathways. As the glycolytic 
activity increases, the TCA capacity to consume the excess of acetyl-CoA is insufficient and 
acetate is accumulated as a by-product. This is in a good agreement with the experimental 
results that confirmed the increase in qG and qA for plasmid-bearing cultures and the 
simultaneous failure to increase the level of TCA metabolites, most likely because TCA 
intermediates are being consumed for the synthesis of amino acids. 
It is evident that plasmid burden causes the shortage of certain biosynthetic products, namely 
amino acids, generating a metabolic imbalance that might also be responsible for the 
accumulation of some by-products. Yet, it was expected that the metabolism of the bacteria 
would be even more largely affected by the expression of the AcGFP1 under the control of a high-
level expression promoter. The plasmid concentration almost doubled compared with the non-
induced culture, which would represent an increase in the amino acids required for the 
production of the Lac repressor and β-lactamase enzyme, and nucleotides and energy for the 
plasmid DNA replication. In fact, besides cellular resources needed for the synthesis of AcGFP1, 
plasmid maintenance would increase the metabolic load in the IPTG-induced culture. However, 
the observed metabolite profiles did not reflect this phenomenon and only three metabolites, 
benzoate, octanoate and pentadecanoate presented significant different levels between the ITPG-
induced and non-induced cultures. Most fatty acids were characterized by a small decrease when 
cells were induced to produce the recombinant protein, but there are no indications that fatty 
acids biosynthesis is affected during recombinant processes. The increase in some amino acids 
and TCA metabolites levels were not significant, and thus, it is suggested that the increase in qG 
was a consequence of metabolic requisites to replenish precursors for plasmid replication and 
expression, and small differences in metabolite levels resulted from the metabolic unbalance 
caused by these recombinant processes. This study demonstrates that plasmid burden is of 
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major importance when expressing foreign proteins in bacterial cells and, thus strategies to 
enhance recombinant cultivations must consider this as critical. 
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5.7. APPENDIX A 
Relative concentrations of metabolites measured by GC/MS in triplicate samples from chemostat 
cultures: (A) W3110 (∆relA) host cells; (B) W3110 (∆relA) harbouring the pTRC-AcGFP1 plasmid; 
and (C) W3110 (∆relA)/pTRC-AcGFP1 induced with IPTG 1.5 mM. 
 
  
A1 A2 A3 B1 B2 B3 C1 C2 C3
14mpdca 0.186429 0.185507 0.136943 5.283406 5.47573 5.255288 2.041313 1.687848 2.564628
acon-C 0.038408 0.030225 0.025485 0.010684 0.011733 0.00967 0.01763 0.011852 0.023088
asp 0.565733 0.557056 0.514258 0.368158 0.377643 0.319164 0.389346 0.161777 0.418649
bnz 0.114883 0.070905 0.085612 0.055245 0.047175 0.044189 0.026036 0.028837 0.025808
cit 0.337218 0.251821 0.23983 0 0 0 0.146447 0.078008 0.211557
dca 0.102219 0.100025 0.115247 0.124137 0.073598 0.061794 0.027894 0.034146 0.034248
fum 0.301198 0.169623 0.157737 0.060372 0.032003 0.03859 0.021242 0.013923 0.014997
glu 0.736768 0.489133 0.414076 0.188132 0.215817 0.187001 0.334468 0.167956 0.372613
gly 0.360081 0.000339 0.271089 0.200151 0.205155 0.165167 0.190983 0.140309 0.194851
hxa 0.661241 0.571264 0.718048 0.472048 0.436159 0.493936 0.504508 0.564231 0.465243
ile 0.126371 0.153941 0.142446 0.117106 0.087624 0.146101 0.143367 0.081522 0.134098
lac 1.64279 0.925121 0.954811 0.693951 0.578771 0.61849 0.610835 0.676584 0.495655
leu 0.264534 0.298567 0.297116 0.216668 0.191265 0.250048 0.282915 0.17038 0.25006
ocdca 0.289862 0.279734 0.283674 2.376452 2.457453 2.250954 2.364764 2.189778 2.956353
ocdcea 1.313383 1.174697 1.321075 0.625673 0.640545 0.658477 0.90643 0.688921 1.421259
octa 0.888126 0.680638 0.705869 0.73251 0.684583 0.649707 0.533402 0.520965 0.522719
pdca 0.182145 0.084711 0.200047 0.178676 0.193723 0.191308 0.035338 0.027714 0.045461
phe 0.068627 0.081695 0.075779 0.038283 0.042032 0.048652 0.174938 0.102329 0.199001
pro 0.353901 0.312707 0.274698 0.111703 0.099403 0.108202 0.141432 0.098132 0.124664
succ 0.877927 0.668273 0.448312 0.140408 0.089389 0.089135 0.251111 0.247176 0.436227
ttdca 0.676711 0.902067 0.711598 0.780771 0.822851 0.735005 0.430089 0.278018 0.852923
val 0.341881 0.3304 0.32463 0.226384 0.167964 0.18704 0.290087 0.18373 0.284151
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CHAPTER 6 
METABOLIC FOOTPRINT ANALYSIS OF 
RECOMBINANT E. COLI STRAINS DURING  
FED-BATCH FERMENTATIONS 
 
“...in metabolic footprinting the medium is the message.” 
By D. B. Kell. et al in Metabolic footprinting and systems biology:  
the medium is the message,  
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6.1 ABSTRACT 
Metabolic footprinting has become a valuable analytical approach for 
the characterization of phenotypes and the distinction of specific 
metabolic states resulting from environmental and/or genetic 
alterations. The metabolic impact of heterologous protein production in 
Escherichia coli cells is of particular interest, since there are numerous 
cellular stresses triggered during this process that limit the overall 
productivity. Because the knowledge on the metabolic responses in 
recombinant bioprocesses is still scarce, metabolic footprinting can 
provide relevant information on the intrinsic metabolic adjustments. 
Thus, the metabolic footprints generated by Escherichia coli W3110 
and the ∆relA mutant strain during recombinant fed-batch 
fermentations at different experimental conditions, were measured and 
interpreted. The IPTG-induction of the heterologous protein expression 
resulted in the rapid accumulation of inhibitors of the glyoxylate shunt 
in the culture broth, suggesting the clearance of this anaplerotic route 
to replenish the TCA intermediaries withdrawn for the additional 
formation of heterologous protein. Nutritional shifts were also critical in 
the recombinant cellular metabolism, indicating that cells employ 
diverse strategies to counteract imbalances in the cellular metabolism, 
including the secretion of certain metabolites that are, most likely, used 
as a metabolic relief to survival processes.  
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6.2 INTRODUCTION 
The optimization of bioprocesses using recombinant microorganisms is still restrained by the 
lack of information available on the metabolic responses induced by various stress conditions 
(Gnoth S et al., 2008). Significant knowledge could be gained from a comprehensive analysis 
of the metabolic footprint (i.e. extracellular metabolite profiling) by inspecting key metabolic 
changes and understanding their relation with environmental conditions (Allen J et al., 2003; 
Allen J et al., 2004; Kell DB et al., 2005; Kell DB et al., 2003; Pope GA et al., 2007; Villas-
Boas SG et al., 2006; Villas-Boas SG et al., 2008).  
Some work has been published addressing various metabolic responses during the 
production of heterologous proteins in E. coli (Chou CP, 2007). Experimental studies showed 
that the host cell metabolism undergoes a severe metabolic burden, resulting in rapid 
exhaustion of essential precursors and cellular energy (Aldor IS et al., 2005). Typically, 
strong expression systems are employed to assure the production of large amounts of 
heterologous proteins by the host, which uses a large quantity of metabolic and energy 
resources in order to maintain and express the foreign DNA (Seo JH et al., 2003). 
Heterologous protein production is also believed to diminish flow in the TCA cycle through 
the withdrawal of intermediates that serve as precursors for amino acid biosynthesis (Jurgen 
B et al., 2000). Moreover, the difference usually observed in amino acid composition of 
foreign proteins and the average composition of the host proteins contributes to this 
metabolic imbalance (Bentley WE et al., 1990; Bonomo J and Gill RT, 2005; Glick BR, 1995; 
Harcum SW, 2002). 
Stringent response has been associated with the stress phenomenon caused by the depletion 
of certain metabolic resources, namely amino acids (Harcum SW and Bentley WE, 1999). 
The increased level of free tRNA molecules, due to the lack of amino acids, triggers this 
stress response that is characterized by the arrest of the ribosomal translation process and 
the rapid RelA-mediated accumulation of ppGpp (Jain V et al., 2006). This nucleotide has 
been found (Chatterji D et al., 1998; Toulokhonov II et al., 2001; Wu J and Xie J, 2009) to 
bind directly to the RNA polymerase, adjusting the transcriptional activity from the expression 
of genes required for rapid growth, to stress-related genes and amino acid biosynthetic 
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operons (Durfee T et al., 2008; Magnusson LU et al., 2005; Roberts JW, 2009; Srivatsan A 
and Wang JD, 2008). The regulatory mechanisms of this ppGpp-induced stress response are 
known in some detail (Artsimovitch I et al., 2004; Chatterji D and Ojha AK, 2001; Jishage M 
et al., 2002), but the impact of this response on the cellular metabolism has been less 
studied. Knowledge on how these responses take place and how to dodge them is of great 
importance, since E. coli has become one of the most used microbial systems to produce 
heterologous proteins. 
Here, we aimed at investigate the physiological and metabolic changes in E. coli cultures 
during the production of heterologous proteins by performing a metabolic footprinting 
analysis. Furthermore, the focus of the study was not only to evaluate the changes of the 
extracellular metabolite pools during heterologous protein production, but also to assess the 
effect of removing a gene closely related to the initiation of the stringent response (relA) on 
the cellular behaviour. Thus, the W3110 and the isogenic mutant (ΔrelA) E. coli strains were 
grown and induced to produce a heterologous protein (AcGFP1) at different nutritional 
conditions in a controlled fed-batch mode.  
 
6.3 EXPERIMENTAL PROCEDURES 
6.3.1 MICROBIAL STRAINS 
Escherichia coli strains W3110 (F-, LAM-, IN[rrnD-rrnE]1, rph-1) and the isogenic mutant 
containing the ΔrelA251::kan allele (obtained from M. Cashel, National Institute of Health, 
USA) were transformed with the cloned pTRC-HisA-AcGFP1 plasmid encoding the expression 
of the recombinant AcGFP1 protein. The gfp gene was amplified from the pAcGFP1 plasmid 
(Clontech, Takara Bio Company, USA) that encodes for the green fluorescent protein 
AcGFP1, a derivative of AcGFP from Aequorea coerulescens. The PCR product was then 
cloned into the pTRC-HisA vector (Invitrogen Corporation and Applied Biosystems Inc, USA) 
that contains a trc promoter for high-level expression of the fusion protein and an ampicillin 
resistance gene for propagation and selection in E. coli. 
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6.3.2 GROWTH CONDITIONS 
Precultures were prepared in 500-mL shaking flasks filled with 300 mL of minimal medium 
consisting of 5 g.kg-1 of glucose, 6 g.kg-1 of Na2HPO4, 3 g.kg-1 of KH2PO4, 0.5 g.kg-1 of NaCl, 1 
g.kg-1 of NH4Cl, 0.015 g.kg-1 of CaCl2, 0.12 g.kg-1 of MgSO4.7H2O, 0.34 g.kg-1 of thiamine, 2 
mL.kg-1 of trace-element solution (described elsewhere(Rocha I and Ferreira EC, 2002)) and 
2 mL.kg-1 of vitamins solution (described elsewhere(Rocha I and Ferreira EC, 2002)). The 
minimal medium containing additional 20 mg.kg-1 of L-isoleucine and 100 mg kg-1 of 
ampicillin was used to grow the recombinant wild-type strain, while this same medium with 
further addition of 20 mg.kg-1 L-valine and 25 mg.kg-1 kanamycin was used to grow the ΔrelA 
mutant strain. Cells were thereafter washed and transferred to a 5-L fermenter (Biostat MD, 
Sartorius) with a working volume of 2 L containing the same minimal medium, except 
glucose. The fed-batch operation was started immediately after inoculation at 37?C, pH 7 
and dissolved oxygen (DO) above 30%. The feed media used contained 50 g.kg-1 of glucose, 
10 g.kg-1 of NH4Cl, 4 g.kg-1 of MgSO4.7H2O and the additional requirements for amino acids 
and antibiotics as described before. The induction of AcGFP1 production was performed with 
1.5 mM IPTG (isopropyl b-D-thiogalactoside) when the microbial culture reached an OD600nm of 
2.3. Fermentation conditions were monitored and controlled via a computer control system. 
A closed-loop feeding control algorithm was employed to maintain a constant specific growth 
rate (µ) in the fed-batch culture (Rocha I et al., 2008). The algorithm is based on a Monod 
kinetic model using glucose as the only growth-limiting substrate. The model combines terms 
for cell growth (X.µ), glucose consumption (YX/S.Sf) and the online measurement of culture 
medium weight (WR) to control the feeding profile, represented by: 
f
S
X
R
SY
WXF
.
..µ
=
 
The biomass concentration (X) was initially measured by optical density and estimated at 
each acquisition time (every 3 minutes). The predicted growth yields on glucose (YX/S) were 
set to 0.35 and 0.2, when the specific growth rates were set to 0.1 and 0.2 h-1, respectively. 
The fed-batch experiments were at first conducted at µ = 0.1 h-1, corresponding to the pre-
induction (A) and the post-induction (B) phases. Afterwards µ was changed to 0.2 h-1, which 
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was kept during almost 4 hours, corresponding to a nutritional upshift phase (phase C). 
When the feeding was ceased (glucose limitation phase or phase D), growth was followed 
until the OD600nm dropped. 
 
6.3.3 SAMPLING AND ANALYTICAL PROCEDURES 
Cell growth was monitored by measuring optical density (OD600nm) and cell dry weight. In order 
to determine cell dry weight, 10 mL of broth were centrifuged at 10000 g for 20 min at 4ºC, 
washed twice with deionised water and dried at 105 °C to constant weight. The expression 
level of AcGFP1 was determined by fluorescence measurements at a Jasco FP-6200 
spectrofluorometer with excitation and emission wavelengths of 475 and 505 nm, 
respectively, a bandwidth of 10 nm and a high sensitivity response in 0.1 seconds. His-Tag 
purification of the AcGFP1 was performed with HiTrap columns (GE Healthcare Bio-Sciences 
AB, Sweden) and the concentration was determined by the Bradford method using BSA as 
standard. For further analysis, culture samples were centrifuged (15 min, 3000 rpm, 4°C) 
and the resulting supernatants were immediately filtered and collected. Afterwards the 
samples were stored at -20°C for subsequent analysis and lyophilisation. Glucose and 
acetate were analysed by HPLC with a refractive index detector (Jasco, Canada) and a 
Chrompack organic acids column (Varian, USA) at 35ºC. The mobile phase consisted in a 
0.01N solution of H2SO4 at a flow rate of 0.6 mL/min.  
 
6.3.3.1 Derivatization and GC-MS analysis 
One millilitre of the extracellular samples was lyophilized in triplicate. The lyophilized 
samples were then derivatized using the methyl chloroformate (MCF) method (Villas-Boas SG 
et al., 2003) and analyzed with a GC-MS system - GC7890 coupled to an MSD5975 - (Agilent 
Technologies, Inc., Santa Clara, CA, USA) equipped with a ZB-1701 GC capillary column, 30 
m x 250 mm id x 0.15 mm (film thickness) with 5 m guard column (Phenomenex, Inc., 
Torrance, CA, USA), at a constant flow rate of 1.0 mL/min of helium. Samples (1 µL) were 
injected onto the column under a pulsed splitless mode (1.8 bars until 1 min, 2 0mL/min 
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split flow after 1.01 min) and the detector was set with a scan interval of 1.47 seconds and 
m/z range of 38-650. The oven temperature was initially held at 45ºC for 2 minutes. 
Thereafter, the temperature was raised with a gradient of 9ºC/min until 180ºC and held at 
this value for 5 minutes. The temperature was raised again at a gradient of 40ºC/min in 
three steps: until 220ºC (held for 5 min), 240ºC (held for 11.5 min) and finally 280ºC (held 
for 2 min). The temperature of the inlet was 290ºC, the interface temperature 250ºC, and 
the quadrupole temperature 200ºC.  
 
6.3.4 DATA PROCESSING AND STATISTICAL ANALYSIS 
The mass fragmentation spectrum was analysed using the Automated Mass Spectral 
Deconvolution and Identification System (AMDIS) (Stein SE, 1999) to identify the compounds 
through matching with a library constructed by using analytical chemical standards. The 
peak intensity values from the AMDIS analysis were refined and corrected for the recovery of 
the internal standard (D-4-alanine) and normalized with the corresponding biomass 
concentration. The corrected and normalized peak intensity values were thereafter 
transformed into Z-scores for each dataset, which corresponds to a single fermentation. Z-
score values were calculated by subtracting the average peak intensity among all the n 
samples (including replicates) of a fermentation from the peak intensity values (IMK) 
corresponding to each metabolite k, and dividing that result by the standard deviation 
(SDM1..Mn) of all measured n peak intensities, according to: 
( )
nMkMk
n
SD
ImeanI
kscoreZ MkMkMk
...1
1...,
−
=−  
Further data processing and statistical analysis were performed with MATLAB (version 
2009b, The Mathworks, Inc) and MultiExperiment Viewer (MeV) (Saeed AI et al., 2003). 
Hierarchical clustering (HCL) was used to cluster the samples and metabolites based on the 
Pearson correlation metrics and principal component analysis (PCA) was used to visualize 
whether samples could be discriminated based on their metabolic footprints. Component 
coefficients were computed to expose the metabolites that contributed the most to 
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discriminate between sample clusters determined by the HCL analysis, i.e to characterize the 
metabolic shifts, sample clusters defined by HCL were used to determine which metabolites 
suffered the highest alterations. Pearson's correlation coefficients (r) were computed to 
evaluate the degree of association between the metabolite profiles produced by the W3110 
and ∆relA E. coli cultures. p-values associated with each Pearson correlation coefficient was 
calculated using a Student's t distribution to test the null hypothesis (H0) of no significant 
correlation between the metabolite profiles from the two cultures, against the alternative 
hypothesis (H1) that establishes a significant correlation between the profiles. The p-value for 
Pearson's correlation coefficient is based on the test statistic, s, with n-2 degrees of 
freedom: 
21
2
r
nrs
−
−×
=  
 
6.4 RESULTS 
6.4.1 FED-BATCH FERMENTATIONS OF W3110 AND ΔRELA E. COLI 
CELLS 
To elucidate the physiological responses of the W3110 and ΔrelA mutant E. coli strains 
during recombinant fed-batch fermentation, cells were grown aerobically with a closed-loop 
feeding control to maintain a quasi-steady state growth. Fed-batch cultures were started with 
a low specific growth rate setpoint (between 0.09 and 0.16 h-1) and growth characteristics 
were determined prior and after IPTG induction (phases A and B, respectively). Then, the 
glucose feeding rate was increased to maintain the specific growth rate around 0.2 h-1 (phase 
C) to evaluate the impact of nutritional upshift on the E. coli cultures during heterologous 
protein production. Nutrient limitation by ceasing the glucose feeding (phase D) was finally 
examined in these E. coli cultures until growth arrested. 
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Figure 6.1. Growth curves for the W3110 [pTRC-His-AcGFP1] E. coli and the isogenic 
derivative ∆relA251::kan strains cultured in fed-batch fermentations with closed-loop 
feeding control.  
Phases: A- prior to induction; B- after IPTG induction; C- after growth upshift; and D- after nutrient downshift. 
 
In Figure 6.1, biomass, glucose, acetate and AcGFP1 concentrations are depicted for each 
fed-batch culture. Table 6.1 shows the growth parameters determined at each experimental 
condition. As demonstrated, prior to IPTG induction the specific growth rates were similar for 
both strains (around 0.16 h-1), but after IPTG induction the growth of the wild-type strain was 
significantly reduced (0.092 h-1) while the ΔrelA mutant had a specific growth rate of 0.13 h-1. 
In contrast, the AcGFP1 production increased after IPTG induction to a maximum of around 
7×10-3 g.g-1DW.h-1 for both cultures. Upon the nutritional upshift (phase C), both strains 
increased their growth rates and the AcGFP1 production rates. The maximum AcGFP1 
production was determined to be close to 20×10-3 g.g-1DW.h-1 in both cultures. At these 
conditions acetate accumulation was detected in both cultures at rates below 90×10-3 g.g-
1DW.h-1. When the glucose feeding was stopped (phase D) acetate was consumed and growth 
was arrested. However, AcGFP1 production continued until the carbon sources (i.e. glucose 
and acetate) were completely depleted from the medium. 
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Table 6.1. Growth parameters of the fed-batch cultures of the W3110 and ∆relA E. coli 
strains. 
 
Ph
as
es
 
Specific growth 
rate set point  
(h-1) 
Expected 
biomass yield  
(gDW.g-
1substrate) 
Specific rates (g.g-1DW.h-1) 
Biomass 
yield  
(gDW.g-
1substrate) 
µ YX/S μ 
qAcGFP1 
(×10-3) 
qGluc qAc YX/S 
W
31
10
 s
tr
ai
n A 0.1 0.35 0.16±0.020 0.60±0.12 0.30±0.067 - 0.59±0.038 
B 0.1 0.35 0.092±0.023 6.8±4.5 0.29±0.052 - 0.36±0.065 
C 0.2 0.2 0.17±0.023 19±6.0 0.64±0.11 0.089±0.0074 0.26±0.068 
D - - - 5.3±5.8 0.24±0.043 -0.49±0.27 0.31±0.069a 
Δ
re
lA
 m
ut
an
t 
st
ra
in
 
A 0.1 0.35 0.16±0.019 0.60±0.45 0.21±0.016 - 0.62±0.059 
B 0.1 0.35 0.13±0.026 6.9±3.8 0.25±0.036 - 0.48±0.022 
C 0.2 0.2 0.20±0.030 17±1.8 0.56±0.089 0.084±0.0072 0.36±0.010 
D - - - 14±2.1 0.47±0.14 -0.92±0.23 0.04±0.049a 
 
Specific growth rates (μ), AcGFP1 production (qAcGFP1), glucose uptake (qGluc) and acetate formation (qAc).  
aThese parameters were calculated for biomass growth under acetate consumption. 
 
6.4.2 METABOLIC FOOTPRINT ANALYSIS 
Gas chromatography–mass spectrometry (GC-MS) has been widely used in the analysis of a 
large number of compounds such as amino acids, sugars, and organic acids. In this work, a 
GC-MS-based analytical plataform established by Villas-Bôas’ group (Smart KF et al., 2010) 
was used to detect amino and nonamino organic acids secreted by E. coli cells during fed-
batch cultures. Samples harvested at different time points in the fermentation growth phases 
were analyzed and the relative concentrations for each detected metabolite were determined. 
Analytical data was further examined to address any changes in the metabolic footprints 
resulting from the alteration of culture conditions and to verify if the relA gene mutation could 
actually influence the metabolic behaviour of this recombinant E. coli strain.  
A wide variety of metabolites was detected in the extracellular medium, including fatty, amino 
and organic acids (see Figure 6.2) that ultimately resulted from the metabolic activities of 
cells at the various tested conditions. These metabolites were found to be mainly involved in 
the central carbon metabolism, including the tricarboxylic acid cycle (TCA cycle), the 
biosynthesis of amino and fatty acids as well as other energy generating metabolic reactions.  
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Figure 6.2. Schematic diagram of the E. coli metabolic map involving the metabolites 
secreted into the extracellular medium during recombinant fed-batch cultivations.  
The accumulation (or assimilation) of metabolites was evaluated along four phases: the pre-IPTG induction phase 
(A), the post-IPTG induction phase (B), the post-nutrient upshift phase (C) and the glucose limitation phase (D). 
Graphs represent the relative concentration levels of each metabolite in the metabolic footprint along the 
fermentation process for the W3110 strain (dark line) and the ΔrelA mutant (light gray line) cultures. Bold dashed 
lines connecting metabolites and biochemical reactions indicate known inhibitory effects on those reaction-
associated enzymes. Grey boxes represented in the metabolic map indicate other metabolites that participate in the 
metabolism, but were not detected in these experiments. The dashed square lists the detected metabolites with 
unknown biosynthetic reactions in E. coli.  
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However, we detected metabolites such as itaconate, malonate, 2-phenylglycine and 
benzoate that could not be linked directly to any known metabolic pathway of E. coli, 
according to public databases, such as KEGG (Kanehisa M and Goto S, 2000) and EcoCyc 
(Keseler IM et al., 2009), and genome-scale metabolic models, like iAF1260 model of E. coli 
K12 (Feist AM et al., 2007). However, these metabolites are known to participate in 
metabolic reactions of other organisms (Kim YS, 2002; Willke T and Vorlop KD, 2001). 
Therefore, resemblances between enzyme-coding genes from other organisms that produce 
these metabolites with the E. coli genome were investigated, but it was not possible to 
establish with confidence their participation as reactants/products in E. coli reactions. Yet, 
itaconate and malonate have been described as in vitro inhibitors of a key enzyme of the E. 
coli anaplerotic metabolism, i.e.; isocitrate lyase, the first enzyme of the glyoxylate cycle 
(Hoyt JC et al., 1988), indicating that at least these metabolites are likely to be produced 
during E coli growth.  
Principal components analysis (PCA) was performed to investigate whether the samples from 
different fermentation phases could be distinguished based on their metabolic footprints 
profiles and to determine the significant metabolic differences between the W3110 and ΔrelA 
mutant E. coli strains (Figure 6.3).  
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Figure 6.3. Principal component analysis (PCA) 2-dimensional projection of samples from 
fed-batch cultures of E. coli grown at different conditions based on mass fragment profiles 
of extracellular metabolites analysed by GC-MS.  
Each sample is represented by a letter that designates the cultivation phase: samples withdrawn during the pre-
induction phase [A] represented by squares, the post-induction phase [B] by circles, after growth upshift [C] by 
diamonds and after nutrient downshift [D] by triangles; and a number that indicates the sampling sequence in each 
cultivation phase. Samples from the W3110 culture are represented by opened symbols, whereas the ∆relA mutant 
culture samples are depicted by full symbols.  
 
As represented in Figure 6.2, the relative accumulation of metabolites varies during the fed-
batch experiments as the culturing conditions are changed. Some of these variations were 
different in the two recombinant cultures, indicating that the W3110 and ΔrelA mutant E. coli 
strains might respond differently to those experimental conditions. Accordingly, metabolites 
that presented similar profiles are expected to participate in metabolic activities that were 
stimulated in both E. coli cultures. Table 6.2 shows the Pearson's correlation coefficients (r) 
with p-values using a Student's t distribution for testing the hypothesis of no correlation 
against the alternative, which considers the existence of significant correlations between the 
metabolite profiles produced by the W3110 and ΔrelA mutant strains at similar experimental 
conditions.  
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Table 6.2. Correlations between metabolite profiles of two E. coli strains, W3110 and ∆relA 
mutant, during fed-batch fermentation phases: (A) pre-induction phase; (B) IPTG post-
induction phase; (C) growth upshift phase; and (D) nutrient downshift phase.  
Pearson correlation coefficients (r) are given with their p-values. Underlined p-values indicate metabolite profiles that 
are significantly correlated with a 95% confidence level. See metabolite abbreviations in Figure 6.2.  
 A B C D 
 r p-value r p-value r p-value r p-value 
2paac -0.805 0.100 0.182 0.770 0.938 0.062 0.969 0.031 
3c3hmp     (b) 0.338 0.662 
4hbz   (b) (b) 0.280 0.720 
acglu       (a) 
acon-C   0.810 0.097 0.677 0.323 0.190 0.810 
asn       0.515 0.485 
asp   (b) 0.678 0.322 -0.086 0.914 
bnz 0.349 0.565 0.748 0.811 0.860 0.140 -0.353 0.647 
cbm 0.839 0.075 0.972 0.576 0.006 0.424 -0.236 0.764 
cit (a) (a) 0.941 0.059 -0.046 0.954 
fum 0.484 0.409 -0.089 0.887 0.301 0.699 0.063 0.937 
glu   0.766 0.131 0.845 0.155 0.576 0.424 
gly     0.989 0.864 0.011 0.424 
ile       (a) 
itcon   0.983 -0.607 0.003 0.393 -0.418 0.582 
lac   (a) 0.696 0.304 0.829 0.171 
leu       0.954 
mal 
0.046 
(b)     0.120 0.880 
mlt   0.656 0.229 -0.290 0.710 -0.876 0.124 
ocdca -0.342 0.573 0.161 0.795 0.958 0.539 0.042 0.461 
ocdcea       (a) 
phe       (a) 
succ 0.710 0.179 -0.035 0.956 0.834 0.166 0.551 0.449 
ttdca       (a) 
a Undetected in the W3110 culture.  
b Undetected in the ∆relA mutant culture.  
 
PCA analysis (Figure 6.3), on the other hand, shows that the metabolic footprints from the 
pre-induction phase (phase A) are identical for both cultures, but during the production of 
heterologous protein, especially during fermentation phases B to D, these strains behaved 
very differently. When looking at the Pearson correlation coefficients it is evident that during 
fermentation phases B to D the amount of metabolites that did not present significant 
correlated profiles is large. Only a few metabolites were found to be significantly correlated to 
each other. For example, in the last phase only 2-phenylglycine (2paac) and leucine (leu) 
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profiles were significantly correlated with 95% of confidence. The other seventeen 
metabolites detected in both cultures, at these conditions, presented profiles that were not 
considered significantly correlated. In fact, some of these metabolites presented negative 
correlations, evidencing opposing tendencies regarding their accumulation in the extracellular 
medium. Moreover, some metabolites were only detected in one of the fed-batch cultures, 
which indicates that E. coli strains were at different metabolic states. For example, the 
accumulation of isoleucine (ile), phenylalanine (phe), acetyl-L-glutamate (acglu), 
octadecenoate (ocdcea) and tetradecanoate (ttdca) was only detected in the fed-batch culture 
with the ΔrelA mutant strain during the last fermentation phase.  
Although the distinct metabolic states between the ΔrelA mutant and W3110 strain may result 
from changes associated with the genetic perturbation (i.e. relA gene mutation), we cannot ignore 
the intrinsic metabolic variability that is common to most metabolic systems. As reported 
previously (Steuer R et al., 2003), intrinsic metabolic fluctuations may arise because organisms 
are never in the same exact metabolic stage, even when growing in the same conditions, and 
small differences in enzyme concentrations may also affect metabolite concentrations. Thus, to 
better understand these differences, the metabolic footprints from each culture were further 
examined by clustering analysis (Figures 6.4 and 6.5). 
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Figure 6.4. Analysis of the metabolic footprint profiles obtained from fed-batch aerobic 
culture of E. coli W3110.  
(a) Hierarchical clustering (HCL) distinguished four data classes (vertical clusters), corresponding to extracellular 
samples taken during each fermentation phase, and several metabolite clusters (horizontal clusters) that 
characterized the metabolic footprint profiles during the recombinant fed-batch cultivation. (b) Principal component 
analysis (PCA) was performed to determine the most significant metabolic changes in the extracellular medium when 
growth conditions were changed: (I) induction of the heterologous protein expression; (II) nutritional upshift; and (III) 
glucose downshift. Principal component coefficients (represented by metabolite vectors) depicted metabolites that 
contributed the most to discriminate between sample clusters defined by the vertical clusters in the HCL analysis. 
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Figure 6.5. Analysis of the metabolic footprint profiles obtained from fed-batch aerobic 
culture of E.coli ∆relA mutant strain.  
(a) Hierarchical clustering (HCL) distinguished four sample clusters (vertical clusters) and several metabolite clusters 
(horizontal clusters). Here, sample clusters did not correspond to each fermentation phases, but illustrate data 
classes that are characterized by different metabolic states defined by the metabolite footprints detected during the 
recombinant fed-batch cultivation. (b) Principal component analysis (PCA) was performed to determine the most 
significant metabolic changes in the extracellular samples classified in each sample cluster. Principal component 
coefficients (represented by metabolite vectors) depicted metabolites that contributed the most to discriminate 
between sample clusters. 
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Hierarchical clustering (HCL) was used to evaluate the metabolic footprints produced by cells 
during the fed-batch fermentations. As shown in Figure 6.4a, for W3310, samples from the 
same fermentation phase were clustered together, which indicates that those samples have 
similar metabolite profiles. Metabolite clusters evidenced the association between metabolite 
patterns generated along the fermentation process. The starting hypothesis is that 
metabolites that show a similar variation are related, a relation that conveys information 
about their proximity or function within the metabolic map. For example, the metabolite 
profiles of citrate (cit), aspartate (asp), 4-hydroxybenzoate (4hbz), cis-aconitate (acon-C) and 
itaconate (itcon) were custered at these experimental conditions, meaning that in the W3110 
E. coli culture these metabolites follow a same pattern. 
Similarly, samples from the recombinant ΔrelA mutant grouped into four major clusters 
(Figure 6.5a). However, in this particular case, samples were clustered differently. Samples 
from phase A clustered together, but samples taken immediately after IPTG induction 
(triplicate samples from B-1 to B-3) clustered together with samples from phase A. The 
following samples from phase B (i.e. samples B-4 and B-5) clustered separatedly. This 
indicates that changes in the metabolic footprint profiles were not immediate after the IPTG 
induction, as observed in the W3110 culture. Only in the late stage of this fermentation 
phase that changes in metabolite profile were detectable. Samples taken immediately after 
nutrient downshift (triplicate samples D-1 and D-2) clustered with samples from phase C, 
which indicates that these samples have metabolic profiles more similar to samples from 
phase C than from to those from phase D. This can be due to the fact that, at this sampling 
time, cells were still consuming the excess of glucose accumulated during phase C (see 
Figure 6.1). The other samples from phase D clustered separatedly. In this fed-batch culture, 
metabolites were not clustered in the same groups as observed in the W3110 E. coli culture, 
which reflect the existence of important differences in the metabolic footprints produced by 
the ΔrelA mutant cells. For example, the 4-hydroxybenzoate (4hbz) is, at these conditions, 
clustered with asparagine (asn), 2-isopropylmalate (2paac) and tetradecanoate (ttdca).  
Besides the observed differences between the metabolic footprints produced at particular 
growth conditions, differences between the set of metabolic variables that better 
characterized each phase (i.e. principal component coefficients represented by vectors) were 
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also explored. Thus, in the next subsections details are exposed on the key metabolites 
involved in the alteration of the metabolic footprints when cells were: (I) induced to express 
the heterologous protein; (II) submitted to nutritional upshift; and (III) submitted to glucose-
limited conditions. 
I - Impact of the IPTG induction on the metabolic footprint. Figure 6.4b shows that the 
metabolites with the highest positive coefficients in PC2 (malonate (mlt), itaconate (itcon) 
and cis-aconitate (acon-C)) had their levels increased after IPTG induction in the E. coli 
W3110 culture. Similarly, these metabolites also presented high positive coefficients in 
PC1of samples from ∆relA mutant culture (Figure 6.5b). In addition, itaconate and cis-
aconitate were clustered using a Pearson correlation metrics, as represented in the HCL 
diagrams (Figure 6.4a and Figure 6.5a) presenting a strong association between their levels 
along both fed-batch fermentations.  
II - The impact of the nutrient upshift on the metabolic footprint. Figure 6.4b shows 
that glycine (gly), succinate (succ), lactate (lac), citrate (cit), aspartate (asp), 4-
hydroxybenzoate (4hbz), cis-aconitate (acon-C) and itaconate (itcon) are the most significant 
variables that explain the differences projected in PC1 (positive coefficients), which are the 
differences between growth phases B and C of the E. coli W3110 culture. In fact, as 
illustrated in Figure 6.4a they were grouped in the same metabolite cluster and represent 
those that were highly accumulated after the nutrient upshift. Similarly, positive coefficients 
for PC1 and negative for PC2 of the ∆relA mutant culture (Figure 6.5b) exposed these 
metabolites as the most relevant variables characterizing the samples after nutrient upshift, 
except for the hydroxybenzote (4hbz) and itaconate (itcon).  
III – The impact of the glucose limitation on the metabolic footprint. In the W3110 E. 
coli culture (Figure 6.4b), negative coefficients projected in the PC1, corresponding to 
leucine (leu), asparagine (asn), 2-isopropylmalate (3c3hmp) and glutamate (glu), showed the 
largest differences after nutrient downshift. These metabolites were also clustered by HCL 
(Figure 6.4a). The principal coefficients of metabolic footprints from the ∆relA mutant culture 
(Figure 6.5b) depicted glycine (gly), succinate (succ) and lactate (lac) as adjacent vectors 
corresponding to metabolites that were immediately assimilated after glucose limitation.  
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6.5 DISCUSSION 
The metabolic footprint analysis is supported on the basis that cells can secrete metabolites 
to the extracellular medium during growth and/or in response to environmental changes 
(Arana I et al., 2004; Lin HY et al., 2004; Srinivasan S et al., 1998). Furthermore, cells may 
activate a variety of efflux transporters that work like metabolic relief valves or defensive 
support to survive an antagonistic environment (Van Dyk TK et al., 2004). In the first case, 
an increase in extracellular metabolites would be associated with an increase in the 
intracellular concentration of those compounds, while in the second case there would be a 
gradient that has to be maintained by the cells to achieve specific purposes. In general, the 
variety and level of the secreted metabolites reflect the metabolic state of the cell and, 
therefore, may be considered the closest indicator of the phenotype (Fiehn O, 2002; Kell DB 
et al., 2005; Raamsdonk LM et al., 2001; Villas-Boas SG et al., 2005). Considering this, and 
the fact that the metabolic impact of recombinant protein expression in the host cells is still 
not well-understood, the metabolic footprints of the recombinant W3110 and ΔrelA mutant E. 
coli cells grown at different experimental conditions were analysed.  
The metabolic responses of E. coli cells were evaluated by measuring some physiological 
parameters, such as the cellular growth and acetate formation (Figure 6.1 and Table 6.1). 
Results corroborated previous works (Bentley WE et al., 1990; Bonomo J and Gill RT, 2005; 
Harcum SW, 2002), indicating that the decrease on the cellular growth is the major 
consequence of the metabolic burden on the recombinant host cells due to higher demands 
of energy and amino acids. The drainage of energy and biosynthetic precursors associated to 
the expression of foreign proteins imposes severe changes in the metabolic activity of cells 
and, as a result, reduces the cellular growth. As shown, upon IPTG induction, the specific 
growth rate of the W3110 and ∆relA mutant E. coli strains decreased 50% and 32%, 
respectively. The ∆relA mutant strain seems to be less affected, which can be explained by 
the failure to stimulate the RelA-dependent stringent response, a stress response that has 
been proposed (Andersson L et al., 1996; Haddadin FT and Harcum SW, 2005; Harcum SW 
and Bentley WE, 1999) to occur when there is a lack of intracellular amino acids associated 
with the additional requirements for the production of recombinant products. Ultimately, this 
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stress response may induce a decrease of cellular growth and protein production. When 
increasing the nutrient availability, cells can generate sufficient metabolic and energetic 
resources for the formation of the heterologous protein, as well as for growth-associated 
processes, and as a result no physiological differences between cultures were observed. 
However, it was expected that at nutrient deprived conditions (phase D), the physiological 
responses of the two strains would be, at some extent, distinct. Besides the substrate uptake 
rates, the estimated physiological parameters did not show significant differences between 
the W3110 and ΔrelA mutant E. coli cultures. Cellular growth was rapidly arrested and 
formation of the heterologous protein decreased to similar levels, which did not allow to 
deduce any fundamental alterations in the cellular metabolism caused by the single gene 
mutation. Nevertheless, the analysis of extracellular metabolites was invaluable to determine 
the main consequences on the physiology of E. coli cells derived from the relA mutation and 
the experimental conditions.  
As previously reported (Arana I et al., 2004; Lin HY et al., 2004), E. coli cells secrete 
metabolites according to the adjustments needed in the cellular metabolism to cope with 
different physiological demands. A small, but considerable number of metabolites 
characterized the metabolic footprints produced during the fed-batch processes and their 
level fluctuations were inspected to estimate their relationship with the intracellular metabolic 
changes. Metabolic footprints allowed not only to discriminate between samples withdrawn at 
different fermentation phases, but also to disclose the main metabolic changes that were not 
evidenced by the physiological characterization of the fed-batch cultures. As illustrated in 
Figure 6.4a, samples from the W3110 E. coli fed-batch culture were discriminated according 
to the fermentation phases, which defined clusters with characteristic metabolic properties. 
In contrast, samples from the ΔrelA mutant E. coli culture (Figure 6.5a) were not equally 
clustered. When cells were induced to express the heterologous protein (I) or submitted to 
glucose-limiting conditions (III), the metabolic footprints observed before and immediately 
after these experimental shifts were equivalent. Samples taken immediately after IPTG 
induction (i.e. samples from B-1 to B-3) were clustered with samples from phase A and 
samples withdrawn after ceasing the glucose feeding (i.e. samples D-1 and D-2) were 
clustered with samples from phase C, indicating that the metabolic changes were more 
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significant at the late stage of this fermentation phase. Nevertheless, it is noteworthy that, 
when cells were submitted to nutritional upshift, there were clear metabolic changes in the 
footprints that established a separate cluster (i.e. samples from phase C were clearly isolated 
from the previous phase). 
Metabolites were clustered according to their relative concentration profiles measured along 
the fermentation phases and revealed the existence of some correlations between 
metabolites. Although most metabolites presented unrelated profiles, some were consistently 
grouped in both experiments. For example, glycine (gly), cis-aconitate (acon-C), citrate (cit), 
aspartate (asp) and itaconate (itcon) were clustered together in both HCL analyses, which 
indicates that these metabolites can be, at some degree, interrelated. Indeed, citrate and cis-
aconitate are neighbours on the metabolic network (i.e. cis-aconitate is an intermediate in 
the enzymatic isomerization of citrate to isocitrate in the TCA cycle) and itaconate and cis-
aconitate are both enzymatic inhibitors of the first enzymatic reaction of the glyoxylate shunt 
(i.e. isocitrate lyase). Nevertheless, it should be emphasized that metabolite correlations that 
were consistent between the W3110 and ∆relA mutant experiments, should be examined 
with care. Metabolite correlations that arise from changes that influence a large number of 
cellular functions (e.g. RelA-dependent responses) are the hardest to interpret in terms of the 
underlying biochemical network. Therefore, to further understand these observed 
“associations” between the metabolite levels and to investigate their changes according to 
the environmental conditions (e.g. IPTG induction), metabolic footprints from each culture 
were independently analysed. 
Regarding IPTG induction of heterologous protein expression in the W3110 E. coli fed-batch 
culture, a set of metabolites were depicted as key elements characterizing the metabolic 
changes associated with this experimental transition. Three carboxylic acids (malonate, 
itaconate and cis-aconitate) were secreted into the culture broth (Figure 6.4b) suggesting 
that they were released from the cells to prevent any inhibitory effects on the activity of the 
isocitrate lyase. As mentioned before, cis-aconitate and itaconate, as well as malonate (Hoyt 
JC et al., 1988), are inhibitors of this enzyme, controlling the activity of the first reaction of 
the glyoxylate shunt that was reported (Wittmann C et al., 2007) as serving an anaplerotic 
function in the cell during heterologous protein production. Since several TCA intermediates 
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are withdrawn from the TCA cycle as amino acid precursors and need to be replenish, these 
anaplerotic reactions are central to balance the intracellular levels of TCA metabolites, 
fulfilling this way the additional biosynthetic requirements associated with the formation of 
the heterologous protein. This could be a plausible assumption, given that induced 
recombinant cells undergo severe metabolic burden counteracted by the activation of 
anaplerotic reactions, and the simultaneous secretion of the abovementioned inhibitors may 
indicate a key point at which the metabolic regulation has changed.  
The ∆relA mutant strain response to the IPTG induction was also manifested by the 
accumulation of the same enzymatic inhibitors: malonate, cis-aconitate and itaconate (see 
Figure 6.5b). Yet, HCL analysis showed that the metabolic footprints produced immediately 
after IPTG induction did not discriminate these samples from the previous fermentation 
phase. Moreover, the metabolic footprints generated after IPTG induction were distinct when 
compared with the W3110 culture and those differences were sufficient to distinguish 
samples from the two strains (Figure 6.3). Also, most metabolites did not present significant 
correlated patterns (i.e. p-values below 0.05) between the two cultures during phase B and 
others showed to have a negative correlation, such as succinate and fumarate (Table 6.2). 
Although some of the changes on the metabolite levels could be associated with the intrinsic 
variability of this kind of experiments, the overall metabolic patterns and the accumulation of 
certain metabolites only detected in the ∆relA mutant culture (e.g. acetyl-L-glutamate (acglu)) 
may result from changes on the cellular metabolism that were not equivalent in the two E. 
coli cultures.  
Despite the extensive knowledge on basic aspects such as the changes of growth rates with 
nutrient concentrations (Ferenci T, 1999; Hua Q et al., 2004; Lendenmann U and Egli T, 
1998; Marr AG, 1991; Tweeddale H et al., 1998), information on the effects of the 
nutritional upshift during recombinant processes on the metabolic footprint is still scarce. In 
general, studies are focused in the secretion of acetate, not only because it retards growth 
and inhibits protein formation, but also because it represents a deviation of carbon that 
might otherwise be used to generate energy and precursors for biosynthetic purposes 
(Eiteman MA and Altman E, 2006; Suarez DC and Kilikian BV, 2000; Van de Walle M and 
Shiloach J, 1998). In this study, a glucose feeding upshift was applied to increase the 
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specific growth rate during heterologous protein production and the metabolic footprints were 
analysed. Numerous metabolites were immediately accumulated in the extracellular medium 
of the W3110 culture after glucose availability increased, such as glycine (gly), 4-
hydroxibenzoate (4hbz), lactate (lac), citrate (cit), cis-aconitate (acon-C), itaconate (itcon), 
succinate (succ), fumarate (fum) and aspartate (asp) (Figure 6.4b). The increasing metabolic 
activity associated with a high rate of glucose consumption resulted in the accumulation of 
most intracellular metabolites, including TCA intermediaries, amino acids and amino acid 
precursors. Moreover, acetate was also accumulated during this fermentation phase resulted 
from the glucose overflow metabolism. It was reported (Majewski RA and Domach MM, 
1990) that in the presence of excess glucose, the carbon flux through glycolysis exceeds the 
capacity of the TCA cycle and acetate is accumulated. The same set of metabolites, except 
the 4-hydroxibenzoate and itaconate, were also accumulated during the ∆relA fermentation 
process at these conditions, which indicate that metabolic adjustments induced by the 
nutrient upshift resulted in similar alterations in the metabolic footprints from both strains. 
Although some metabolite patterns revealed significant differences (Figure 6.3), in general, 
these were less significant than in any other phase. The accumulation of lactate at these 
conditions was found intriguing. Since the conversion of pyruvate to lactate in E. coli is 
usually exclusively induced at anaerobic conditions (Clark DP, 1989; Tarmy EM and Kaplan 
NO, 1968), the presence of this by-product implies that the internal accumulation of pyruvate 
due to the metabolism overflow overrides any other mechanism known to control the activity 
of the lactate dehydrogenase (LdhA) enzyme under aerobic conditions (Jiang GR et al., 2001) 
or, for some reason, local oxygen deficiencies during the E. coli fed-batch process have 
triggered the ArcAB system and other genes involved in the mixed acid fermentation pathway 
(Xu B et al., 1999). The latest assumption seems improbable, as good mixing conditions and 
dissolved oxygen values above 30% were maintained inside the reactor. 
Finally, the metabolic responses to nutritional stress associated with the restriction of 
glucose feeding during recombinant E. coli processes were also evaluated. It is remarkable 
the amount of metabolites found to be secreted after glucose downshift. Besides the 
decreasing levels of metabolites that can serve as carbon sources for E. coli (e.g. acetate), 
the accumulation of unexpected metabolites, like amino acids (e.g. leucine (leu), asparagine 
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(asn), L-glutamate (glu) and aspartate (asp)) and amino acid derivatives (e.g. 2-
isopropylmalate (3c3hmp)), indicate that the cells accumulated these biosynthetic precursors 
as a consequence of the reduced activity of the protein translation machinery, as estimated 
by the experimental AcGFP1 formation rates (Table 6.1). It is acknowledged that under 
nutrient starvation E. coli cells entail complex protective processes that ultimately manage 
the cellular metabolism to sustain cellular maintenance and viability (Matin A, 1991; 
Neubauer P et al., 1995; Nystrom T, 1999). Apparently the RelA-dependent response is 
involved in these metabolic readjustments, as the metabolic footprints exhibited by the wild-
type and ∆relA mutant E. coli cultures were divergent (Figure 6.3). Major differences were 
found in the citrate (cit), fumarate (fum), malate (mal) and aspartate (asp) profiles, which 
indicate that the fine-tuning of the TCA fluxes after glucose depletion and subsequent acetate 
assimilation were differently coordinated. Furthermore, when comparing the metabolite 
patterns of both strains after nutrient downshift, we found that acetate utilization by E. coli 
cells has a strong effect on the accumulation of several metabolites, especially in the ∆relA 
mutant strain. Metabolites such as phenylalanine (phe), isoleucine (ile), leucine (leu), acetyl-
L-glutamate (acglu) and octadecenoate (ocdcea) were accumulated in the medium of the 
∆relA mutant culture shortly after acetate consumption has started (data shown in Appendix 
A). Under these conditions, acetate is converted to acetyl coenzyme A (accoA) at the expense 
of ATP which, in turn, is mainly catabolised via glyoxylate cycle that serves as anaplerotic 
reactions (Brown TD et al., 1977). This shift in the utilization of carbon sources involves the 
activation of various cellular processes, including the synthesis of new catabolic enzymes 
and the activation of substrate-specific transport systems. It seems that the metabolic 
imbalance caused by these metabolic activities coupled with the additional formation of 
heterologous protein is the basis for the accumulation of several metabolites, including 
amino acids, that was more critical in the ∆relA strain. During glucose starvation the 
translational apparatus, as well as cellular growth, are limited via transcriptional control of 
several growth-associated genes, like ribosomal operons. The ppGpp-stringent control has 
been related to this cellular response to nutritional deprivation that redirect the RNA 
polymerase transcriptional activity from stable RNA (ribosomal and transfer RNA) synthesis to 
stress-related genes, in particular genes that have protective functions. In the absence of the 
RelA activity, the ppGpp accumulation is limited and the translational apparatus stays 
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unaffected. This seems to be the main cause for the only slight reduction of heterologous 
protein production rate in the ∆relA mutant. However, while protein production seems to be 
unaffected by nutrient starvation, bacterial growth was arrested in this strain, probably by 
action of responses mediated by other stress proteins. These facts apparently generated an 
imbalance in the mutant strain’s metabolism (probably due to differences in amino acid 
composition between heterologous and average E. coli proteins) that was evidenced by the 
accumulation of some amino and fatty acids. For example, the synthesis of fatty acids is 
known to be inhibited during glucose starvation, which did not seem to happen in the mutant 
strain. However, since these compounds had not been used for biomass production, there 
was an accumulation of octadecenoate (ocdcea) and tetradecanoate (ttdca) in the ∆relA 
mutant strain. Moreover, isoleucine (ile), acetyl-L-glutamate (acglu) and phenylalanine (phe) 
were also accumulated at these conditions by the ∆relA mutant strain. It seems evident that 
the failure to accumulate ppGpp at these conditions allowed a continuous production of 
heterologous protein (although slightly reduced) resulting in an unbalanced drainage of 
precursors. Some metabolites were gradually replenished while others (less required for the 
production of AcGFP1) were over-accumulated. The fact that most metabolic resources were 
probably redirected to the formation of AcGFP1, may explain the higher protein synthesis 
rate and lower biomass yield observed for the ∆relA mutant strain when compared to the 
W3110 strain. It is clear that the relA mutation influences the natural cellular responses to 
nutritional downshifts, which can delay, or even suppress, E. coli survival and resistance.  
 
6.6 CONCLUSIONS 
Although the characterization of metabolites in E. coli culture broths has been performed 
using various detection methods, such analyses are mostly confined to specific metabolites 
and have not been done in a global scale. For example, the secretion of acetate during 
aerobic E. coli fermentations is regularly measured, because it is considered a major 
obstacle to enhanced heterologous protein production. However, the present work reveals 
that the complexity of the generated metabolic footprints at different culture conditions is 
much higher than what has been admitted. As demonstrated, E. coli secretes a vast array of 
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metabolites that participate in a wide range of metabolic pathways. Although the metabolism 
in E. coli has been studied more intensively than in any other bacterium, only recently it has 
become clear that targeted studies do not provide an accurate picture of the cellular 
metabolism. A typical metabolomic approach is expected to generate new knowledge from 
the comprehensive analysis of the metabolome and the distinctive metabolic patterns 
produced at different environmental and genetic conditions.  
Metabolic footprints resulted from the IPTG-induction of heterologous protein expression have 
shown that there is a rapid accumulation of unexpected metabolites in the culture broth. The 
secretion of the isocitrate lyase inhibitors suggest that the anaplerotic glyoxylate shunt was 
activated to replenish the TCA intermediaries engaged in the additional formation of 
heterologous protein. Moreover, the detection of compounds unknown to participate in E. coli 
metabolism reinforces the importance of unbiased analytical approaches in research. 
When cells are exposed to conditions of nutrient-excess, the uncoupling of maximum glucose 
uptake rates and the TCA fluxes results in a metabolic overflow with consequent 
accumulation of metabolites. Not only acetate and lactate were secreted at these conditions, 
but also TCA intermediaries (e.g. fumarate, succinate, citrate and cis-aconitate) and some 
amino acids (e.g. aspartate and glycine). Assuming that the demand for metabolic resources 
for cellular growth and heterologous protein production is exceeded, the secretion of these 
metabolites can be understood as a metabolic relief required to avoid adverse effects from 
the imbalanced cellular metabolism (Kell DB et al., 2005).  
At nutrient-limited conditions (i.e. when glucose feeding was discontinued), some of these 
metabolites (e.g. acetate) were assimilated by the cells as carbon and energy sources. These 
metabolic activities coupled with the additional formation of heterologous protein may have 
resulted into severe rearrangements in the cellular metabolism that led to the secretion of 
amino acids like: phenylalanine, asparagine, isoleucine and leucine and the acetyl-L-
glutamate. Once again, these metabolic imbalances were more pronounced in the ∆relA 
strain, which fails to trigger RelA-dependent processes to respond to nutrient deprivation. 
The metabolic flexibility exposed by the alterations in the metabolic footprints, evidenced that 
cells entail diverse cellular mechanisms to sense and rapidly counteract the adverse 
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environmental conditions. This stringent behaviour was prevalent in the W3110 strain, while 
the ∆relA strain showed some difficulties to cope immediately with the metabolic imbalances 
caused by the formation of heterologous protein. However, at nutrient-excess conditions, 
when none of cellular processes dependent on the activity of RelA are triggered, the 
metabolic behaviour of both strains was not significantly divergent. It is evident that, although 
some disadvantages might have been indicated concerning the metabolic behaviour of the 
∆relA strain (e.g. failure to manage metabolic imbalances), the enhanced production rate of 
heterologous protein represents a major benefit.  
Metabolic footprinting, more than most other analytical strategies, is a rapid and non-invasive 
analysis, representing a powerful approach for the characterization of phenotypes and the 
distinction of specific metabolic states due to environmental or genetic alterations. 
Nevertheless, metabolic footprints are just a shallow representation of the metabolic state of 
cells and the full understanding of the underlying mechanisms controlling these metabolic 
imbalances caused by the heterologous protein production, require further inspection of key 
metabolites (e.g. metabolites that are important nodes in the metabolic network) or the 
combination with other experimental strategies (e.g. gene expression  and proteomics). 
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6.8 APPENDIX A 
Details on the accumulation of several metabolites that occurred immediately after the acetate 
consumption by the ∆relA mutant strain. 
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6.9 APPENDIX B 
Relative concentrations of metabolites measured by GC/MS during during fed-batch fermentation 
phases: (A) pre-induction phase; (B) IPTG post-induction phase; (C) growth upshift phase; and (D) 
nutrient downshift phase. 
  
A-1 A-2 A-3 A-4 A-5 B-1 B-2 B-3 B-4 B-5 C-1 C-2 C-3 C-4 D-1 D-2 D-3
RelA 82.10 75.10 65.67 67.59 52.79 37.11 30.71 31.03 28.26 29.51 13.58 5.47 6.55 5.20 6.61 14.86 18.65
W3110 0.00 0.00 49.69 43.87 44.11 26.69 26.49 31.71 27.22 18.53 12.96 7.65 6.50 4.41 4.37 10.73 15.37
RelA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10.11 10.32
W3110 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.93 12.66 11.69 14.58
RelA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 40.49 38.02
W3110 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 18.35 18.77 22.83 24.33 38.82 33.31 34.12 29.50 35.67
RelA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 16.95
W3110 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
RelA 0.00 0.00 0.00 0.00 0.00 19.12 18.08 23.79 23.05 28.02 34.88 43.76 53.36 49.32 50.67 43.43 44.07
W3110 0.00 0.00 0.00 0.00 0.00 31.63 35.66 44.77 37.26 43.55 59.27 78.10 87.36 63.29 43.52 34.19 50.55
RelA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10.76 12.11
W3110 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.23 14.62
RelA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 335.71 399.53 566.06 446.41 452.35
W3110 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 147.47 261.84 449.27 611.85 464.45 392.30 385.79 587.31
RelA 99.27 237.23 97.72 82.85 69.65 139.22 111.20 81.75 53.54 85.61 48.21 41.70 36.75 33.40 40.36 25.45 13.45
W3110 106.67 84.15 66.99 46.07 64.69 86.83 91.33 38.06 49.03 31.50 60.48 46.45 22.07 34.67 17.45 10.63 25.02
RelA 6242.49 5025.13 5461.03 5344.66 4218.20 3301.16 2557.74 2212.88 1711.03 1455.14 1382.78 1043.24 813.88 704.99 826.24 585.38 541.48
W3110 4956.60 2926.65 3867.89 2722.77 2705.70 2674.03 2198.67 1847.86 1669.44 1087.78 993.32 1127.34 977.15 701.19 479.61 319.42 657.91
RelA 0.00 0.00 0.00 0.00 78.98 80.51 93.38 77.93 115.41 170.56 328.04 448.05 760.24 790.86 980.42 865.33 812.91
W3110 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 662.70 748.55 1267.47 1075.61 814.33 596.28 916.43
RelA 60.78 84.10 61.30 45.39 0.00 43.06 38.16 42.07 32.37 44.99 71.97 75.96 79.21 49.98 57.14 83.07 35.66
W3110 293.16 169.46 130.45 92.17 94.17 104.08 120.45 43.32 46.69 28.32 80.69 199.34 128.11 115.33 46.85 40.18 59.20
RelA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 14.76 23.82 35.72 46.53 20.70 24.80 21.98 29.85 93.21 72.56
W3110 0.00 0.00 0.00 0.00 0.00 0.00 0.00 28.21 25.36 20.60 43.76 29.91 33.89 20.53 25.15 59.57 56.84
RelA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 17.81 21.07 22.24 8.85 0.00
W3110 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 13.12 13.67 20.71 24.11 12.65 6.05 7.25
RelA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.05
W3110 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
RelA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6.51 6.41 5.15 4.70 6.21 4.75 5.70 4.44 4.10
W3110 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.30 9.63 9.37 12.52 8.58 9.13 4.75 3.90 7.99
RelA 0.00 0.00 0.00 0.00 0.00 48.06 44.89 44.77 23.15 29.12 331.81 485.40 362.85 314.29 360.00 208.28 0.00
W3110 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 360.20 660.66 405.34 546.27 205.78 0.00 0.00
RelA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.03
W3110 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.84
RelA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 28.85
W3110 228.62 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 37.40 27.88
RelA 0.00 0.00 0.00 0.00 0.00 43.00 43.10 42.08 28.24 35.71 22.92 17.66 17.71 17.59 19.00 16.22 9.90
W3110 0.00 0.00 0.00 0.00 0.00 58.70 59.74 29.47 28.39 22.32 19.24 35.54 17.98 18.93 7.86 6.59 16.54
RelA 35.98 26.64 31.30 0.00 0.00 18.57 11.76 12.19 11.02 8.80 9.79 5.50 4.93 4.97 5.28 9.40 9.97
W3110 0.00 28.70 28.14 29.49 17.32 14.12 11.18 17.61 13.25 13.26 11.12 8.32 6.83 6.41 6.68 7.94 12.01
RelA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.00
W3110 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
RelA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.08
W3110 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
RelA 91.13 70.38 62.28 46.94 0.00 48.06 49.37 64.37 31.34 41.08 215.78 320.51 351.03 331.99 453.26 348.24 194.09
W3110 139.98 144.66 99.95 38.27 66.04 63.99 94.94 27.75 41.78 35.10 183.20 460.51 392.42 561.66 262.73 149.03 207.66
RelA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 17.39 31.05 41.79
W3110 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
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CHAPTER 7  
 
CONCLUSIONS AND OUTLOOK 
 
 
“...stress emerges when there is a demand-capability imbalance.” 
 
By HI McCubbina and JM Patterson in The Family Stress Process: 
The Double ABCX Model of Adjustment and Adaptation, 
Marriage & Family Review, 1983; 6(1):7-37 
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This thesis investigated the extent of metabolic changes induced by recombinant protein 
production in E. coli cells and, more specifically, the influence of the stringent response during 
recombinant bioprocesses. Metabolomics approaches based on a GC/MS method were at the 
core of these studies and supported the identification of potential metabolic bottlenecks that may 
be behind some hindering phenomena during recombinant bioprocesses. 
To capture the metabolic behaviour of E. coli cells when overexpressing recombinant proteins, a 
hybrid modelling approach was developed (see Chapter 3). The main purpose of this modelling 
approach was to estimate, at a systems-level perspective, the degree of metabolic burden 
imposed by recombinant biosynthetic processes and to predict the induction of stress-responsive 
events, in particular the ppGpp-induced stringent response triggered by intracellular amino acids 
shortages. As exemplified, the withdrawn of amino acids for recombinant proteins formation 
normally exceeds the biosynthetic capacities of the E. coli cells, a phenomenon aggravated by the 
differences in the amino acid composition of recombinant and biomass proteins. As reported in 
previous studies, drainage of amino acids may result in the sudden induction of the RelA enzyme 
activity, which synthesizes ppGpp above basal levels (Chatterji D and Ojha AK, 2001; Goldman E 
and Jakubowski H, 1990; Rojiani MV et al., 1989; Wendrich TM et al., 2002). The pleiotropic 
effects of this global regulator have been described (Chang DE et al., 2002; Durfee T et al., 
2008; Traxler MF et al., 2006), but besides inducing amino acid biosynthetic genes there is little 
knowledge about its effects on the overall cellular metabolism.  
Therefore, the RelA activity was studied both in recombinant and non-recombinant cultures 
applying a metabolomics approach. First, it was fundamental to understand the influence of the 
RelA activity in the E. coli metabolism at different growth conditions. Chapter 4 presented a 
metabolic profiling analysis of E. coli W3110 and the isogenic ∆relA mutant cells performed to 
characterize the activity of this enzyme under different growth conditions. Apparently, the relA 
mutation affects the metabolic behaviour of E. coli strains, in particular at lower dilution rates. 
For example, it was observed that E. coli cells lacking the relA gene presented a “relaxed” 
phenotype that may have led to important shortages in certain metabolites (e.g. amino acids). 
Moreover, it was suggested that (directly or indirectly) the RelA enzyme might be involved in the 
synthesis of ppGpp when cells are grown in nutrient-deprived conditions, which potentiates the 
expression of several stress-response genes, namely the transcriptional regulator cAMP receptor 
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protein (Crp) that governs catabolite repression (Traxler MF et al., 2006). This points to the idea 
that RelA-mediated ppGpp synthesis is fundamental for the coordination of several metabolic 
responses to cope with nutritional deprivations. 
After exploring the influence of the relA mutation in the E. coli W3110 cells’ metabolism, it was 
proposed to investigate if this gene mutation can actually bring any productivity advantages 
during recombinant processes, as it has been previously reported (Dedhia N et al., 1997; Sanden 
AM et al., 2003). First, to isolate the impact of recombinant biosynthetic processes from the 
RelA-mediated metabolic responses to potential amino acid shortages, a chemostat culture with 
E. coli W3110 ∆relA [pTRC-His-AcGFP1] was performed (Chapter 5). The metabolic profiles of 
host cells were evaluated to investigate the metabolic impact of biosynthetic activities required to 
maintain the plasmid DNA and recombinant protein expression. It was found that plasmid burden 
did significantly change the metabolic profiles of the host cells. It was also evident that plasmid 
burden caused the shortage of certain biosynthetic products, namely amino acids, generating a 
metabolic imbalance that might also be responsible for the accumulation of some by-products, 
like acetate. Second, to inspect the metabolic rearrangements associated with the relA mutation 
and the simultaneous production of recombinant protein, fed-batch cultures with recombinant E. 
coli W3110 and ∆relA cells were performed (Chapter 6). Although some studies have shown that 
cells that carry a relA mutation are able to produce higher amounts of recombinant protein 
compared to cells with the stringent (relA+) phenotype (Harcum SW and Bentley WE, 1999), those 
did not explore the impact of this mutation in the metabolism of host cells, which may ultimately 
impair cellular survival. A different metabolomic approach, i.e. metabolic footprinting, was 
devised to estimate the metabolic responses engendered by these cells during the recombinant 
bioprocess. The metabolic footprints from recombinant E. coli W3110 and ∆relA cultures were 
compared and it was observed that “relaxed” phenotypes (i.e. ∆relA cells) are less effective to 
stimulate certain metabolic changes, as demonstrated by the delay in the metabolic shift after 
IPTG-induction. Metabolic profiles of chemostat cultures with non-recombinant E. coli W3110 and 
∆relA cells were studied in Chapter 4. It was suggested that “relaxed” phenotypes might be 
inefficient when inducing certain metabolic activities that are required to adjust the cells’ 
metabolism, in particular those that are dependent on the ppGpp-mediated regulation, like 
anaplerotic functions. Moreover, metabolic footprints revealed that metabolic imbalances were 
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less pronounced in the E. coli cells carrying the relA gene. Although the productivity levels were 
higher in the E. coli ∆relA cells, the unexpected accumulation of various metabolites in the 
extracellular medium, most likely due to the inability to cope with metabolic imbalances caused 
by recombinant processes, indicates that this cellular system needs to be fine-tuned during 
recombinant bioprocesses. An option could be the supplementation of the culture medium with 
amino acids, but it must be acknowledged that though it is a straightforward alternative it may 
induce severe metabolic constraints, since the excess of some amino acids can stimulate the 
inhibition of certain amino acid biosynthetic pathways, creating an imbalance in the metabolism. 
Thus, to enhance the productivity of recombinant proteins, it is crucial to reach a finer balance 
between strain improvement strategies and culturing conditions. This is the primary goal of 
biosystems engineering in recombinant bioprocesses to meet the increasing demands of 
industry.  
Altogether, the major outcomes of this thesis contributed significantly to understand the 
metabolic impact caused by the recombinant protein production and the participation of the RelA 
enzyme to mediate a series of metabolic adjustments to cope with such demands. It is expected 
that this information will further contribute to improve the proposed model for the stringent 
response (Chapter 2). Although modelling approaches are still reliant on bioinformatic and 
mathematical developments needed to incorporate omics data and, most importantly to manage 
the complexity of dynamic processes to be modelled, these findings imply that major metabolic 
changes are stimulated during the RelA-mediated stringent response and, most likely, are closely 
related with recombinant-induced metabolic imbalances. Ultimately, it is envisioned to create a 
modelling framework that represents the metabolic behaviour of recombinant cells after ppGpp 
synthesis has been induced. The integration of new dynamic descriptions that represent these 
ppGpp-mediated processes in the metabolic network of E. coli will improve model predictability 
when analysing the behaviour of recombinant systems. As previously stated (Hoppe A et al., 
2007; Ow DS et al., 2009) flux distributions predicted by FBA are hypothetical and strongly 
dependent on the cellular objective, and it has been demonstrated that under certain 
environmental or genetic conditions (e.g. recombinant microorganisms) this approach does not 
provide the best description of the underlying physiological state of the cells. Therefore, the 
extension of FBA with other modelling approaches is foreseen to increase the reliability of FBA 
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results and assess new metabolic bottlenecks that must be considered in such systems. For 
instance, anaplerotic pathways need to be further inspected as they seem to be implicated both 
in responses to metabolic burden caused by recombinant processes and in the stringent 
response. Eventually, fluxomics and proteomics data will expose more details about these 
metabolic activities, providing more detailed models of the E. coli metabolism useful for the 
simulation of recombinant processes. 
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